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Summary 
It is widely accepted that achieving the highest and most equitable levels of 
health of populations through the most rational use of resources is the 
ultimate goal of national and international policymakers, public health officials 
and health professionals at large. However, doing this depends upon 
understanding the burden of disease, its distribution and causes in a given 
population and the effectiveness of different preventive, curative and palliative 
interventions that can reduce these burdens. 
 
Demand for comparable cause-specific mortality data of high quality has 
grown due to increased pressure to meet ambitious short-term goals and 
targets set by the international donor community. Robust data are urgently 
needed to assist policy makers and health planners in setting intervention 
priorities, the allocation of resources, and the analysis of the equity and 
effectiveness of health interventions and systems. 
 
The counting of births, deaths by age and sex, and documentation of causes 
of death is the norm for all routine vital registration systems implemented 
throughout the developed world.  But in most developing countries, routine 
empirical data on population burden of disease are usually missing, or at best, 
grossly incomplete due to the lack of systems and resources to support their 
collection and documentation.  
 
Mortality surveillance systems or surveys using verbal autopsy have the 
potential to provide invaluable data for informing the health system on the 
burden of disease, and for monitoring and evaluating of the impact of different 
health and health system interventions as they are being implemented. The 
sentinel surveillance platform that includes the Ifakara, Rufiji and AMMP 
Demographic Surveillance System sites in Tanzania offers a great opportunity 
to examine this potential. 
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The goal of this thesis was to explore a variety of innovative approaches to 
evaluating the implementation of health interventions and their impact on child 
survival in Tanzania.  
 
This was pursued by analyzing the burden of disease for the period from 
2000-2002 in the rural areas of Kilombero and Ulanga district in which a 
population of approximately 65,000 people is under continuous surveillance. I 
also examined health systems access for pregnant women and children 
younger than five in a rural area in Rufiji district by combining demographic 
surveillance systems with geographic information systems in a population of 
approximately 70,000 people in 12,000 households.  Using a sentinel 
surveillance platform in a non-randomised “plausibility” design across the four 
districts of Kilombero, Ulanga, Morogoro Rural and Rufiji, the thesis also 
examines the child survival effectiveness, cost and impact of the integrated 
management of childhood illness (IMCI). 
 
The main findings were: 
 42% of mortality in children younger than five years of age occurred 
due to conditions that are well known and for which Districts have the 
technology to prevent or treat. 
 Spatial access to health care by children and pregnant women in Rufiji 
District was similar with an average travel time to a health facility of 
less than 1 hour. 
 Facility based IMCI improved quality of care and was associated with a 
13% reduction in mortality in children younger than five in intervention 
districts. 
 The costs of child health care in districts implementing IMCI was similar 
to or lower than those in comparison districts. 
 Introduction of IMCI led to improvements in child health that did not 
occur at the expense of equity. 
 Changes in the programmatic delivery strategy of vitamin A 
supplementation improved coverage in Tanzania and has been 
sustained for more than three years. 
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 Delivery of high dose of vitamin A supplementation in mothers and 
children less than six months of age was well tolerated, but did not 
confer any important absolute effect on morbidity. 
 
Experience gained from the studies documented in this work can contribute to 
the body of knowledge on the estimation of causes of death, inform future 
evaluations, and help to shape child health policy in Tanzania and other 
similar settings. The need for robust, representative routine demographic and 
health statistics is critical for the monitoring and evaluation of health 
interventions and systems. The model recently proposed by the Health 
Metrics Network provides this opportunity for more countries. Investing in the 
strengthening of health systems, including health information sub-systems 
such as sentinel surveillance, is necessary if strategies like IMCI are to be 
prioritized and implemented effectively. IMCI implementation was successful 
in Tanzania because of the strong health system support that existed. 
Although results form the DHS 2004 and from sentinel surveillance indicate 
dramatic improvements, overall, infant and under five mortality rates are still 
unacceptably high. Achieving the Millennium Development Goal of reducing 
the 1990 level of child mortality by two-thirds by 2015 will require intensified 
efforts and new interventions to prevent deaths from major killers of children in 
Tanzania which include malaria, pneumonia, diarrhoea, under nutrition and 
perinatal causes. Wider and more equitable coverage is required, especially 
for the districts that are still lagging behind in the implementation. 
 
This thesis shows that important progress can be made with a practical mix of 
population based evidence used in a health systems approach. 
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Zusammenfassung 
Es gilt als unbestritten, dass das Streben nach dem bestmöglichen 
Gesundheitszustand der Bevölkerung bei gleichzeitig rationalem 
Ressourceneinsatz und höchster Verteilungsgerechtigkeit das ultimative Ziel 
von nationalen und Gesundheitspolitikern, von Gesundheitsbeamten und von 
Gesundheitsfachleuten im Allgemeinen darstellt. Der Erfolg solcher 
Bemühungen hängt vom Verständnis von der Krankheitslasten sowie ihrer 
Ursachen und ihrer Verbreitung innerhalb einer gegebenen Bevölkerung 
sowie von der Wirksamkeit der verschiedenen präventiven, kurativen und 
palliativen Behandlungen ab. 
 
Die ehrgeizigen und kurzfristigen Ziele und Vorgaben der internationalen 
Gebergemeinschaft haben die Nachfrage nach vergleichbaren, qualitativ 
hochstehenden und ursachenspezifischen Daten zur Sterblichkeit wachsen 
lassen. Verlässliche Daten werden dringend benötigt, um 
Entscheidungsträger und Planer im Gesundheitsbereich bei der Definition von 
Massnahmenprioritäten, beim Ressourceneinsatz und bei der Analyse der 
Verteilungsgerechtigkeit und Wirksamkeit von Gesundheitsmassnahmen und 
-systemen zu unterstützen. 
 
In den entwickelten Ländern ist die statistische Erfassung der Geburten und 
Todesfälle, aufgeschlüsselt nach Alter und Geschlecht, und die 
Dokumentation der Todesursachen in der Vitalstatistik Standard. In den 
meisten Entwicklungsländern hingegen fehlen solche empirischen 
Routinedaten über die Krankheitslasten in der Bevölkerung, oder sie sind, im 
besten Falle, sehr unvollständig, da Systeme zur Erfassung und 
Dokumentation solcher Daten inexistent sind und dafür auch keine Mittel 
bereitstehen. 
 
Mortalitätsüberwachungssysteme (Demographic Surveillance Systems, DSS) 
oder andere Beobachtungssysteme, die auf Befragungen basieren, können 
den Gesundheitssystemen unschätzbare Daten über die Krankheitslast der 
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Bevölkerung liefern. Diese Daten sind ausserordentlich wertvoll für die 
Beobachtung und Beurteilung der Wirksamkeit der unterschiedlichen, die 
Gesundheit oder die Gesundheitssysteme betreffenden Massnahmen – und 
zwar bereits während ihrer Implementierung. Die Sentinel Surveillance 
Platform, die Resultate aus verschiedenen Regionen Tansanias, in denen 
Daten durch Demographic Surveillance Systems DSS gewonnen werden 
(Ifakara, Rufiji und AMMP), zusammenfasst, bietet die unschätzbare 
Möglichkeit, dieses Potential zu überprüfen. 
 
Das Ziel dieser Dissertation war es, verschiedene innovative Ansätze zur 
Evaluation der Implementierung von Gesundheitsinterventionen und ihrer 
Auswirkungen auf die Überlebenschancen von Kindern in Tansania zu 
analysieren. 
 
Dieses Ziel wurde durch eine Analyse der Krankheitslast während der Jahre 
von 2000 bis 2002 in den ländlichen Regionen des Kilombero- und des 
Ulangadistrikts verfolgt, in denen annähernd 65'000 Einwohnerinnen und 
Einwohner unter ständiger demographischer Beobachtung stehen. Ich habe 
ausserdem den Zugang zu Gesundheitsdiensten für schwangere Frauen und 
Kinder unter fünf Jahren in den ländlichen Gegenden des Rufiji Distrikts 
untersucht (ca. 70'000 Einwohnerinnen und Einwohner in 12'000 Haushalten), 
indem ich Daten aus DSS mit Daten aus geographischen 
Informationssystemen (GIS) kombiniert habe. Die Arbeit untersucht 
ausserdem die Überlebenschancen von Kindern („child survival 
effectiveness“) sowie Kosten und Nutzen von Integrated Management of 
Childhood Illness (IMCI) auf der Grundlage der Sentinel Surveillance Platform 
in den vier Distrikten Kilombero, Ulanga, Morogoro Rural und Rufiji im 
Rahmen eines nicht-zufälligen Plausibilitätsansatzes („non-randomised 
plausibility design“). 
 
Die Hauptergebnisse lassen sich so zusammenfassen: 
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• 42% der Sterblichkeit bei Kindern unter fünf Jahren lässt sich 
bekannten Ursachen zuschreiben, für die Präventions- und 
Behandlungsmöglichkeiten im Distrikt vorhanden sind. 
• Im Rufiji-Distrikt ist der Zugang zu Gesundheitsdiensten für Kinder und 
schwangere Frauen ähnlich: durchschnittlich beträgt die Distanz zur 
nächsten Gesundheitseinrichtung weniger als eine Stunde. 
• In jenen Distrikten, in denen IMCI zur Anwendung kommt, verbesserte 
sich durch das in Gesundheitseinrichtungen basierte IMCI die 
Behandlungsqualität und reduzierte sich die Sterblichkeit bei Kindern 
unter fünf Jahren um 13%. 
• Die Kosten für die Gesundheitsfürsorge bei Kindern in Distrikten mit 
IMCI waren gleich hoch oder fielen geringer aus als in den 
Vergleichsdistrikten. 
• Die Einführung von IMCI führte zu einer Verbesserung der Gesundheit 
von Kindern ohne negative Folgen für die Verteilungsgerechtigkeit. 
• Veränderungen in der Verteilstrategie von Vitamin-A-Beigaben haben 
deren Verfügbarkeit in Tansania nachhaltig verbessert, sie konnte über 
mehr als drei Jahre aufrechterhalten werden. 
• Die Abgabe von hohen Dosen von Vitamin A-Beigaben an Mütter und 
Kinder unter sechs Monaten wurde gut aufgenommen, ohne allerdings 
einen wichtigen absoluten Effekt auf die Sterblichkeit zu zeitigen. 
 
Die Erkenntnisse aus den Studien in dieser Arbeit können dazu beitragen, das 
Wissen um mögliche Todesursachen zu vermehren und künftige Evaluationen 
zu verbessern. Sie helfen bei der Gestaltung einer Gesundheitspolitik für 
Kinder in Tansania und in anderen Ländern in vergleichbarer Situation. Der 
Bedarf nach verlässlichen, repräsentativen und routinemässig erhobenen 
demographischen und Gesundheitsstatistiken ist zentral für die Beobachtung 
und Evaluation von Massnahmen und Systemen im Gesundheitsbereich. Das 
jüngst vom internationalen Health Metrics Network vorgeschlagene Modell 
bietet diese Möglichkeit für zahlreiche Länder. Investitionen in die Stärkung 
von Gesundheitssystemen, und dazu gehören auch 
Gesundheitsinformationssysteme wie Sentinel Surveillance, sind notwendig, 
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sollen Strategien wie IMCI priorisiert und wirksam implementiert werden. Die 
Einführung von IMCI in Tansania war deshalb erfolgreich, weil das 
Gesundheitssystem diese Strategie sehr unterstützt hat. 
 
Obwohl die Ergebnisse des Demographic and Health Survey 2004 und 
andere Erhebungen dramatische Verbesserungen aufzeigen, sind die 
Sterblichkeitsraten für Säuglinge und Kinder unter fünf Jahren noch immer 
inakzeptabel hoch. Soll das im Millennium Development Goal formulierte 
Teilziel, die Kindersterblichkeitsrate von 1990 bis ins Jahr 2015 um zwei 
Drittel zu reduzieren, erreicht werden, so sind in Tansania verstärkte 
Anstrengungen und neue Massnahmen erforderlich, um die den fünf 
Haupttodesursachen zuzuschreibenden Todesfälle zu verhindern (Malaria, 
Lungenentzündung, Diarrhoe, Unterernährung und perinatale Ursachen). 
Notwendig ist eine breitere und gerechtere Abdeckung, gerade auch für jene 
Distrikte, die bei der Implementierung von Massnahmen immer noch 
zurückbleiben. 
 
Die Arbeit zeigt auf, dass durch eine Kombination bevölkerungsbasierter 
Ergebnisse mit einem Gesundheitssystemfokus wichtige Fortschritte erzielt 
werden können. 
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INTRODUCTION 
1.1 Millennium Development Goals 
In September 2000, the world’s largest gathering of Heads of State at the 
United Nations Millennium Summit met to resolve action on the most pressing 
problems of humanity (United Nations 2001). A declaration, endorsed by 189 
countries, was then translated into a roadmap setting out goals to be reached 
by 2015. This declaration is what has become to known as the eight 
Millennium Development Goals (MDGs) (Millennium Assembly of the United 
Nations 2000). The MDGs build on agreements made at United Nations 
conferences in the 1990s, represent commitments to reduce poverty and 
hunger, and to tackle ill-health, gender inequality, lack of education, lack of 
access to clean water and environmental degradation.  
 
 
 
 
 
 
 
 
                   
Improving health received considerable prominence in the MDGs. Three out 
of eight goals, eight of the 16 targets and 18 of the 48 indicators relate directly 
to health: maternal and perinatal conditions, diseases affecting infants and 
children and major communicable diseases. Targets for each goal were 
developed to help assess and monitor progress. The three health related 
goals are MDG 4,5 and 6. MDG-4 specifically calls for a reduction in under-
five mortality by two-thirds, MDG-5 sets a target to reduced maternal mortality 
by three quarters and MGD-6 pledges to combat HIV/AIDS, malaria and other 
diseases over 25  years between 1990 and 2015. 
 
Millennium Development Goals 
1. Eradicate poverty and hunger 
2. Achieve universal primary education 
3. Promote gender equality and empower women 
4. Reduce child mortality 
5. Improve maternal health 
6. Combat HIV/AIDS, TB, malaria and other diseases 
7. Ensure environmental sustainable 
8. Develop global partnership for development 
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Since their adoption, these time-bound goals have been criticized as over-
ambitious, immeasurable and therefore inadequate to guide progress (Attaran 
2005),  and too biased towards communicable diseases, ignoring the 
increasing non-communicable diseases epidemic in developing countries 
(WHO 2005b;WHO 2005c). Despite this, the goals have been widely accepted 
as a framework to stimulate increased efforts to achieve social and economic 
development. 
 
In 2005, world leaders gathered at the UN to review progress and reaffirm 
their commitment (United Nations 2005) . While some countries have made 
impressive gains, many more are falling behind. Progress is particularly slow 
in many countries of sub-Saharan Africa (Sachs & McArthur 2005). The 
reasons are many, including lack of preventive care and treatment, fragile 
health systems, and socio-economic stagnation due to conflict, instability and 
AIDS. Cambodia and Iraq are countries in other regions where conflict has 
slowed or even reversed progress. Countries like Bangladesh and Tanzania, 
have made important progress recently, even then though their economies 
are very poor.  Bangladesh has reduced maternal mortality from 514 in 1989 
to 382/100,000 live births in 2001 (AbouZahr & Wardlaw 2001).  Tanzania has 
reduced infant mortality  from 100 in 1995-1999 to 68/1000 live births in 2004 
respectively (Tanzania National Bureau of Statistics & Macro International 
Inc.Calverton 2005).  
 
In less than 10 years, in 2015, governments of the world will meet again to 
assess whether the world’s community has achieved these mostly widely 
ratified and loudly trumpeted set of development goals ever signed onto by 
every country in the world (United Nations 2001).  
 
1.2 Child survival 
The Child Survival Revolution was launched in 1982 by the late Executive 
Director of UNICEF Dr. James P. Grant (United Nations International 
Children’s Emergency Fund)  (UNICEF 1996).  Major international 
organizations that were active in child health, regional and national leaders 
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pledged their support to the initiative. In many countries, substantial progress 
in reducing child mortality was made in the 15 years that followed. Globally, 
under five mortality on average fell by 21% from 117 in 1980 to 93 per 1000 
live births in 1990 (UNICEF 2001).  
 
Unfortunately, during the 1990s, this momentum was lost, and the trends that 
were observed earlier either stagnated or even reversed (Ahmad, Lopez, & 
Inoue 2000;Bryce et al. 2003b;Bryce et al. 2005). Estimates show that more 
than 10 million children younger than five years continue to die each year 
(Ahmad, Lopez, & Inoue 2000), a majority of whom come from low and 
middle-income countries. They continue to bear the brunt of almost one third 
of the total burden of disease and worse still, 40% of all under five deaths 
occur in newborn babies (Lawn, Cousens, & Zupan 2005a). Two thirds of all 
under five deaths could be prevented by interventions that are available and 
affordable in low income countries today (Jones et al. 2003b). Although 
HIV/AIDS rates are high, it’s emergence has yet to become a major threat to 
child survival in Africa (Walker, Schwartlander, & Bryce 2002).  
 
Two series of The Lancet – Child survival (Black, Morris, & Bryce 2003;Bryce 
et al. 2003a;Claeson et al. 2003;Jones et al. 2003a;Victora et al. 2003) and 
Neonatal survival (Darmstadt et al. 2005;Knippenberg et al. 2005;Lawn, 
Cousens, & Zupan 2005b;Martines et al. 2005) have helped to focus attention 
and reinvigorate the efforts to reduce child and newborn deaths and hence to 
achieve MDG-4. More published reports on progress in child survival are 
being published annually by country (Adjuik et al. 2006;Ahmad, Lopez, & 
Inoue 2000;WHO 2005a), and trends are extrapolated (Child Mortality 
Coordination Group 2006) to see whether the countries are likely to achieve 
the goals or not. Public commitments to investing more in reducing child 
deaths have been made by international community leaders from WHO and 
UNICEF (Mason 2005). More efforts have now been put into forming global 
and synergistic alliances with one and the same aim of improving maternal, 
newborn and child health.  
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1.3 Global Health Initiatives 
The advent of the new millennium has brought a different perspective on 
global health aid. There is more money now than ever before directed towards 
improving health especially in poor countries. More than a dozen massive new 
efforts have been created, including the Global Fund to Fight AIDS, 
Tuberculosis and Malaria which has committed more than $4.9 (The Global 
Fund 2006) billion to 131 countries, the US President’s Emergency Plan for 
HIV/AIDS Relief (PEPFAR) that has pledged $15 billion for five years to 
selected countries (US Department of State Bureau of Public Affairs 2003), 
Global Alliance for Vaccine and Immunization with $3 billion is assisting 72 
countries to vaccinate more that 100 million children, potentially sparing more 
than 1 million from premature death due to Haemophilus influenzae B, 
pertussis, hepatitis B, measles and other disease. The World Bank has also 
pledged to implement global antimalaria scheme worth up to $1 billion over 5 
years (World Bank 2005).  
 
Some of the major donors supporting such partnerships and global health 
initiatives come outside the health care industry and many Global Health 
Initiatives are public:private partnerships. Together they have committed more 
than $35 billion to fight diseases of the world’s poor (Cohen 2006). At the 
forefront of these efforts is the Bill and Melinda Gates Foundation, which since 
1999 has pledged approximately $6 billion (Bill and Melinda Gates Foundation 
2006), roughly the budget of the World Health Organization (WHO) during the 
same time to fight HIV/AIDS, malaria, tuberculosis and other long under 
funded diseases.  
Despite the mobilization, the Macroeconomics and Health Commission 
estimates on the resources required to meet global public health needs are 
unfortunately still short of the requirements. An estimated $30 billion is 
needed in aid per year ($27 billion by 2007, rising to $38 billion by 2015) 
(Sachs 2001). Current health-related annual transfers are in the order of 
magnitude of about $8 billion. There are also concerns about the lack of 
global health architecture (Godal 2005). There is considerable confusion on 
how these new entities fit together, as well as how they mesh with traditional 
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agencies such as WHO, United Nation’s Children’s Fund (UNICEF) and the 
World Bank.  The UNAIDS report  (UNAIDS 2005) and the Paris declaration 
(OECD-DAC Development Cooperation 2005) together call for increased 
efforts in harmonisation, alignment and managing aid for results with a set of 
actions and indicators that are easy to monitor. 
 
1.4 Health Sector Reforms in Tanzania 
Health sector reforms are a dynamic process; many countries have gone 
through them and will continue doing so if their health systems are to respond 
to the changing needs and the environment. Tanzania like most developing 
nations is no exception. The history of health sector reforms in Tanzania 
shows four marked waves dating back to pre-independence 1884-1961, post-
independence 1962-1972, 1973-1983 and pre-pluralism 1984-1994.  
 
During the first wave where Tanzania was subject to German colonial rule, 
some form of health services were introduced mainly along the coastal areas 
of Tanga, Pangani, Bagamoyo, Dar es Salaam and Kilwa and in sisal 
plantations (GTZ 2001). Further expansion inland to Tabora, Mwanza and 
Bukoba was mainly driven by economic and administrative reasons. At the 
same time missionaries also established some medical services where they 
settled especially in the highland areas. However after World War I, the British 
took over the surrendered or abandoned hospitals and devoted time to 
reconstruct and establish the civil medical services that formed the basis of 
the current health services.  
 
The second wave of health sector reforms started with post-colonial 
independence, 1962-1972. The new government declared war on three major 
enemies, namely disease, ignorance and poverty (Jonsson 1986). During this 
time there was more decentralization to local government in the districts and 
emphasis on health services provision to rural areas. Local governments were 
mandated to collect tax revenue and run health services (Government of 
Tanganyika 1962). To honor its political commitment to eradicating diseases, 
the government commissioned an appraisal of the health system and went on 
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to implement recommendations that included construction of more health 
facilities and integrating services run by the local governments to those under 
the central government (Titmus et al. 1963). This wave was also marked by 
the Arusha Declaration 1967, which emphasized self reliance as a strategy to 
achieve social development including health. 
 
The third wave of health sector reforms was from 1973 to 1983. Problems of 
inadequate resources and finances for rural areas were challenges that were 
still facing the government. Decentralization had given power to local 
authorities for provision and management of health was abolished during this 
period. The central government took over all the functions of local government 
including all health facilities and personnel. This led to an increase in 
government expenditure to purchase drug supplies, equipment and pay 
salaries. Less and less funds became available for the health sector as a 
result of countrywide drought and the war in Uganda. The economic situation 
became worse since independence and some structural adjustments 
measures were imposed (Peabody 1996). These included cutting public 
spending for the social sector including health. 
 
The fourth wave came when the economic turmoil was still persisting. 
Government spending on health declined substantially  Soon it was realized 
that free health care for all was no longer a feasible endeavour and therefore 
user fees or cost sharing were introduced to increase financial resources for 
health care provision. In this wave, the government reverted back to 
decentralization. The move was meant to increase efficiency, community 
participation and management responsibility. 
 
 In 1993, the central government approved the Health Sector Reform Act and 
this was the beginning of the current health sector reforms. This was also the 
same year which the World Bank launched the World Development Report: 
Investing in Health (World Bank 1993) that was a clear reversal of its previous 
policies of restricted financing of public programs. It was realized that 
increased investment in health was a key element to economic development. 
It prescribed that such investment should be based on evidence that would 
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target and focus cost-effective interventions on the local "burden of disease" 
that exists in a particular ecosystem. In 1999, the National Package of 
Essential Health Interventions was defined by the MOH as an initial step 
towards implementing the Bank’s policies. 
 
1.5 National Package of Essential Health Interventions 
The National Package of Essential Health Interventions is a catalogue of both 
public health measures and clinical services which are supposed to be highly 
cost-effective and help to resolve major health problems. The guiding principal 
for selecting which services to include in the package are; the magnitude of 
the burden caused by a particular disease and the cost effectiveness of 
interventions that deal with the problem (Bobadilla et al. 1994). 
 
The Tanzania Package of Essential Health Interventions addresses related 
conditions that were clustered together into five groups. It was not designed in 
the spirit of a minimum package but rather on an inclusive consensus. The 
package includes, reproductive and child health, communicable disease 
control, non-communicable diseases control, treatment of other common 
disease of local priorities within districts and community health promotion and 
disease prevention. Not all interventions found in the package were chosen by 
virtue of their cost-effectiveness partially because of lack of adequate 
knowledge and health information systems at that time, and also due to 
stakeholders working to serve their interests with interventions that were more 
inline with their own ongoing activities. 
 
At least nine sources of information or systems are now present to help in the 
process of redesigning a package in a more rigorous way than before.  These 
included population-based sources such as the decennial census, the 
National Demographic and Health Surveys (DHS), and the demographic 
surveillance systems run by various projects of the Tanzania Essential Health 
Interventions Project (TEHIP), Adult Morbidity and Mortality Project (AMMP), 
and KISESA at Morogoro, Hai, Dar es Salaam, Kilombero/Ulanga, Rufiji, and 
Magu, as well as health facility-based sources such as the Health 
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Management Information Systems (HMIS), Integrated Disease Surveillance 
(IDS), Essential Drug Programme (EDP) and the Expanded Program on 
Immunization (EPI),.   
 
1.6 Evidence-based planning 
Information demand and use has changed considerably in all levels in 
Tanzania. The need for reliable, current and longitudinal indicators of 
demographic, health conditions and poverty are rapidly increasing. Health 
sector reforms, sector wide approaches and global health initiatives such as 
the Global Fund to Fight AIDS, TB and Malaria (GFATM) come with major 
obligations to monitor and evaluate progress and impact to meet demands of 
results and accountability. Simultaneous with these demands, decentralization 
of responsibilities for local planning has encouraged the spread of evidence 
based approaches to policy and practice. 
 
A number of both multi- and bilateral donors and programmes have supported 
Tanzania in achieving its goal of using evidence in planning. But, the 
government has also been on the forefront is setting up the pace of reforms 
and shaping the process. Under the Health Sector Reform program, Tanzania 
had to initiate several strategies towards the improvement of the health 
services which had deteriorated to the extent of collapse. Among the changes 
instituted by the government were; the establishment of cost-sharing 
arrangements in public hospitals through user fees, introduction of health 
insurance in the form of Community Health Funds (CHF) at district/ local 
levels, and regulatory reforms whereby the private sector was also allowed to 
operate to supplement government efforts. 
 
On the other side, the Ministry of Health’s reform partners such as AMMP and 
TEHIP and Ifakara Health Research and Development Center (IHRDC) who 
are linked to the demographic surveillance sites for health and poverty have 
provided burden of disease information to the districts plus other simple to use 
costing and management tools that have enabled the districts to make rational 
spending of their funds. 
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Data generated from the demographic surveillance sites in Rufiji and 
Morogoro Rural was instrumental in assisting the districts to choose and 
implement a number of of new interventions such as Insecticide Treated Nets 
for malaria,  and Vitamin A Supplementation (VAS) and the Integrated 
Management of Childhood Illness (IMCI) for under-fives.  In this thesis we 
examine the IMCI and VAS, hence some introductory background is provided 
here. 
 
1.7 Integrated Management of Childhood Illness (IMCI) 
The Integrated Management of Childhood Illness (IMCI) is strategy for 
improving children’s health and development through the combined delivery of 
essential child health interventions (WHO 1999). It began with a set of case 
management guidelines for sick children seen at first level health facilities. 
Later, the strategy expanded to include guidelines for case management and 
preventive interventions against the leading causes of childhood mortality; 
pneumonia, diarrhoea, malaria, measles and malnutrition. A training course 
was later organized by WHO and UNICEF in 1996 targeting health workers at 
first level facilities to make correct decisions in the management of sick 
children (Gove 1997). The guidelines were further refined and tested through 
research and field testing in several countries including, The Gambia (Weber 
et al. 1997), Ethiopia (Simoes et al. 1997), Kenya (Perkins et al. 1997) and 
Tanzania (WHO Division of Child Health and Development & WHO Regional 
Office for Africa 1997). 
 
A broader strategy followed later which included both preventive and curative 
interventions for promoting child health development. The three components 
of these interventions included: 1) improving the health systems to support 
IMCI; 2) improving the skills of health workers; and 3) improving family and 
community practices. 
 
Typically, IMCI implementation in a country goes through three phases. In the 
first phase or introduction, for many countries IMCI provides them with an 
opportunity to review child health policies and recognize their services and 
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interventions. The main objective is to ensure that key personnel in the 
ministry of health understand the IMCI strategy and its implications as the 
basis to go ahead with the planning and preparation. The second phase is for 
early implementation, in which the country adapts the generic IMCI guidelines 
to ensure that the materials are consistent with the epidemiological situation 
and with the treatment guidelines and other policies and that it is feasible to 
implement the guidelines through the health system. At this stage IMCI is also 
introduced in a limited number of areas and the experience carefully 
documented and analyzed. The third phase is expansion to more areas based 
on experience gathered from the second phase. 
 
By the end of 2002, more than 80 countries had adopted IMCI as part of their 
national child health policy. A need to evaluate the strategy as a holistic 
approach to the delivery of these interventions was necessary. 5 countries 
were selected to participate in the evaluation as a result of a worldwide review 
of 12 possible sites based on the application of standard set of criteria (WHO 
2002).  
 
1.8 Multi-Country Evaluation of IMCI (MCE-IMCI) 
In 1998, the Multi-Country Evaluation of IMCI cost, effectiveness and impact 
(MCE-IMCI) was launched in five countries: Bangladesh, Brazil, Peru, 
Tanzania and Uganda (Bryce et al. 2004). The different countries were 
selected to provide a broad variability of contextual factors, including different 
health systems, mortality levels and patterns, social and economic 
characteristics. The evaluation is coordinated by the Department of Child and 
Adolescent Health (CAH) of the World Health Organization, with support from 
Bill and Melinda Gates Foundation.  
 
The objective of IMCI-MCE is to evaluate the effectiveness, cost and impact of 
IMCI on child health and survival. A major aim is to help determine the best 
ways of delivering integrated child health care, especially to poor children and 
families. Its outcome is expected to contribute to the improved delivery of 
effective interventions for child survival, health and development at high and 
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sustained levels of coverage. The MCE team then developed an impact model 
describing how the introduction of IMCI might to reduce child mortality and 
improve nutrition. 
  
Studies of the effectiveness, cost and impact of the IMCI strategy were carried 
out in 5 countries using a range of study designs from an ecological study in 
Peru to a randomized controlled trial in Bangladesh (Habicht, Victora, & 
Vaughan 1999). Four countries, Brazil (Amaral et al. 2004), Uganda (Pariyo et 
al. 2005), Peru (Huicho et al. 2005) and Tanzania (Armstrong Schellenberg et 
al. 2004) have completed their evaluations. The Bangladesh study is expected 
to complete in 2007 (el Arifeen et al. 2004). 
 
IMCI implementation in Tanzania started in late 1996 and was preceded by 
the global field test of the IMCI field materials for first line health workers in 
Arusha in 1995 (Gove 1997). In 1998, Tanzania also became the first country 
to introduce IMCI in pre-service training institutions. The presence of reform 
partners including Adult Morbidity and Mortality Project (AMMP) and Tanzania 
Essential Health Interventions Project (TEHIP) working with the Morogoro 
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Rural and Rufiji Districts Council Health Management Teams (CHMT) 
facilitated these districts to be early users of the strategy. The two districts 
were part of the MCE study which evaluated the improved case management 
and system support components of IMCI strategy. The third component, 
community IMCI was not implemented at the time of the study. 
 
1.9 IMCI implementation in Rufiji 
The introduction and expansion of IMCI implementation in Rufiji district was 
facilitated by the prominence of IMCI addressable causes in the burden of 
disease that dramatized the need to prioritize IMCI. The burden of disease 
profile in the first few years before the sentinel site in Rufiji was ready to 
provide cause-specific mortality data came from the Morogoro Rural district 
sentinel which had already been running for more than five years (Tanzania 
Essential Health Interventions Project & Ministry of Health 2002). The district 
had also the privilege of simulated Sector Wide Approach (SWAp) health 
“basket funding” from TEHIP since 1997. In this funding they had less than $1 
USD per capita of additional incremental funding at their disposal that they 
could use for any cost-effective health system change that would improve the 
ability to address a substantial part of disease burden.   
 
During the first quarter of 1997 a total of six district level Trainer of Trainers 
(TOTs) attended an eleven day IMCI Training of Trainers course that also 
included four days of facilitation skills.  With the simulated basket funds, the 
districts were able to finance the training and procure IMCI supplementary 
drugs and equipment from the Medical Stores Department (MSD) on a credit 
basis.  
 
Eight training courses for frontline providers were conducted between 1997 
and 2001.  A total of 90 health workers of different cadres had been trained 
during this period. These included assistant clinical officers (ACOs), clinical 
officers (COs), nursing officers, maternal and child health aides, nurse mid-
wives and nursing assistants. By the end of 1999, the CHMT had trained 
health workers to the level of 1 for every 300 children. Three special courses 
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for non-clinicians  lasting 16 days each were conducted 1999 and 2000 in 
Rufiji because the district had a shortage of medically qualified health 
personnel. The target was nurse assistants who are mainly in charge of health 
facilities and also managing children younger than five years (Mbuya et al. 
2003). 
 
Potential impact of IMCI depends on coverage. For the MCE, one definition of 
IMCI coverage was to have 60% or more of health workers who normally 
attend children younger than five years in a health facility IMCI trained, 
followed-up and supported by the system. The MCE target for this indicator 
was that 80% of all health facilities in the said district meet this criterion. This 
was achieved in the first quarter of 2000.  
 
1.10 Vitamin A Supplementation 
Vitamin A Supplementation (VAS) is one of the most simple, easy to 
implement and highly cost effective intervention that is available in public 
health (World Bank 1993). A dose of vitamin A is estimated at $0.02 and 
supplementation programmes are being implemented in more than 70 
countries worldwide. In areas where vitamin A deficiency (VAD) is problem of 
public health importance (WHO 1998), vitamin A supplements are 
recommended as prophylaxis and as treatment to at-risk groups and sick 
individuals respectively. These are children 6-59 months and post-partum 
women. Evaluation from efficacy programs have shown that given high dose 
supplements to at least 80% of the population 6-59 months of age at 4-
5months intervals is likely to have an impact on mortality.  A meta-analysis of 
eight randomized controlled trials (Beaton et al. 1993) showed an average 
reduction of 23% (95% CI:12-32%) in child mortality from diverse populations 
that were presumably free of HIV infection (Fawzi et al. 1993). Randomized 
control trials in HIV infected populations have also been reported elsewhere 
(Fawzi et al. 1999;Humphrey et al. 2006;Malaba et al. 2005;Semba et al. 
2005). 
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The effect of vitamin A supplementation on maternal and neonatal health is of 
extreme importance.  However, evidence from different studies on vitamin A 
supplementation during pregnancy (van den Broek et al. 2002)  and in 
children less than 6 month have been conflicting. A large dose of vitamin A 
given to neonates of normal birth weight in Indonesia was associated with a 
reduction in mortality (Humphrey et al. 1996). In a similar trial in India, 
beneficial effects were found in infants of low birth weight (Rahmathullah et al. 
2003). Vitamin A supplementation given in high doses to mothers at birth and 
children during their routine vaccination in a multi centre trial in Ghana, Peru 
and India (WHO/CHD Immunisation-Linked Vitamin A Supplementation Study 
Group 1998) found no evidence of an effect on infant mortality. A similar trial 
(chapter 9) in Tanzania by Idindili and colleagues (in preparation) found no 
effect on short term morbidity.  
 
1.11 Vitamin A Supplementation in Tanzania 
Vitamin A deficiency is a problem of public health importance in Tanzania, 
affecting mainly children and women of child-bearing age. The magnitude of 
the problem was first documented in a national prevalence survey (TFNC & 
Ministry of Health 1998) and revealed that 24% of children 6-71 months of age  
and 69% of lactating mothers had serum retinol levels below  the 
recommended threshold of <0.70µmol/L and <1.05 µmol/L respectively (WHO 
1998). 
 
The first national programme to combat vitamin A deficiency (VAD) in was 
initiated in 1995, two years prior to the national survey. The efforts were 
mainly focused on supplementation as a short term measure and promotion of 
production of vitamin A rich foods as a long term solution. Nutritional 
education was given to further support these measures. In 1987 vitamin A 
capsules were incorporated into the Essential Drugs Program (EDP). This 
was confined to government-owned primary health care facilities and targeted 
therapeutically to children between 6-59 months suffering from xerophthalmia 
or diseases precipitating vitamin A Deficiency. Consequently, many young 
children at risk of VAD in Tanzanian communities were not reached.  
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Due to persistent problems of low coverage, vitamin A supplementation was 
integrated into routine services of the Expanded Programme on Immunization 
(EPI) in 1997. Under these services, vitamin A supplementation is given to all 
children under two years of age, at 9 months together with measles 
vaccination and at 15 and 21 months of age. Postpartum women are 
supplemented within four weeks after delivery.  Vitamin A supplementation 
coverage under routine EPI has been increasing during measles immunization 
for nine month-old children (from 55% in 1999 to 82% in 2002), but has been 
very low for children 15 and 21 months of age. Most important, the distribution 
system excludes eligible children between two and five years of age. 
Coverage for postpartum women increased at a slow pace — from 45% in 
1999 to 62%t in 2002. 
 
Efforts to increase coverage led to the integration of VAS into sub-national 
measles immunization days in 30 of 113 districts of mainland Tanzania in 
1999 and later in 52 districts in 2000. Coverage estimates from these 
campaigns were 94% and 99% respectively (Mugyabuso 2002). Experience 
gathered from these campaigns formed the basis of integration of VAS into 
the commemoration of the Day of the African Child in June and World AIDS 
day in December.  VAS campaigns with the two events have been in effect 
since 2001.  This thesis examines the performance of these two delivery 
approaches (Chapter x). 
 
1.12 The Demographic Surveillance System platform 
A demographic surveillance system (DSS) is a set of field and computing 
operations to handle the longitudinal follow-up of well defined entities or 
primary subjects (individuals, households, and residential units) and all related 
demographic and health outcomes within a clearly circumscribed geographic 
area. Unlike a cohort study, a DSS follows up the entire population of such a 
geographic area (INDEPTH Network 2002b)  
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The potential benefits of DSS systems are seen in their methodological 
strength of longitudinal follow-up of defined populations. The DSS provides a 
platform on which to base a range of health, social, economic and behavioural 
studies. These can take advantage of the sampling frame inherent in a DSS, 
whether at individual, household/compound or neighbourhood level. Studies 
may be inter-linked, exploit a mix of qualitative and quantitative 
methodologies, and address a diversity of formative, hypothesis generating, or 
hypothesis driven issues where findings can be related to underlying patterns 
of mortality, fertility and migration.  The DSSs also provide rich information on 
trends in demographics, fertility, and health equity as well as empirical life 
tables of use to a great many analyses (INDEPTH Network 2002a;INDEPTH 
Network 2005),(cause-specific mortality monograph in preparation).  
 
In the absence of vital registration in most parts of the developing world, DSS 
systems provide an information and evidence base for which decisions on 
targeting priority diseases and health conditions, allocating scarce financial 
and human resources, improving the efficiency of programs, and developing 
the skill-base of health workers can be made.  Accurate age-specific mortality 
rates can be produced for the population under surveillance. In most of the 
sites, verbal autopsies are used to assign causes of death. The interviews are 
held with one of the adult relatives of the deceased (preferably a caretaker) 
well informed of the sequence of events leading up to the death (Anker 
1996;Chandramohan et al. 1994;Snow et al. 1992).  
 
Furthermore, the impact of interventions on mortality, non-fatal health 
outcomes, fertility and migration can be rigorously assessed. Interventions 
may be therapeutic (such as new drugs or vaccines), behavioural (e.g. sexual 
and reproductive behaviours) or involve changes to routine service delivery, 
health policy, or more extensive health reforms and development strategies. 
They may address the maximum impact of interventions under strictly 
controlled conditions (efficacy), or the impact of introducing new interventions 
into already existing services and systems (effectiveness).  
A demographic surveillance system forms a framework for longitudinal 
population based research on poverty and equity. Routine data collected in a 
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DSS can be used to quantify equity in health in the area (Armstrong 
Schellenberg et al. 2003;INDEPTH Network 2005;Nathan et al. 2004) and 
also assist in assessing poverty monitoring strategies. DSS complements 
other information systems such as the Demographic and Health Surveys and 
Health Management Information System which are infrequent and facility 
based respectively.  
 
These research environments provide unparalleled applied training 
opportunities for health and other professionals, with a particular emphasis on 
strengthening national capacities to seek, interpret and apply available 
information in the essential effort of evidence-based policy, practice and 
resource allocations.  
 
Tanzania, like many countries in Sub Saharan Africa is faced with the dearth 
of reliable information for planning due to fragmentary routine data collection 
systems. However, over that last decade it has observed an increase in the 
number of DSS sites.  These sites were chosen because certain intrinsic 
characteristics of interest to research communities. The locations in which 
some were established provided good opportunities to study the impact of 
interventions on AIDS and malaria. Others were selected because it was felt 
that they provided a range of living standards and conditions in the country 
that might be related to a health and demographic transition in Tanzania. 
Approximately 700,000 people participate in demographic surveillance in 
Tanzania, which is approximately 2 percent of the national population. This is 
roughly seven times the number participating in the National Household 
Budget Survey (Tanzania National Bureau of Statistics 2003) and almost 
twenty five times the sample of the most recent DHS (Tanzania National 
Bureau of Statistics & Macro International Inc.Calverton 2005). In addition to 
the Demographic and Health Surveys, the DSSs have also been integrated 
into the MKUKUTA Poverty Monitoring System Master Plan to assess 
progress in poverty reduction (Government of Tanzania 2005) 
 
1.13 Poverty and equity evaluation in health 
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Over the last two decades, epidemiology literature has witnessed an 
explosion in questions relating socioeconomic patterning of health and 
disease. This has broadened our understanding of the interplay between 
socioeconomic status, health and disease. Along with these advances, data 
collection instruments and methods to evaluate inequities in health have been 
developed. Health inequities refer to health inequalities that are both unfair 
and unjust according to some theory social justice. They provide a picture of 
the gaps that exist between the rich and the poor, between and within 
countries.   
 
Several methods have been suggested and are used extensively to group 
communities or individuals based on income, expenditure or wealth. In 
developing countries where income or expenditure data are rather hard to get 
let alone reliable, simpler methods that reflect the household or individual 
socio economic position have been used (Filmer & Pritchett 1999;Filmer & 
Pritchett 2001). The asset index pioneered by Filmer and colleagues is 
intended as a proxy for income and expenditure. It is based on simple 
weighted sum of the number of different items owned by the household. 
Within the DSS framework, it has been possible to develop tools and measure 
health inequities in small geographic areas, something that had not been done 
previously (INDEPTH Network 2005). The concentration indices and Lorenz 
curves have also become increasingly popular as measurement tools for 
equity and inequality in health and health care (Wagstaff 2002). 
 
The World Bank’s Health, Population and Nutrition Programme has supported 
analyses from data collected from over 50 developing countries by the USAID 
Macro International Demographic and Health Surveys. These analyses 
usually compare rural and urban populations, and quite often showing 
important health differentials between richer and poorer families in mortality, 
nutrition, care-seeking behaviour and coverage of interventions.  However 
DSS sites find stark inequity gradients even in small areas with more 
homogeneous populations (INDEPTH Network 2005). 
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The next chapters of this thesis state the objectives and details of the different 
methodologies pursued to provide answers to the questions. The burden of 
disease and the need to have robust and comparable cause-specific mortality 
data is discussed in chapter 4. This is followed by the analysis on how spatial 
access to health care can assist in informing health planners on how best to 
plan the provision of health services (chapter 5). The following three chapters 
6, 7 and 8 were evaluations within the framework of the Multi-Country 
Evaluation of the IMCI strategy. In chapter 6 we analysed the effectiveness 
and cost of facility based IMCI whereas in chapter 7 we analysed the change 
in programmatic delivery strategy of vitamin A supplementation on coverage. 
In Chapter 8 we analysed the impact of introducing large scale effectiveness 
studies inequalities in child health. Chapter 9 describes our experience in the 
evaluation of vitamin A supplementation in children less than six months in a 
randomized control trial and points to issues that need to be considered 
during such trials and in under programme conditions. A general discussion 
and conclusions are summarized in Chapter 10; key messages from the 
thesis are underscored and future research work is proposed. 
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CHAPTER 2: OBJECTIVES 
2.1 Goal and general objective 
The objective of this thesis is to explore innovative approaches to evaluating 
the implementation of health interventions and their impact on child survival in 
Tanzania. 
 
2.2 General objectives 
i. To describe the development of the longitudinal Demographic 
Surveillance System (DSS) as a platform for evaluating child survival, 
effectiveness of health interventions and health systems in Tanzania; 
ii. To analyze the geographical mode of primary health care usage 
patterns at household level across the demographic surveillance area 
in Rufiji District. 
iii. To analyze changes over time in equity of access (mosquito nets, 
vitamin A, health care, health care utilization) and outcome (nutritional 
status) through cross-sectional community surveys in 1999 and 2002, 
during and after the implementation of Integrated Management of 
Childhood Illnesses in southern Tanzania; 
iv. To evaluate safety and efficacy of two vitamin A supplementation 
schedules in Tanzanian infants. 
 
2.3 Objective 1 
To describe the potential of longitudinal demographic surveillance system 
(DSS) as a platform for evaluating child survival, effectiveness of health 
interventions and health systems in Tanzania 
3.2.1 Specific objectives 
i. To describe the development of DSSs in Tanzania and their potential 
as a platform for evaluating health interventions and health system in 
Tanzania. 
ii. To analyze and describe cause-specific mortality using verbal autopsy 
tool in Ifakara DSS  
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2.4 Objective 2 
 To analyze the geographic mode of primary health care usage patterns at 
household level across the demographic surveillance area in Rufiji District. 
3.2.2 Specific objectives 
i. Describe and summarize variations in travel times to health facilities 
ii. Calculate Distance Usage Indices for health facilities within the DSS 
iii. Predict travel time to health facilities for different modes of access 
2.5 Objective 3 
To analyze changes over time in equity of access (mosquito nets, vitamin A, 
health care, health care utilization) and outcome (nutritional status) through 
cross-sectional community surveys in 1999 and 2002, during and after the 
implementation of Integrated Management of Childhood Illnesses in southern 
Tanzania; 
3.2.3  Specific objectives 
i. To describe the overall coverage and measure inequalities for specific 
childhood health indicators including Vitamin A, mosquito nets, 
nutritional status, access to health care, and health care utilization 
through community surveys in the 1999 and 2002  among poor children 
in southern Tanzania during and after MCE-IMCI implementation. 
ii. To measure intervention performance in specific child health indicators 
including vitamin A, mosquito nets, nutritional status, access to health 
care and health care utilization through community surveys in the 1999 
and 2002 during and after MCE-IMCI implementation. 
iii. To summarize the change in vitamin A supplementation coverage 
between 1999 and 2002, and describe the context of a change in 
policy. 
 
2.6 Objective 4 
To evaluate safety and efficacy of two vitamin A supplementation schedules in 
Tanzanian infants. 
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3.2.4 Specific objectives 
i. Measure the effect of 400,000IU of vitamin A given in two divided 
doses of 200,00IU to mothers and 50,000IU of vitamin A given to 
infants concurrently with DPT/Polio immunizations, on vitamin A status 
of infant at 26 weeks of age. 
ii. Compare the effect of such a regimen to the previously recommended 
dosage of 200,000IU of vitamin A given to mothers and 3 doses of 
25,000IU given to infants concurrently with DPT/Polio immunizations. 
iii. Measure the short term side effects of each of the two doses of 
200,000IU given to mothers and of 50,000IU of vitamin A administered 
with each of the three DPT/Polio immunizations 
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CHAPTER 3: METHODS 
3.1 Study Area 
The study area for the health interventions discussed in this thesis is the four 
districts of Rufiji, Kilombero, Ulanga and Morogoro Rural. The districts have a 
total population of approximately 1.2m people, of whom 200,000 are less than 
five years of age (http://www.tanzania.gov/census). Rufiji and Kilombero are 
low lying, and much of the land is in the fertile flood plains of the Rufiji and 
Kilombero rivers. Morogoro Rural and Ulanga have mountainous areas as 
well as low-lying plains. There are two main rainy season, October-December 
and February-May. There are several ethnic groups, although Swahili, the 
national language is widely spoken.  
 
The majority of the people are subsistence farmers. Farming areas are often 
set some distance from the family home to take advantage of periodically 
flooded alluvial soils. The dwellings are simple, comprising a mixture of huts 
with walls made of mud and wooden poles, with thatched or corrugated roofs, 
as well as conventional brick houses in the townships. Rural roads are 
generally unpaved, and transport can be difficult in the rainy season. The 
public health system has a network of hospitals, health centres, and 
dispensaries with approximately 3,300-7000 people served by each facility 
(ref). Rates of use of health facilities are high; routine reports from the Health 
Management Information System suggest 3.0 visits per child under five years 
old for curative care in 1999 (ref). Malaria and waterborne diseases, such as 
cholera and diarrhoea, are the major health problems in the area, according to 
both the health services and local people. Major causes of mortality include 
acute febrile illnesses (including malaria), acute lower-respiratory infections, 
tuberculosis, AIDS, and conditions arising during the perinatal period (Chapter 
4). Seasonal food shortages are common, and a famine affected much of the 
country in early 1999. 
 
Details of the designs and methodology used for the studies are described 
below. 
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3.2  Design Issues 
3.2.5 Verbal autopsy  
Assignment of causes of death using verbal autopsy (VA) is one of the 
sources of cause-specific mortality data in countries where vital registration 
systems are rudimentary or non-existent. In Tanzania, verbal autopsies for 
cause of death have been used to generate information to inform decision 
makers and planners at district level (de Savigny et al. 2001;Tanzania 
Essential Health Interventions Project & Ministry of Health 2002).  
 
The process involves interviewing close relatives of the deceased through a 
structured questionnaire that details an account of the sequence of events 
and symptoms leading to death. Methods of arriving at possible cause of 
death include physicians review; predefined expert and data derived 
algorithms (Byass et al. 2006;Fantahun et al. 2006;Kahn et al. 1999;Quigley, 
Armstrong Schellenberg, & Snow 1996). In Ifakara DSS, physician panels 
review and code the forms using The International Classification of Diseases 
and related health problems, tenth revision (ICD10). For each death, two 
physicians independently assign an primary or underlying and an associated 
cause if present. The codes are then compared using a custom written 
programme in Foxpro 2.6. A final cause of death is reached if there was a 
consensus between the two coders. A third physician is asked to 
independently code the cause of death in the case of discordant results. 
Where there are three discordant codes, the cause is registered as 
“undetermined.” So far, we have tried to attribute each death to a single cause 
although the coding form allows for multiple causes. 
 
3.2.6 MCE-IMCI Tanzania study 
The Multi Country Evaluation of IMCI Tanzania study adopted non-
randomized control trial or “plausibility” design (Habicht, Victora, & Vaughan 
1999;Victora, Habicht, & Bryce 2004) in which there is monitoring of process 
measures to improve the internal validity of the study and of contextual factors 
to check out whether any apparent effect of the intervention is due to other 
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factors. Two intervention (Morogoro Rural and Rufiji) and two comparison 
(Kilombero and Ulanga) districts were selected and compared for children’s 
health and survival in 1999 and 2000. IMCI implementation in the intervention 
districts started in 1997-1998 and in 2002 for the comparison districts. The 
selection of comparison districts was based on several factors including, the 
existence of continuing demographic surveillance, had similar or lower 
mortality rates, existence of natural barrier between intervention and 
comparison areas and they had no immediate plans of implementing IMCI. 
 
First, we carried out a 
cross-sectional survey in 
August 2000 in a sample 
of health facilities in the 
four districts and 
assessed quality of case 
management for illness in 
children, availability of 
drugs and vaccines and 
supervision of case 
management (Armstrong 
Schellenberg et al. 2004). 
Second, we conducted 
two household surveys in 
1999 and 2002 in a 
probability sample from all 
the four districts to assess 
indicators of children’s 
health (Armstrong Schellenberg et al. 2003;Masanja et al. 2005). Third, we 
tracked mortality through demographic surveillance throughout the study, with 
a particular emphasis on a pre-defined 2- year period from mid 2000, by which 
time IMCI implementation was thought to have reached sufficiently long period 
for an effect on survival to be measurable. Four, we documented information 
on contextual factors (programmes and issues other than IMCI that might 
have affected children’s health in the four districts during the study period) 
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through interviews with all stakeholders in the health study districts and desk 
review of plans, budgets and reports, and data from child-health surveys 
(Victora et al. 2005). Finally, we estimated the economic cost (including the 
value of donated goods, volunteered time by staff, and replacement of costs 
of assets such as building) of children’s health care in IMCI and comparison 
districts though interview and record review at national, district, facility and 
household levels (Adam et al. 2003;Adam et al. 2004). 
 
3.2.7 Kilombero Vitamin A study 
A two-arm randomized double–blind trial was designed to compare the safety 
and efficacy of two vitamin A supplementation regimens. In the lower dose 
group, mothers received 60,000µg (200,000 IU) vitamin A (as vitamin A 
palmitate) at the time of their infant’s BCG vaccination and their infants 
received three doses of 7,500µg (25,000 IU) at the time of vaccinations with 
DPT/OPV at approximately 1, 2 and 3 months of age. In the higher dose 
group, mothers received an additional dose of 200,000IU when their infant 
received the first DPT/OPV vaccination, and their infants received three doses 
of 15,000µg (50,000IU) alongside the three DPT/OPV vaccinations. 
 
Mothers who were residents and brought their children at St. Francis 
Designated District Hospital Maternal and Child Health Clinic (SFDDH/MCHC) 
for BCG vaccination within 7 days after delivery were invited to participate in 
the study. Details of the study were explained to them before seeking consent. 
A questionnaire on demographic information was completed and a study 
number issued to mother-child pair for those consenting. Individual 
randomization to intervention or comparison groups was achieved through 
block randomization that was provided by the data and safety monitoring 
board. 
 
Children were given a dose of vitamin A at the time of DPT/OPV vaccinations 
and followed up for two days for immediate adverse reactions. Safety of the 
two regimens was assessed through passive case detection using a Clinical 
Surveillance System (CSS) that was set up at the Saint Francis District 
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Designated Hospital (SFDDH) for previous studies (Schellenberg et al. 2001) 
and active visits at home for two consecutive days after each 
supplementation.  Efficacy was assessed using biochemical indicators of 
vitamin A status for which blood samples were collected during cross-
sectional surveys when children were aged 6 and 9 months. 
 
3.2.8 GIS mapping 
Aproximately 17,000 households in the DSA were positioned using a 
handheld global positioning system (GPS) (Garmin 12, Garmin Ltd Kansas, 
USA). Each enumerator was provided with a GPS device and recorded the 
coordinates of the household during update rounds. Other locations such as 
health facilities, markets, schools, churches and mosques were also 
positioned. Information on the use of health facilities for child care and 
pregnant women was sought from the head of household or any other reliable 
member of the household present during the interview.  These locations were 
then superimposed on a base map that consisted of a series of geographical 
layers of the district that included; administrative ward boundaries, roads, 
rivers and natural reserve boundaries digitized from 1:50 000 topographical 
maps using MapInfo (MapInfo Corporation, New York). 
 
 
 
 
 
 
 
 
Tanzania showing Rufiji District and Rufiji sentinel surveillance area.
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4.1 Summary 
 
Cause-specific mortality using verbal autopsy is one of the most reliable 
means of establishing causes of deaths in many developing countries where 
routine data system are lacking or fragmented. The study on causes of deaths 
was established in September 2000 in Ifakara and runs parallel to the 
demographic surveillance system. The DSS provides denominators for the 
calculation of all cause and cause-specific mortality rates.  
 
We registered more than 1,800 deaths between September 2000 and 
December 2002 and obtained over 4,000 codes for causes of death from 
physician panel reviews. More than half (54%) of the deaths occurred at home 
and about one third occurred at a health facility. Most of the deaths (42%) 
were in children less than five years of age. Malaria is common in this area 
and is the number one cause of deaths across all ages. Mortality rate due to 
conditions arising during the perinatal period were high at 33.7 per 1000 
person year. As expected, HIV/AIDS was a leading cause of death among the 
economically active group 15-49. Overall communicable diseases accounted 
for over 70% of all deaths. The public health importance of non-communicable 
diseases as cause of death cannot be over emphasized. Mortality rates in due 
cardio-vascular diseases ranged between 3 and 20 in the 50-79 and 80 years 
or above respectively. 
 
The shortcomings of this study due to misclassification could not be avoided. 
Validation studies of the VA tools and ways to deal with misclassification 
errors have been well documented.  Such corrective measures were not dealt 
with in this study and hence our results need cautious interpretation. However, 
despite the caveats, VA data has successfully been used to guide the priority 
setting and resource allocation process at district level through the use of 
district health services profile. 
 
4.2 Introduction 
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Description of the site:  
The Ifakara Demographic Surveillance System (DSS) site covers part of 
Kilombero and Ulanga districts which are both in Morogoro region (latitudes 
8°00′–8°35′S, longitudes 35°58′–36°48′E) southern Tanzania. It is run and 
managed by the Ifakara Health Research and Development Center (IHRDC). 
Demographic surveillance in this area started as part of a social marketing 
programme in the two districts, that aimed at assessing coverage and the 
impact of insecticide treated nets on child survival (Armstrong Schellenberg et 
al. 1999). A baseline census was conducted between September and 
December 1996. A total of 25 villages are covered with a population of about 
65,000 people in 14,000 households.  Since January 1997 each household is 
visited on quarterly basis to record pregnancies, births, deaths and migration. 
In order to determine causes of death in the community, we started 
conducting verbal autopsy (VA) interviews in September 2000. 
 
Population under surveillance 
The area is predominantly rural with scattered households and the mean 
household size is 5.0. There are four main ethnic groups: Wapogoro, 
Wandamba, Wabena, and Wambunga and other smaller ones. Maize and rice 
are cultivated at subsistence level. The literacy rate is 88% for men and 69% 
for women. The rainy season is from November to May. There are occasional 
floods in April in several parts of the DSS area, more details are found 
elsewhere (INDEPTH Network 2002). 
 
Description of health delivery system 
A network of health facilities is in place. Within the DSS area, there are two 
government health centers, seven dispensaries and several private 
dispensaries. There are two district hospitals which are not located in the DSS 
area though one of the two is easily accessible by the DSS population. About 
65% of the patients in the study site seek care from formal health facilities as 
first choice. Reproductive and child health services are provided for free but 
other services are offered within the cost-sharing framework. Apart from the 
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health facilities, first-line anti-malarial drugs and antipyretics are available in 
local shops. Traditional healers are also quite popular in this community. 
 
Selected indicators 
The top five prevalent diseases in the area during the year 2001 were malaria, 
ARI, pneumonia, intestinal worms and fungal infection (Council Health 
Management Team reports, 2001) malaria was the most common. Malaria 
transmission by Plasmodium falciparum is intense and perennial (Smith et al. 
1993). The area also regularly experiences cholera outbreaks and sporadic 
cases of meningitis.   
 
The population structure is typically young with 43% children under 15 years. 
In 2001 the infant mortality rate was approximately at 73.1 per 1,000 live 
births. The probability of dying before age five (5q0 was 131. The life 
expectancy at birth for men and women was 56, and 58 years respectively1. 
Although the prevalence of HIV/AIDS is not known for the DSS area, within 
the past four years, reports from the Kilombero district hospital which 
neighbours the study area show that AIDS has remained the leading cause of 
death among adults. 
 
4.3 Methods 
Demographic and mortality surveillance 
Notification of death events originates from two sources: the quarterly round 
visits by the DSS interviewers and the reporting of vital events by community- 
based key informants or ‘Vitongoji Reporters’ (VRs). DSS interviewers record 
on the field-based household registers: deaths, births, migrations and 
pregnancy events which are then entered into a computer using Household 
Registration System (HRS) software. Each household is visited on quarterly 
basis by the interviewers. The VRs method of collecting vital events runs 
parallel to the demographic surveillance system of quarterly reporting of vital 
events. There are a total 104 sub-villages, each with one reporter who is 
resident in the particular sub-village to facilitate easy identification of events. 
                                            
1
 Life expectancy estimated from the Ifakara DSS database 
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The vitongoji reporter’s duty is to record all deaths and births with that occur 
within his or her area of jurisdiction. Training of the VRs on who to record vital 
events on notebooks was done before they started the exercise. Once a 
month, each reporter is visited by a field supervisor who verifies the events 
and pays an allowance of 500 Tanzanian shillings (equivalent to about US$ 
0.60) per event. The supervisor transfers the information from the notebooks 
into special forms (one for each death or birth), which are forwarded to the 
data room for processing. The latter system serves as a check mechanism of 
the former. Lists that contain identification number of the deceased, name, 
date of birth, sex and date of death are printed out on regular basis from the 
database and are provided to the VA interviewers to facilitate planning of 
interview schedules with the bereaved families. 
 
Data collection 
The field team comprises of 26 enumerators whose responsibility is to visit all 
the households every four months to update demographic events. There are 
three experienced DSS interviewers who were specially trained to conduct VA 
interviews and offer support to the community-based key informants. All the 
three lay-interviewers have attained secondary school education and are 
fluent in Swahili. There are a total of six field supervisors who have a fairly 
long experience in structured interviews and good leadership skills. The 
supervisors are responsible for providing support to the enumerators. They 
perform quality control by checking completeness of the questionnaires, 
performing repeated interviews, and spot checks on the interviewers. Two 
field managers who are based at the headquarters make supervisory visits 
regularly and oversee the running of the DSS and logistics. They are also 
responsible for holding weekly field meetings with the supervisors to share 
experiences and resolve field problems.  
 
Implementation of the VA questionnaire 
The preferred respondent is the person who took care of the deceased during 
the terminal illness. For children, the majority of the respondents are the 
mothers. Normally, the mourning period in the community lasts for about 40 
days and interviews are not conducted earlier than that.  
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Informed consent: 
VA interviews are sensitive as the respondents are usually the close relatives 
of the deceased. Thus, in order to gain community’s acceptance in the study 
on causes of death using VA, the project appointed only interviewers who are 
residents and respected by the community members. They usually participate 
in various social events which include burial ceremonies. Community’s 
willingness to take part in DSS activities such as VA interviews has further 
been enhanced by the provision of canvas sheets to villages by the project. 
Those sheets are specifically meant to provide shade during the mourning 
gatherings. The interviewers are trained on how to express their condolences 
to the bereaved family before explaining the purpose of the visit. The 
respondents are also reassured on the confidentiality of the information 
collected.   
 
Quality control 
Control measures are executed both at the field and data entry levels. Once 
interviews are completed, each form is checked for accuracy and 
completeness and spot-check done by field supervisors on a randomly 
selected sample of questionnaires to ascertain the accuracy of information 
collected and verification of the appropriateness of the respondent. Once this 
is done, the forms are logged in before being processed. Due to the sensitivity 
of the subject, repeated interviews are not conducted. 
 
 
Nature of the VA tool 
Three sets of VA questionnaires for specific age groups:  <28 days; ≥ 28 days 
to 11 years and ≥ 12 years, are used in the study site. The tools originated 
from the WHO cause of death questionnaires and were adapted for INDEPTH 
cross site comparison. Each of the three questionnaires has five main parts: 
identification, history of events that led to death, signs and symptoms, 
treatment (formal and traditional) and the medical records. The open-ended 
part of the questionnaires includes history of illness and medical records while 
the rest are closed. The signs and symptoms section has filter questions that 
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allow for detailed information of the signs and symptoms mentioned in the 
open-ended part. The questionnaires were written in Kiswahili which is the 
national language. 
 
 
Assigning cause of death 
Physician reviews are used to ascertain the cause of death using The 
International Classification of Diseases and related health problems, tenth 
revision (ICD10) (WHO 1992). There are three physicians assigned to review 
VA questionnaires. Each form is reviewed and coded independently by any 
two of the three physicians. For each death, physicians assign an underlying 
and associated cause of death if any. The codes are then entered in a 
computer. The final diagnosis for each case is arrived at using a custom 
programme written in Fox pro which picks out cases where there was a 
consensus between the two physicians on a cause of death. Where there is 
disagreement, a third physician reviews the form and makes an independent 
diagnosis which is again compared with the previous two. If there is a 
consensus on at least two of the physicians, then a cause of death is 
established. If all the three disagreed on cause of death then the final 
diagnosis is coded as ‘undetermined’. Up to now the established final cause of 
death is derived from the underlying cause only and therefore is single 
diagnosis.  
 
 
Data management 
Completed VA forms were brought to Ifakara on weekly basis where they 
were logged in by a filing clerk before being processed. VA data was entered 
by three data clerks and data processing done by a data manager. The same 
data clerks also processed the core DSS data. A stand-alone double data 
entry system built in Foxpro 2.5 with internal consistency checks was used to 
enter and check the data.  
 
 
Data Analysis 
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Analysis for all results presented in this chapter was done using Visual Foxpro 
9.0 and Excel 2000©. A person time matrix (time at risk) was calculated for all 
individuals in the DSS area excluding periods when they were outside the 
area under surveillance. All cause mortality rates were calculated by dividing 
the number of deaths in each age group by the total person time at risk in the 
particular age group. Cause-specific mortality rates for each age group were 
calculated by multiplying all-cause mortality rate by the proportion of deaths 
assigned to each cause. All death rates were multiplied by 1000 and ranked.  
 
 
4.4 Results 
2,129 deaths were registered between January 2000 and December 2002. 
The study on cause specific mortality using VA covered a period from 
September 2000 to December 2002, where a total of 1,893 deaths had a VA 
completed. 1,848 (97%) had a cause of death assigned and were included in 
the analysis. Family migration deceased relatives was the main reason for 
most of the missed interviews. Out of 1,848 deaths, 583 (31.5%) died in 
health facilities, 997 (54.0%) died at home and the remaining 268 (14.5%) 
occurred elsewhere. The mean recall period was five months. The distribution 
of deaths by age and sex is shown in Table 4.1. Most deaths occurred in the 
age group < 5 years (41.8%) followed by deaths in the middle age group (15 – 
49 years) as illustrated in Table 4.1. An excess of males died in the age 
groups 50-79 and ≥80 years while female deaths were higher in the remaining 
age groups including those within the childbearing age (15 – 49 years). 
 
 
 
 
 
 
 
Table 4.1 Distribution of deaths by age, sex at Ifakara DSA, 2000-2002 
Age group Male Female Total M:F 
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 No. % No. % No. % ratio 
Under 1 year 260 24.4 266 25.0 526 24.7 1:1.02 
1 – 4 years 170 16.0 193 18.1 363 17.1 1:1.14 
5 – 14 years 47 5.4 48 4.5 95 4.5 1:1.02 
15 – 49 years 257 24.1 278 26.1 535 25.1 1:1.08 
50 – 79 years 268 25.2 222 20.9 490 23.0 1:0.83 
≥80 years 63 5.9 57 5.4 120 5.6 1:0.91 
Total 1065 100 1064 100 2129 100 1:0.99 
 
Table 4.2 shows annual and total age-sex specific mortality rates.  Extreme 
age groups experienced higher mortality rates compared to other age groups 
throughout the study period.  Overall crude death rates were similar in both 
males and females. 
Table 4.3 shows rates per 1000 person years of top ten causes of death. 
Infectious diseases, conditions arising during the perinatal period and 
HIV/AIDS mortality rates are common, typical of rural populations in 
developing countries. In Table 4.4 conditions arising during the perinatal 
period are the leading cause of deaths in infants. Malaria and respiratory 
infections are among the top three killers of under-fives in this setting. 
Mortality due to injuries is emerging is an important cause of death in the 5-14 
and 15-49 age groups.  
 
 
 
 
 
 
 
 
 
Table 4.2 Age-sex specific mortality rates (per 1000 person years) at Ifakara 
DSA, 2000-2002 
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 Female Male Overall 
Age 
group 2000 2001 2002 00-02 2000 2001 2002 00-02 00-02 
<1 80.0 79.1 82.6 80.6 95.3 65.5 75.3 77.6 79.1 
1-4 16.4 13.6 18.0 16.1 14.2 11.8 16.8 14.4 15.2 
5-14 1.4 1.7 2.5 1.9 1.9 2.3 1.3 1.8 1.9 
15-49 5.6 6.6 6.7 6.3 5.5 6.4 6.2 6.0 6.2 
50-79 15.5 16.9 26.3 19.7 26.5 23.7 28.8 26.4 22.7 
80+ 86.3 101.0 149.0 113.2 151.0 104.0 127.0 126.0 119.6 
CDR 9.8 10.5 12.5 11.0 11.6 10.6 11.8 11.3 11.2 
Deaths 296 342 426 1064 337 336 392 1065 2129 
Pyrs 30086 32564 34061 96711 29086 31714 33213 94013 190724 
 
 
 
     Table 4.3 Top ten causes (/1000 pyrs) of death at Ifakara DSA, 2000-2002 
 
Rank  Cause of death (per 1000 person-years) Rate 
1 Malaria 3.32 
2 Conditions arising during perinatal period 1.38 
3 Respiratory infections 1.03 
4 HIV/AIDS 0.70 
5 Other infectious diseases 0.67 
6 Other 0.63 
7 Cardiovascular diseases 0.57 
8 Accidents and Injuries 0.46 
9 Tuberculosis 0.43 
10 Diarrhoeal diseases 0.42 
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Table 4.4 Top ten causes of death per 1000 person-years by age group. 
 
Cause (per 1000 person-years) 
R
a
n
k
  
<1 year 
1-4 years 5-14 years 
15–49 
years 
50-79 
years 
≥ 80 years 
1 Conditions 
arising during 
the perinatal 
period 
(33.7) 
Malaria  
(9.60) 
Malaria  
(0.87) 
Malaria  
(1.18) 
Malaria  
(3.65) 
Malaria  
(28.4) 
2 Malaria  
(23.0) 
Respiratory 
infections 
(1.03) 
Injuries 
(0.16) 
HIV/AIDS 
(1.14) 
Cardio-
vascular 
diseases 
(3.45) 
Cardio-
vascular 
diseases  
(20.10) 
3 Respiratory 
infections 
(11.2) 
Injuries 
(0.95) 
Other 
infectious 
diseases 
(0.10) 
Other 
(0.55) 
Other 
infectious 
diseases 
(2.39) 
Respiratory 
infections  
(15.90) 
4 Other 
infectious 
diseases 
 (2.40) 
Nutritional 
deficiencies 
(0.81) 
Other 
(0.10) 
Injuries 
(0.48) 
Other 
(2.30) 
Other 
(10.90) 
5 Nutritional 
deficiencies 
(1.54) 
Diarrhoeal 
diseases 
(0.72) 
Tuberculosis 
 (0.09) 
Tuberculosis 
 (0.47) 
Respiratory 
diseases 
 (1.87) 
Other 
infectious 
diseases 
 (9.52) 
6 Diarrhoeal 
diseases 
(1.45) 
Other 
infectious 
diseases 
 (0.67) 
Meningitis 
(0.09) 
Neuro-
psychiatric 
conditions 
(0.45) 
Tuberculosis 
(1.52) 
Diarrhoeal 
diseases 
 (9.52) 
7 Meningitis 
(1.31) 
Other 
(0.38) 
Neuro-
psychiatric 
conditions 
 (0.08) 
Respiratory 
infections 
(0.33) 
Malignant 
neoplasms  
(1.23) 
Respiratory 
infections 
(6.17) 
8 Other 
(1.29) 
Tuberculosis 
(0.28) 
Diarrhoeal 
diseases 
 (0.07) 
Cardio-
vascular 
diseases 
(0.27) 
HIV/AIDS 
(1.22) 
Injuries 
(4.41) 
9 Injuries 
(1.29) 
HIV/AIDS 
(0.23) 
HIV/AIDS 
(0.07) 
Diarrhoeal 
diseases 
(0.26) 
Diarrhoeal 
diseases 
 (1.00) 
Tuberculosis 
(4.05) 
10 Childhood 
cluster 
diseases 
Genito-
urinary 
disease  
(0.19) 
Injuries 
(0.09) 
Digestive 
diseases 
(0.19) 
Genito-
urinary 
diseases 
(0.74) 
HIV/AIDS 
(2.47) 
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   Figure 1: Mortality rates by age of top five causes of death at the  
           Ifakara DSS site, 2000-2002 
 
 
  Table 4.5 Percentage of deaths by sex and by broad cause at Ifakara DSA, 
      2000-2002 
Male Female Overall 
Category 
n % N % N % 
Communicable 657 70.3 681 74.6 1338 72.4 
Non-communicable 160 17.1 152 16.6 312 16.9 
Accidents and injuries 44 4.7 21 2.3 65 3.5 
Other  11 1.2 5 0.6 16 0.9 
Undetermined 63 6.7 54 5.9 117 6.3 
Total 935 100 913 100 1848 100 
 
As expected, mortality rates due to HIV/AIDS ranked highest in the 15-49 year 
age group. Death rates from cardio-vascular diseases ranked second after 
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malaria in the older age groups. Overall, malaria dominated as the major 
cause of deaths in this endemic rural setting. 
 
Overall, communicable disease contributed to most deaths in this population 
(72.4%), and in both males and females, Table X.5. The percentage of deaths 
due to accidents and injuries were higher among males (4.7%) compared to 
females (2.3%).  Approximately, 6% of the deaths were assigned as 
undetermined. 
 
 
4.5 Discussion  
Slightly more than 2,100 deaths were registered from January 2000 to 
December 2002. Verbal interviews and causes were available for 1,848 
deaths (87%) from September 2000 and December 2002. Migration is 
common in this area, and accounted for most of the missed interviews. The 
study on cause specific mortality is part of the Ifakara Demographic 
Surveillance System that documents vital events including, births, deaths and 
migrations. The DSS provides accurate denominators by excluding time at 
risk of disease or deaths for individuals under surveillance. 
 
In our study, the majority of deaths reported occurred at home (54%) and only 
about a third (32%) occurred in a health facility (data not shown). This is 
consistent with experiences from others rural areas in Tanzania (AMMP 1997) 
and is the main reason for relying on the verbal autopsy method for describing 
the mortality profile of a population.  
 
An excess of adult males died in the age group 50-79 compared to females, 
most likely due to cardiovascular diseases. Mortality experience was similar in 
other age groups even for the 15- 49 category where women may have a 
higher risk due childbearing complications. The lack of apparent sex 
differentials in mortality in this age category could be attributed to many 
causes including HIV/AIDS, which is increasingly becoming an important 
cause of death in this population. 
Chapter 4: Causes of death at the Ifakara Demographic Surveillance Area 
 - 58 - 
 
Increased drug resistance to anti malarial, poor case management and delays 
in seeking appropriate care are among factors contributing to high malaria 
death rates as shown in our results. Mortality rates due to conditions arising 
during the prenatal period including, prematurity, asphyxia and/or low birth 
weight account for the majority of deaths in this age group similar to other 
settings in rural Africa. HIV/AIDS ranked as the third most important cause of 
death and is among the top ten causes for all ages except infants. The 
epidemiology of HIV/AIDS has not been well described in this area hence our 
results may be difficult to interpret with respect to possible changes that may 
be occurring.  
 
Most of the causes responsible for under five mortality including, malaria, 
conditions arising during the perinatal period, respiratory infections and 
nutritional deficiencies are either be treated or prevented (Jones et al. 2003). 
There was no IMCI in Kilombero and Ulanga districts during the time of this 
study, implementation started in 2002. The costs of IMCI strategy were shown 
to be similar or less than conventional care (Adam et al. 2004) and under five 
mortality was 13% lower than in the comparison districts (Armstrong 
Schellenberg et al. 2004). Vaccination coverage is high in Tanzania (Tanzania 
National Bureau of Statistics & Macro International Inc.Calverton 2005) and 
this is depicted by low rates of vaccine preventable causes, a credit to the EPI 
programme. The phenomenon of re-emergence of TB, which has recently 
been observed in many developing countries (Raviglione 2003), is clearly 
manifested in our site, where it features as one of the leading causes of death 
among adults.  
 
Disease categories do not show sex selection except for the accidents and 
injuries category where more men than women die of that cause. This reflects 
a gender aspect of division of labour among the adults given that the specific 
causes in this category are associated with male economic activities of fishing  
(animal bites) and picking coconuts and taping palm wine (falling). However, 
these results should be interpreted with caution due to small numbers. 
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Communicable diseases account for over 70% of all deaths which compares 
with the rest of sub-Saharan Africa (Murray & Lopez 1994). The public health 
importance of non-communicable diseases as a cause of death in the study 
area can also not be overlooked. A closer monitoring of a possible rise in the 
proportion of deaths attributed to non-communicable diseases reported 
through verbal autopsy would be necessary in the future. Injuries and 
accidents in the 1-4 years age group had a substantial contribution to the 
causes of death. All deaths due to injuries or accidents in this age group were 
due to burns and drowning. 
 
Deaths caused by meningitis are a notable feature in this setting, a total, 7 
individuals died from this cause. The study area experiences sporadic 
outbreaks of meningitis, though at a small scale.  
 
Limitations of results/findings 
Verbal autopsy remains the most reliable tool for assigning causes of death in 
many parts developing world and especially in Sub-Saharan Africa where 
routine statistics are fragmented or non-existent. Validation of the VA tools 
and ways to deal with misclassification errors which are considered to have 
potential effect on the estimates of the cause-specific mortality based on VA 
studies have been debated and documented extensively (Chandramohan et 
al. 1994;Chandramohan, Setel, & Quigley 2001;Kahn et al. 2000;Kalter et al. 
1990;Setel et al. 2006). Such corrective methods have not been dealt with 
here; therefore our results might suffer from that limitation. However, results 
from Setel and colleagues suggest that same tools that we also used here 
reliably estimated cause specific mortality fractions (CSMFs) for diseases of 
public health importance in all age groups (Setel, Whiting, Hemed, 
Chandramohan, Wolfson, Alberti, & Lopez 2006). The high proportion of 
undetermined causes among adult deaths is perhaps a manifestation of the 
limitation of verbal autopsies to adulthood. Due to the overlap in symptoms 
and signs between malaria and other acute febrile illnesses such as 
pneumonia, coders assumed most of these deaths were due to malaria unless 
there was strong evidence to suggest otherwise.  
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TB and other opportunistic infections that are closely associated with 
HIV/AIDS limit the power of the VA as a tool to assign causes of death to such 
cases. Many deaths that might have primarily been due to TB could be easily 
classified as HIV/AIDS.  
 
Information generated from VA is invaluable to both district health planners 
and researchers because of its utility in making efficient allocation of scarce 
resources and planning for appropriate community health interventions. This 
has indeed been successfully demonstrated in some Tanzanian rural districts, 
Rufiji and Morogoro (de Savigny et al. 1999). The experience showed a 
dramatic improvement in allocation of health resource as guided by the 
District Health services profile developed from the VA diagnoses (Tanzania 
Essential Health Interventions Project & Ministry of Health 2002). Verbal 
autopsies also provide useful baseline information for monitoring and 
evaluation of health service delivery and interventions to specific diseases.  
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5.1 Introduction 
Health service provision through primary health care is undoubtedly the most 
reliable means of reaching the majority of the populations in the developing 
world. However, health systems in Africa face the challenge of increasingly 
diverse and complex health problems, rapid population growth and 
inadequate resources to respond to these demands. Further, optimal access 
to primary health care services is impeded by many factors including physical, 
temporal, organizational, social, cultural, gender and economic factors. 
Geographic factors play a major role in modulating access to and utilization of 
health services. People living far from health services tend to have lower rates 
or utilization and consequently poorer health outcomes (Perry & Gesler 2000). 
Proximity to health services has been associated with decreased maternal 
and child mortality (Debpuur et al. 2002;van den Broek et al. 2003) and 
increased compliance with new intervention programmes (de Souza et al. 
2006) 
 
The health sector in general and Africa in particular have been late in adopting 
Geographic Information Systems (GIS) as a tool for managing and 
understanding health data, either in research or in health services (de Savigny 
& Wijeyaratne 1995). However recent years have seen several advances.  An 
digital atlas of malaria risk in Africa has been produced based on prediction 
models using spatial databases of infection prevalence, biologic transmission 
intensity and climate (MARA Collaboration 1998).  This, when combined with 
population data allowed estimation of populations at risk of exposure, 
morbidity and mortality (Snow et al. 1999).  Practical GIS applications have 
been produced and increasingly used.  A good example is the WHO 
HealthMapper software application, originally used by large disease control 
programs such as Guinea Worm Eradiation and the Onchocerciasis Control 
Program in Africa, and now used by many students, health researchers and 
health information systems. But it is fair to say that in Africa in general, there 
has been limited use of the GIS technology in health systems and health 
systems research that has, as a result, hindered its contribution as a health 
planning and management tool. 
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That is changing. There are encouraging prospects on the use of GIS in 
health systems research in recent work associated with demographic 
surveillance systems (Tanser, Gijsbertsen, & Herbst 2006) and that ongoing. 
GIS has been applied to equitably distribute workload among fieldworkers in a 
large survey in South Africa (Tanser 2002). A study in Kenya reported the use 
of GIS to model access and utilization of health services as tool to monitor 
millennium development goals to reduce the burden of HIV/AIDS, tuberculosis 
and malaria (Noor et al. 2006). Models to investigate rural and peri-urban 
usage of health facilities and the quantification of the effect of physical access 
to usage have been studied in rural South Africa (Tanser, Gijsbertsen, & 
Herbst 2006) . The models have been extended and applied to a rural area in 
Tanzania and are the subject of this paper. 
 
Most parts of rural Tanzania have a good network of primary health care 
facilities as a result of post independence policies that aimed at equitable 
health services for all. Although geographical variations in access to health 
services exist, on average, rural populations in Tanzania tend to be nearer to 
health facilities compared to neighbouring countries (Beegle 1995). 
Approximately 90% of the population is within 1 hour walking distance to a 
government health facility (Tanzania National Bureau of Statistics 2003) 
where care for under-fives and pregnant women are officially free in 
government health facilities. 
 
Despite this good network of health facilities in most parts of the country, 
studies on spatial barriers of access to health services and travel time in 
Tanzania are lacking. This could partly be due to the assumption that the 
majority of the population are within 5 km from a health facility, lack of interest 
or expertise in modelling such patterns. 
 
To investigate spatial patterns of access and travel to health facilities in a rural 
setting in Tanzania, we used information from geographically positioned 
households and health facilities normally used by the households for under 
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fives and pregnant women care to assess the pattern of primary health care 
usage in the Rufiji District Surveillance area. 
 
5.2 Methods 
Study area 
The study area has been described in detail elsewhere; briefly the Rufiji 
Demographic Surveillance Area (DSA) extends between latitudes 7.47° and 
8.03° South and longitudes 38.62° and 39.17° East. The Rufiji DSS is in Rufiji 
District, Tanzania, about 178 km south of Dar es Salaam. Rufiji is one of six 
districts of the Coast Region, the others being Bagamoyo, Kibaha, Kisarawe, 
Mafia, and Mkuranga. Rufiji, in the south, has 6 divisions, with 19 wards, 
divided into 94 registered villages and 385 hamlets. The district covers an 
area of about 14,500 km2. The Rufiji DSS operates in 6 contiguous wards and 
31 villages (about 60 km long × 30 km wide) and covers an area of 1813 km2. 
 
Rufiji has a population of about 182,000, of which 85,000 (about 47% of the 
district) is under surveillance in the DSA. The mean household size for the 
whole district is about 5.0 (TBS 1994). The district is largely rural, but the 
population is clustered around Utete (district headquarters), Ikwiriri, Kibiti, and 
Bungu townships. The main economic activities are subsistence farming and 
fishing. 
 
The DSAs main transportation route is the north–south Dar es Salaam–Lindi 
and Mtwara trunk road, half of which is paved; and the other, unsealed. 
Unpaved feeder roads and tracks link most of the villages to this trunk road. 
 
The geography is characterized by river flood plains and gentle uplands with 
maximum elevation of 500m above sea level. The vegetation mainly 
composed of tropical forest and grassland. The district receives an average 
annual precipitation of 800-1000.mm. There are two rainy seasons; with short 
rains in October to December and long rains in March to May. Occasional 
floods in parts of the DSA deposit rich alluvial soils on an area stretching more 
than five kilometres on both sides on the Rufiji River. The district borders the 
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Selous Game Reserve which has a variety of wild animals. The reserves acts 
as natural barrier between the Rufiji District and Morogoro Rural district 
(INDEPTH Network 2002) 
 
Primary Health Care in Rufiji District 
Like most districts of Tanzania, Rufiji District has good network of health 
facilities that are located within villages. In total there are 55 health facilities: 2 
hospitals (1 government and 1 mission), 5 government health centres, 44 
government dispensaries, and 4 non government dispensaries. A private 
dispensary based at Kibiti offers the services of a mobile clinic in some parts 
of the district. The DSA is served by one of the two hospitals, two of the five 
health centres and 11 of the 44 dispensaries. Over-the-counter drugs are 
available from many private shops and kiosks in the villages. Many people 
also obtain services from traditional healers, including traditional birth 
attendants (de Savigny et al. 2004). Malaria and waterborne diseases, such 
as cholera and diarrhoea, are the major health problems in the area, 
according to both the health services and local people.  TB and HIV/AIDS are 
also major shares of the burden of disease according to data from the DSS. 
 
GIS for primary health care research 
In 2002 approximately 14,000 households in the DSS area were geo-
positioned using a hand held global positioning systems (GPS) (Garmin-12, 
Garmin Ltd., Kansas USA). Each enumerator was provided with a GPS device 
and recorded the coordinates of each household during one of the quarterly 
visits to the household.  Key locations in each village, including health 
facilities, markets, churches, mosques and schools were also positioned. In a 
subsequent visit we sought to determine the usual choice of health service 
unit by the household. We asked a question to the head or a knowledgeable 
member of the household present during the interview “which health facility 
they normally used for general, under-five and maternal care.”  We were able 
to visit approximately 12,000 household because the implementation of the 
questionnaire had started a few weeks after the start of the update round.  
Results for this question were available for approximately 9,392. In 
approximately 1,330 of the households respondents were not asked this 
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question because they were either away at the time of the survey or there was 
no one to provide reliable information on the health facility usage by the 
household. 
 
The households and health facility point locations were then superimposed on 
a base map of the DSS area comprising of a series of geographical layers of 
the area including roads, rivers and natural reserves digitized from 1:50 000 
topographical maps using MapInfo 7.0 (MapInfo Corporation, Troy, NY,USA) 
 
Prediction model of health facility catchments 
We built our walking and travel (using public or private transport) time models 
to nearest health facilities using the costgrow algorithm in raster GIS using 
IDRISI (Clark University, Worcester, MA, USA).  For the transport model we 
initially superimposed the road network on a 10 meter pixel raster grid with 
friction values corresponding to speeds shown in Table 1. The same algorithm 
was also used to predict household catchment areas of nearest health 
facilities for both walking and travel models. Walking and travel speeds on 
each surface were assigned based on local knowledge and national speed 
limits on major roads. For the walking model, a speed or friction value of 5 
km/h was assigned to all major and secondary roads and 4 km/h on minor 
roads or footpaths. Friction values between roads, tracks or footpaths were 
assumed to be the same as the slowest footpath value.  
 
The costgrow algorithm uses the friction values to compute a path of least 
resistance from each pixel on the image to nearest target cell, in this case 
health facilities. 
 
Indices of health facility usage 
Cross tabulations of model predicted health facility use against actual reported 
use were used to produce an error matrix.  We then calculated the inclusion 
and exclusion errors as defined by Tanser and colleagues (Tanser et al. 
2001). Inclusion error was defined as the proportion of households using a 
particular health facility which are from other catchment areas and the 
exclusion error was defined as the proportion of households from a particular 
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catchment area which use another facility or none at all.  A clinic with a high 
inclusion error attracts patients from within other catchment areas while health 
facilities with high proportion of households within their catchment area which 
use other health facilities will have high exclusion errors 
 
The differences between the expected and the actual usage were used to 
compute the distance usage index (DUI) of each facility (Tanser, Hosegood, 
Benzler, & Solarsh 2001). The DUI is derived as the sum of travel times 
between all households within a predicted health facility catchments and the 
health facility divided by the sum of travel times between all households who 
reported using a particular health facility and the health facility itself. It 
measures how strong patients are attracted to or repelled from a health 
facility. Thus a high DUI greater the 100% indicates greater attraction of a 
particular health facility to patients outside its catchment area, while a low DUI 
less that 100% implies that the facility only attracts patients from within its 
catchment area and mostly from short distances.  
 
5.3 Results 
A total of 9,392 (67%) of the 14,000 geo-referenced households in 2002 had 
complete data on access to health facility. Average travel times to health 
facilities for pregnant women and for children younger than five years were 
36.8 and 36.5 minutes respectively. (78 %) of the DSA population is within 30 
minutes from a health facility. 
 
       Table 1: Speed assignment in the transport model 
Description Public transport model (km/h) 
Walking model 
(km/h) 
Level 1 road 100 5 
Level 2 road (primary) 50 5 
Level 3 road (secondary 30 5 
Level 4 road 20 5 
Level 5 road (tracks) 5 4 
 
Table 2 shows the error matrix and other spatial indices of the actual against 
predicted travel time and health facility usage.  Three government 
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dispensaries, Kimbuga, Mng’aru and Mlanzi had low inclusion errors 2.2%, 
1.5% and 0.4% suggesting repulsion from these health facilities. A large 
proportion of households whose catchment area is Mariam Consolata used 
other health facilities or none (exclusion error=92%)..  
 
The distance usage indices for both children younger than five and pregnant 
women were similar, 96.3% and 96.0%. All three private dispensaries in the 
DSS area except the hospital had DUI values less than 50% suggesting 
repulsion.  
 
The predicted health facility catchments from two models (either using some 
form of transport or walking), were similar with differences only in the Kibiti 
area where the predicted catchment area for Mariam Consolata Mission 
dispensary is much smaller for the walking model compared to the transport 
model. 
 
95% of children younger than five in the least poor quintile had access to 
health facilities of less than half an hour compared to 71% in the poorest 
quintile. The average travel time to a health facility for children in the least 
poor quintile was 17 minutes compared to 42 minutes in the poorest quintile. 
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Table 2: Error matrix of the relationship between actual health facility usage and nearest facility. Inclusion and exclusion error, 
average travel time and distance usage index by health facility for under five children. 
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Ikwiriri HC 491 81 0 0 0 0 3 12 1 0 0 1 0  589 418 16.6 17.6 80.7 
Ikwiriri 20 54 0 0 0 0 1 1 1 0 0 0 0  266 228 79.7 18.5 45.8 
Bungu 1 0 894 1 2 54 8 24 0 0 0 2 2  988 756 9.5 43.9 80.4 
Jaribu Mpakani 0 0 43 407 102 1 1 2 0 0 0 5 0  561 403 27.5 33.1 76.9 
Mjawa 1 0 16 71 163 0 0 1 0 0 0 0 0  252 174 35.3 34.1 58.9 
Nyambunda 0 0 3 0 0 138 27 34 1 0 0 0 0  203 130 32.0 50.9 59.3 
Kibiti HC 0 0 18 0 0 1 464 198 1 0 1 1 0  684 444 32.2 41.5 55.5 
Mariamu Consolata 1 1 0 0 0 0 487 43 2 0 6 3 0  543 429 92.1 51.3 7.2 
Kimbuga 0 0 0 0 0 0 44 1 316 1 0 0 0  362 198 12.7 35.3 97.5 
Mng'aru 0 0 0 0 0 0 2 0 1 65 0 0 0   68 32 4.4 19.4 95.7 
Mchukwi 1 0 0 0 0 0 26 14 0 0 212 28 0  281 147 24.6 34.8 47.7 
Mchukwi Hospital  0 0 0 0 0 0 0 9 0 0 236 132 0  377 168 65.0 38.7 61.1 
Mlanzi 0 1 40 0 0 0 0 3 0 0 1 9 532  586 215 9.2 38.9 96.3 
Total  704  137 1,014  479  267  194 1,063  342 
 
323 
  
66  456  181 
 
534 9,353 3,742 58.2   
Inclusion error (%) 30.3 60.6 11.8 15.0 39.0 28.9 56.3 90.0 2.2 1.5 53.4 72.9 0.4      
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Table 3: Error matrix of the relationship between actual health facility usage and nearest facility. Inclusion and exclusion error, 
average travel time and distance usage index by health facility for pregnant women  
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Ikwiriri HC 424 187 0 1 1 0 4 2 2 0 0 7 0  628 378 67.5 19.3 82.5 
Ikwiriri 162 140 0 0 0 0 2 0 1 0 0 1 0  306 188 54.2 14.9 43.4 
Bungu 1 0 995 1 2 35 8 16 2 0 1 1 2 1,064 679 7.5 44.1 83.1 
Jaribu Mpakani 1 0 42 276 211 1 2 0 1 0 0 1 0  535 425 48.4 35.3 77.3 
Mjawa 0 1 12 43 194 1 0 0 0 0 0 1 0  252 174 23.0 32.9 50.8 
Nyambunda 0 0 4 0 0 179 29 30 0 0 0 0 0  242 91 26.0 46.2 76.2 
Kibiti HC 0 0 15 0 0 0 487 205 1 0 1 3 0  712 415 31.6 39.8 54.2 
Mariamu Consolata 1 1 0 0 0 0 563 30 3 0 8 7 0  613 358 95.2 55.4 6.5 
Kimbuga 0 0 0 0 0 0 46 0 319 0 0 0 0  365 195 12.6 35.3 96.5 
Mng'aru 0 0 0 0 0 0 2 0 1 65 0 0 0   68 32 4.4 19.2 100 
Mchukwi 2 0 0 0 0 0 28 5 0 0 112 128 0  275 150 59.3 38.5 45.1 
Mchukwi Hospital  0 0 0 0 0 0 0 0 0 0 109 234 0  343 177 31.8 35.5 51.8 
Mlanzi 1 1 42 0 0 0 0 0 0 0 0 20 426  490 204 13.1 38.8 96.0 
Total  592  330 1,110  321  408  216 1,171  288 
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428 5,893 3,466 34.1   
Inclusion error (%) 28.4 57.6 10.4 14.0 52.5 17.1 58.4 89.6 3.3 0.0 51.5 41.9 0.5      
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Figure 1: Walking model: Reported use versus predicted access to health care in Rufiji DSS (A) pregnant women, (B) under fives 
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Figure 2: Socioeconomic status quintiles in Ikwiriri, Rufiji 
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Discussion 
Using GIS software we were able to analyze spatial access to health care in 
pregnant women and children younger than five in Rufiji sentinel surveillance 
area. The mean travel time to health facilities in Rufiji DSA is less than one hour. 
However, important inequities may be masked by the averages.  Our data also 
shows that the poorest people have on average much longer travel times 
compared with the least poor who live closer to health facilities.  
 
Although there is cost sharing of health services through different schemes, 
health care in government health facilities is still officially free for pregnant 
women and children younger than five years in Tanzania. This is meant to 
increase utilization of health services for the poor mothers and children who 
cannot afford them.  Our study did not assess utilization rates, but findings from a 
large health impact in the district around the same time as our study showed 
relatively high utilization rates among children compared to other developing 
countries (Armstrong Schellenberg et al. 2003). The low distance usage indices 
in particular in the three private health facilities in the DSS area is probably a 
reflection of the costs that people including pregnant women and children have to 
pay when they access them.  
 
Proximity to health facilities favoured children from least poor families than from 
poorer households. Their mean travel time was one third of what a child from the 
poorest quintiles would need to travel to access a facility. Our results are in 
agreement with what has been reported in another study by Armstrong and 
colleagues (Armstrong Schellenberg, Victora, Mushi, de Savigny, Schellenberg, 
Mshinda, & Bryce 2003). In their study, they found that children from least poor 
households were more likely to receive better quality health care than children 
from poorer families and were more likely to have had shorter distance to health 
facilities. 
 
Our study is bound to some limitations regarding the assumptions on the travel 
speeds and land use. For the model, we made educated guesses on the speeds 
for the different road levels in the district. Measured average speeds on the 
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different road levels may improve the model estimates. Similarly, information on 
natural barriers to movement would have enhanced the validity of our model.  
 
There are several implications of this initial GIS study that are being followed up.  
First the travel time model is being refined to take account of measured speeds, 
and land use barriers.  Secondly, the travel time DUI is being explored to 
determine if it correlates with other indicators of health facility quality.  Third, we 
will examine the travel time model to determine if there is any population cluster 
that would benefit from either a new static health facility, or from dedicated 
outreach services.  Fourth, we will examine how the DUI operates regarding 
compliance with chronic care interventions such as TB DOTS or anti-retroviral 
therapy which require repeated return visits to health facilities.  Finally, we will 
take advantage of the health service and population spatial databases to 
examine other environmentally determined health risks and their interventions.  A 
good example of this is malaria transmission in relation to coverage density of 
insecticide treated nets which tend to have higher coverage among the least 
poor. 
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6.1 Abstract  
 
Objectives: To evaluate the safety and efficacy of vitamin A supplementation 
alongside routine vaccination in young infants. 
Design: A two-arm randomised double-blind controlled clinical trial. 
Setting: District hospital and Mother and Child Health Clinic, Ifakara, southern 
Tanzania. 
Participants: Newborn infants, followed until 9 months of age, and their mothers. 
Interventions: Lower dose group – 60,000µg (200,000IU) vitamin A (as vitamin A 
palmitate) for mothers shortly after delivery and 7,500µg (25,000IU) to their 
infants alongside vaccinations at approximately 1, 2 and 3 months of age. Higher 
dose group – a second maternal dose of 200,000IU when their infant was aged 1 
month, and 15,000µg (50,000 IU) to the infant alongside routine vaccinations at 
1, 2 and 3 months of age.  
Main outcome measures: Safety – community-based active and hospital-based 
passive case detection. Efficacy – prevalence of vitamin A deficiency (VAD) 
defined as a Modified Relative Dose Response (MRDR) test result ≥0.060 at 6 
months of age. 
Results: Higher dose vitamin A supplementation was well tolerated by mothers 
and infants.  The prevalence of VAD in 6 month old infants was 43% (125/293) in 
the higher dose arm and 47% (132/282) in the lower dose arm (relative risk 0.91 
(95% confidence interval 0.76-1.09), p=0.32). Serum retinol concentrations and 
the incidence of illness episodes were also similar in the two groups. Some 
vitamin A capsules degraded towards the end of the study, but the results were 
essentially unchanged when infants who could have received such doses were 
excluded.  
Conclusions:  This study provides evidence that doubling the doses of vitamin A 
to mothers and their young infants is likely to be safe but is unlikely to reduce 
short-term morbidity or to enhance the infant’s biochemical vitamin A status at 6 
months of age. The stability of vitamin A capsules, especially those with 25,000 
IU and 50,000 IU, merits further investigation. 
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6.2 Introduction 
There is strong evidence that supplementation with vitamin A from the age of 6 
months reduces morbidity and mortality in areas with endemic vitamin A 
deficiency (VAD) (Beaton et al. 1993;Fawzi et al. 1993). In practice, one of the 
main opportunities for supplementing this age group is at the time of measles 
vaccination, usually given as soon as possible after the infant is 9 months old. 
However, because a high proportion of all child deaths occur before the age of 9 
months the effects of earlier vitamin A supplementation have been investigated. 
Results have been conflicting (Daulaire et al. 1992;Humphrey et al. 1996;Malaba 
et al. 2005;Rahmathullah et al. 2003;West, Jr. et al. 1995). Two trials in Asia 
gave approximately 50,000IU of vitamin A to infants within the first few days of 
life, and showed 22-64% reductions in infant mortality (Humphrey, Agoestina, 
Wu, Usman, Nurachim, Subardja, Hidayat, Tielsch, West, Jr., & Sommer 
1996;Rahmathullah, Tielsch, Thulasiraj, Katz, Coles, Devi, John, Prakash, Sadan 
and, Edwin, & Kamaraj 2003). A more recent trial involving 9,208 mother infant 
pairs in a less vitamin A deficient population in Zimbabwe showed that 400,000IU 
of vitamin A for mothers and 50,000IU for their infants, given within 96 hours of 
birth, did not lower infant mortality (hazard ratio 1.28 (95% confidence interval 
0.83, 1.98)) (Malaba, Iliff, Nathoo, Marinda, Moulton, Zijenah, Zvandasara, Ward, 
& Humphrey 2005).  
 
A further study explored the effect of supplementation in slightly older infants and 
made use of the Expanded Program on Immunisation (EPI). EPI routinely 
delivers three doses of diphtheria-pertussis-tetanus/oral polio vaccines 
(DPT/OPV) (sometimes with Hepatitis B and/or Haemophilus influenzae vaccine) 
to millions of children younger than 6 months living in VAD endemic settings. The 
World Health Organization (WHO) co-ordinated a randomised, double-blind, 
placebo-controlled trial in 9,424 infants to investigate the effects of 
supplementation with 25,000IU of vitamin A at the time of these routine 
vaccinations at 6, 10 and 14 weeks of age. This study, conducted in Ghana, India 
and Peru, showed that the intervention was safe but produced only a modest and 
short-lived improvement in vitamin A status when children were aged 6 months 
(serum retinol ≤0.70µmol/L 29.9% versus 37.1%, risk difference -7.2% (95% 
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confidence interval  -14.3, -0.2%). The benefits were no longer apparent on 
biochemical testing when the infants were 9 months old (WHO/CHD 
Immunisation-Linked Vitamin A Supplementation Study Group 1998).  
 
Supplementation of mothers has been shown to improve the vitamin A intake of 
breast-feeding infants. Four studies, all in Asia (Basu, Sengupta, & Paladhi 
2003;Humphrey & Rice 2000;Rice et al. 1999;Roy et al. 1997;Stoltzfus et al. 
1993), showed that a single dose of 200,000IU-300,000IU of vitamin A given to 
mothers within three weeks of birth significantly increased their breast milk retinol 
concentration for between three and eight months. Combined supplementation of 
mothers, shortly after delivery, and their young children may help improve 
children’s vitamin A status. An assessment of vitamin A requirements in infancy 
suggested that supplementation of women post-partum with two doses of 
200,000 IU, and infants with three doses of 50,000 IU in the first 6 months of life 
would be sufficient to prevent VAD in the majority of infants (Humphrey & Rice 
2000) Metabolic studies also suggested that this dosing regimen was very 
unlikely to be toxic (Allen & Haskell 2001). 
 
We conducted a double-blind, randomised two-arm study to compare the safety 
and efficacy of the previously-tested lower dose regimen (25,000 IU units at the 
time of DTP/OPV doses 1, 2 and 3) with that of the suggested higher dose 
regimen (a further 200,000 IU dose to mothers when their infants were 1 month 
old and 50,000 IU units for infants at the time of DTP/OPV doses 1, 2 and 3). 
 
6.3 Methods 
Setting 
The study was conducted in Ifakara, southern Tanzania, where 56% of children 
aged 6 months to 6 years had serum retinol concentrations ≤0.70µmol/L in 1997 
(TFNC & Ministry of Health 1998) The town is served by St Francis Designated 
District Hospital (SFDDH) and an adjacent Maternal and Child Health Clinic 
(MCHC). The MCHC provides routine EPI vaccinations: Bacille-Calmette-Guerin 
(BCG) and OPV are given immediately after birth, doses of DPT/OPV at 1, 2 and 
3 months, and measles vaccination at 9 months of age. The study area covers a 
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6 km radius from SFDDH ensuring good access to the hospital-based clinical 
surveillance systems. The study was approved by the local and national ethics 
review committees in Tanzania and those of the London School of Hygiene and 
Tropical Medicine and the World Health Organisation. 
 
Design and intervention  
This two-arm randomised double–blind trial was designed to compare the safety 
and efficacy of two vitamin A supplementation regimens. In the lower dose group, 
mothers received 60,000µg (200,000 IU) vitamin A (as vitamin A palmitate) at the 
time of their infant’s BCG vaccination and their infants received three doses of 
7,500µg (25,000 IU) at the time of vaccinations with DPT/OPV. In the higher dose 
group, mothers received an additional dose of 60,000µg (200,000 IU) when their 
infant received the first DPT/OPV vaccination, and their infants received three 
doses of 15,000µg (50,000 IU) alongside the three DPT/OPV vaccinations. In 
accordance with national guidelines, all infants received 30,000µg (100,000 IU) 
vitamin A at the time of measles vaccination. Vitamin A capsules providing 
different doses were manufactured by Accucaps Industries, Canada (25,000 IU 
and 50,000 IU) and Aprilia, Italy (200,000 IU), and were supplied to the project by 
the World Health Organisation. Capsules were transported and stored in light-
proof boxes and kept in an air-conditioned room at the trial site. 
 
Recruitment, randomisation and administration of vitamin A 
Mothers who were resident in the study area and brought their infants to 
SFDDH/MCHC for BCG vaccination within 7 days of birth were invited to 
participate in the trial. Details of the trial were explained and a series of 
standardised questions asked to ensure adequate understanding before seeking 
written, informed consent. Demographic information was documented before the 
lowest available study number was assigned to mother-infant pairs. Individual 
randomisation was achieved using a list of study numbers which had been 
randomly assigned to an intervention arm in blocks of 10, generated by the data 
and safety monitoring board.  
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Mothers were invited to bring their child to the MCHC for vaccination and vitamin 
A dosing on a specific date when the child would be approximately one month 
old. Before each supplementation, project clinical officers examined mothers 
and/or their infants and a standardised morbidity questionnaire was completed. 
The contents of a vitamin A capsule, labelled only with the participant’s study 
number, were squeezed into the recipient’s mouth. Mother-infant pairs who had 
not attended the MCHC within one week of their appointment were visited at 
home to confirm residence and survival status, and, if present, reminded to 
attend the study clinic.  
 
Follow-up  
The timing of the interventions and follow-up is summarised in figure 1. Safety 
was assessed throughout the study by passive case detection using a Clinical 
Surveillance System (CSS), and actively at home on each of the two days 
following each supplementation. The primary assessment of efficacy was based 
on biochemical indicators of vitamin A status for which blood samples were 
collected during cross-sectional surveys when children were aged 6 and 9 
months. 
 
Assessment of safety 
Mothers were encouraged to bring their infant to the CSS if they experienced any 
illness at any time during follow-up. The CSS was established at SFDDH in 1994 
to document all outpatient attendances of study infants and paediatric 
admissions, around the clock, every day of the year. Specially trained Clinical 
Officers examined and completed a standardised pre-coded morbidity 
questionnaire for each infant including, for example, the presence or absence of 
fever, bulging fontanelle, diarrhoea, clinical malaria and anaemia. The CSS thus 
generated detailed clinical data for the assessment of safety and secondary 
efficacy endpoints. Necessary laboratory tests and appropriate management 
were provided free of charge. 
 
Active clinical surveillance was by field workers visiting mothers and/or their 
infants at home for two consecutive days after each maternal and infant 
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supplementation.  A standard form was completed documenting any symptoms 
or clinical signs of illness. Study participants found to have potentially serious 
clinical symptoms or signs were asked to attend the hospital for re-examination 
by a study clinician.  
 
Assessment of efficacy 
Vitamin A status was assessed by analysis of capillary blood samples collected 
from infants during cross-sectional surveys at age 6 and 9 months. A field worker 
invited mother-infant pairs to attend these surveys, having documented that the 
infant was alive and still resident in the study area.  Those who did not attend 
were re-invited each week for a total of four weeks. Breast milk was collected into 
50ml falcon screw-top tubes for subsequent analysis of retinol content. A single 
oral dose of 3, 4-didehydroretinyl acetate (DRA) was administered to mothers 
(8.8µmol) and/or infants (5.3µmol) for assessing the modified-Relative-Dose-
Response (MRDR test) as previously described (Tanumihardjo et al. 1996a). 
Finger prick capillary blood samples were collected into 500µl microtainer tubes 
(Becton Dickinson, Franklin Lakes, New Jersey, USA) three hours after 
administration of DRA. Height and weight of infants were also recorded using 
standard methods (United Nations Department of Technical Cooperation 1986). 
  
Laboratory procedures 
Blood and milk samples were immediately stored on ice in cool boxes and 
transported to the laboratory within two hours. Exposure to light was kept to a 
minimum. In the base laboratory, serum was immediately separated from whole 
blood and aliquots of serum and homogenised milk stored at -20oC in 2mL 
screw-top Nunc tubes. Frozen samples were transported to the Nutritional 
Intervention Research Unit of the Medical Research Council, Cape Town, South 
Africa, for analysis using standard HPLC procedures (Tanumihardjo & Penniston 
2002;Valentine & Tanumihardjo 2004).  
 
Data management and statistical considerations 
Data were double-entered and daily cross checking routines used to detect and 
correct any discrepancies. Cleaned and locked database files were exchanged 
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for the treatment randomisation code, held by the data and safety monitoring 
board. Analyses were conducted, in a masked manner, according to a pre-
agreed analytical plan using STATA version 7 (Stata Corp LP, College Station, 
Texas, USA). EPINut (EPI Info v6, Atlanta, GA, USA) was used to generate 
anthropometric indices. Prior to the study, a total of 780 six month old infants 
were estimated to provide 90% power to detect a relative decrease of one-third in 
the prevalence of VAD from 37% to 25%, at a 5% significance level.  
 
The primary definition of VAD was an MRDR value ≥0.060 (i.e. the ratio of serum 
3, 4-didehydroretinol (DR) to retinol (R) (DR/R)), three hours after the DRA dose 
was administered, and was evaluated in all randomised children with a valid 
laboratory result. As a secondary endpoint, VAD was also defined as a serum 
retinol concentration ≤0.70µmol/L and was considered severe at a concentration 
≤0.35µmol/L. These and other categorical variables were compared using the 
chi-square test. Mean breast milk and serum retinol concentrations were 
compared using the t-test. Separate analyses evaluated endpoints at six and nine 
months of age. Safety was analysed by comparing the incidence rates of clinical 
signs of illnesses and diagnoses documented by the CSS during the 28 days 
after each supplementation and over all time at risk. Time at risk began from the 
time of recruitment and continued until the earliest of a clinical episode or 
censoring due to withdrawal, death or end of follow-up. Poisson regression 
models with random effects to take into account between-child heterogeneity 
were used to compare incidence rates. The proportions of participants with 
clinical signs of illnesses and symptoms detected actively within 48 hours after 
each supplementation were also compared. The effect of the intervention on 
anaemia and clinical malaria was evaluated by comparing incidence rates 
between the two groups. Anaemia was defined as either mild (a packed cell 
volume (PCV) <33%), severe (PCV<25%) or life threatening (PCV<15%). 
Anthropometric indices were assessed on all randomised infants at 6 and 9 
months of age by comparing the proportion of infants in each group with a weight 
for age z-score (WAZ) <-2, height for age z-score (HAZ) <-2 and weight for height 
z-score (WHZ) <-2.  
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Quality Control 
Standardised quality control procedures were used to ensure consistency in data 
collection and assessment of adverse events. Pre-coded forms with labels 
bearing identification information were used for all routine contacts. Training in 
the assessment of clinical signs of illness and monitoring of Clinical Officers and 
field workers was continued throughout the trial. Field activities were supervised 
through regular accompanied and repeated interviews. Vitamin A capsules for 
quality control were transported at regular intervals to the Institute of Nutritional 
Research, University of Oslo, Norway. These analyses confirmed that the 
200,000 IU and100,000 IU capsules contained a satisfactory amount of retinyl 
palmitate throughout the trial period. The 25,000 IU capsules also had at least 
80% potency up to July 2003, when the last dose of this type of capsule had 
already been given. The 50,000 IU capsules that were tested were also fully 
potent up to and including February 2003. However, between February and July 
2003 the vitamin A content of the 50,000 IU capsules declined markedly, such 
that the 33 capsules that were analysed between August 2003 and January 2004 
contained only 1,800-23,993 IU, with a mean of 15,861 IU, 32% the expected 
amount. Taking into consideration the results of similar analyses from a sister trial 
in Kintampo, Ghana, consensus was reached between the investigators, WHO 
and the trial Data and Safety Monitoring Board, before the code was broken, that 
the 50,00 0IU capsules in Ifakara degraded rapidly after May 2003. Hence, 
secondary statistical analyses were performed excluding the 5% of infants who 
received doses after 31st May 2003, and tertiary analyses excluding the 30% of 
infants who received doses after 31st January 2003. In addition, assessments of 
both efficacy and safety were evaluated taking into consideration the time 
elapsed since the date that recruitment started, using the Likelihood Ratio test 
comparing a model with the effect of the vitamin A with a model where the cohort 
had been split into tertiles of date of recruitment and looking for an interaction 
between the date of recruitment tertile and efficacy.  
 
6.4 Results 
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Recruitment of 780 mother-infant pairs took from April 2002 to March 2003, and 
follow-up was completed by the end of 2003. Completeness of follow-up (figure 
2) and baseline characteristics (table 1) were similar in the two groups.  
 
The incidence of all clinical signs of illnesses, symptoms and diagnoses detected 
by the CSS was similar in the two groups of infants during the 28 days after each 
supplementation (data not shown) and during all time at risk (table 2). Active case 
detection documented a lower prevalence of fever after the first dose of vitamin A 
given to infants in the higher dose arm (147/308 (48%)) versus the lower dose 
arm (183/318 (58%), risk ratio 0.83 (95% confidence interval (CI) 0.71, 0.96), 
p=0.01). No similar pattern was seen after other doses and the prevalence of 
other signs and symptoms (e.g. fits, jaundice, and chest in drawing) was similar 
after all doses (data not shown).  
The proportion of infants with inadequate vitamin A liver stores (MRDR ≥0.060) at 
6 months was 43% in the higher and 47% in the lower dose arm (table 3). 
Vitamin A deficiency of different severities, defined according to serum retinol, 
and mean serum retinol concentrations were also similar in the two groups. 
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Table 1: Baseline characteristics of children and mothers 
Vitamin A Supplementation 
Group 
Higher Dose 
(N=390) 
Lower Dose 
(N=390)   
Variable n % n % p-value 
Male  215 55 197 51 0.20* 
Exclusive breastfeeding at age one month 337 86 338 87 0.92 * 
VAD (mRDR≥0.06) before child’s first dose  255 84 238 82 0.44 * 
None  61 16 71 18 
Primary 314 81 301 77 
Maternal education  
Secondary 15 4 18 5 0.52 * 
1st tertile 112 34 124 37 
2nd tertile 112 34 107 32 
Distance from hospital 
(km)  
3rd tertile 108 33 100 30 0.60 * 
Insecticide Treated Net use  334 86 337 86 0.76 * 
 
 
 
Mean SD Mean SD p-value 
Age at Dose 1 (months) 1.41 0.96 1.38 0.89 0.68# 
Mean birth weight (Kg) 2.94 0.46 2.90 0.76 0.33 # 
Serum retinol (µmol/L) before child’s first dose 0.67         0.19 0.67 0.18 0.76 # 
Breast milk retinol(µmol/L) after delivery 4.34 3.01 4.60  3.52  0.34 # 
 
The incidence of malaria and anaemia during follow up, and the cross-sectional 
prevalence of anaemia and malaria, and anthropometric indices, were similar in 
the two groups (table 4). 
 
The secondary and tertiary analyses excluding data from children receiving 
vitamin A supplements after May 31st 2003 and January 2003, respectively, did 
not significantly change these results (data not shown). 
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          Table 2: Incidence o signs and symptoms detected by clinical surveillance system from recruitment to end of time at risk 
                        
Higher Dose Lower Dose Comparison 
Outcome 
Episodes PYAR Rate Episodes PYAR Rate RR 95%CI p-value 
Fever 739 197.8 3.74 768 195.6 3.93 0.95 ( 0.83, 1.08) 0.44 
Runny Nose 451 208.4 2.16 478 206.7 2.31 0.94 ( 0.79, 1.12) 0.47 
Diarrhoea 272 222.6 1.22 288 222.6 1.29 0.95 ( 0.79, 1.15) 0.59 
Vomiting 120 234.0 0.51 138 233.5 0.59 0.87 ( 0.67, 1.13) 0.29 
Coughing 741 186.4 3.98 798 183.1 4.36 0.91 ( 0.79, 1.04) 0.17 
Fast breathing 28 240.6 0.12 27 241.6 0.11 1.01 ( 0.55, 1.85) 0.97 
Fitted 2 242.6 0.01 3 243.3 0.01 0.67 ( 0.11, 4.00) 0.66 
Pallor 13 241.9 0.05 12 242.7 0.05 1.07 ( 0.47, 2.45) 0.87 
Jaundice 0 242.7 0 2 243.3 0.01 . . . 
Nasal flaring 76 237.1 0.32 74 237.9 0.31 1.01 ( 0.72, 1.44) 0.93 
Chest indrawing 164 230.3 0.71 159 232.0 0.69 1.02 ( 0.80, 1.30) 0.85 
Pus in ears 19 241.3 0.08 28 241.4 0.12 0.67 ( 0.35, 1.28) 0.23 
Bulging fontanelle 0 242.7 0 0 243.4 0 . . . 
Wheezing 230 225.2 1.02 243 225.1 1.08 0.95 ( 0.76, 1.17) 0.62 
Stiff Neck 5 242.4 0.02 4 243.2 0.02 1.25 ( 0.34, 4.67) 0.74 
Hepatomegaly 8 242.2 0.03 3 243.2 0.01 2.68 ( 0.71,10.09) 0.15 
Splenomegaly 95 235.5 0.4 86 236.9 0.36 1.11 ( 0.83, 1.49) 0.48 
Oedema 6 242.2 0.02 3 243.2 0.01 2.01 ( 0.50, 8.03) 0.32 
Oral candidiasis 1 242.7 0 1 243.3 0 1 ( 0.06,16.03) 1 
Chest crackles 363 215.5 1.68 369 216.1 1.71 0.99 ( 0.82, 1.18) 0.88 
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Table 3: Prevalence of vitamin A deficiency and mean serum retinol concentration at 6 and 9 
months 
Outcome 
  
Higher dose 
%  (n/N) 
Lower dose  
 % (n/N) 
Relative Risk  
(95% CI) 
p 
value 
  
6 months 
mRDR≥0.06 43 (125/293) 47 (132/282) 0.91  (0.76,1.09) 0.32* 
  Serum retinol ≤0.70µmol/l 36 (111/306) 41 (121/296) 0.89  (0.73,1.09) 0.25* 
  Serum retinol ≤0.35µmol/l 1  (3/306) 2.4 (7/296) 0.41  (011,1.59) 0.18* 
  Mean serum retinol µmol/l 
(SD) 0.79  (0.24) 0.81  (0.25)  - 0.16Ŧ 
Mean breast milk retinol 
µmol/l (SD) 1.82 (1.09) 1.88 (1.09) -  0.49Ŧ 
9 Months 
mRDR≥0.06 41 (113/278) 40 (108/269) 1.01  (0.83,1.24) 0.91* 
  Serum retinol ≤0.70µmol/l 29 (85/292) 32 (90/286) 0.93  (0.72,1.18) 0.54* 
  Serum retinol ≤0.35µmol/l 1.7 (5/292) 1.8 (5/286) 0.98  (0.29,3.35) 0.97* 
  Mean serum retinol µmol/l 
(SD) 0.86 (0.32) 0.90 (0.36) - 0.16Ŧ 
Mean breast milk retinol 
µmol/l (SD) 1.86 (1.19) 1.95 (0.97) - 0.33Ŧ  
* Chi-squared test, Ŧ t-test 
 
Table 4: Anthropometric, malaria and anaemia indices 
Higher Dose Lower Dose 
Outcome 
n/N % n/N % 
Relative Risk 
(95% CI) 
p-
value 
Prevalence at 6 months of age 
WAZ1 <-2 12/305 3.9 15/289 5.2 0.76 (0.36,1.59) 0.46 
HAZ2 <-2 29/309 9.4 18/297 6.1 1.55 (0.88,2.73) 0.13 
WHZ3 <-2 3/304 1.0 7/289 2.4 0.41 (0.11,1.56) 0.17 
Moderate anaemia†  125/311 40.2 121/304 39.8 1.01 (0.83,1.23) 0.92 
Severe anaemia‡  3/311 1.0 3/304 1.0 0.98 (0.20,4.81) 0.98 
Prevalence at 9 months of age 
WAZ1 <-2 38/287 13.2 43/272 15.8 0.84 (0.56,1.25) 0.39 
HAZ2 <-2 39/297 13.1 31/279 11.1 1.18 (0.76,1.84) 0.46 
Chapter 6: Randomized control trial of the vitamin A supplementation 
 - 94 - 
WHZ3 <-2 12/298 4.2 12/271 4.4 0.94 (0.43,2.06) 0.88 
Moderate anaemia†  87/298 29.2 89/288 30.9 0.94 (0.74,1.21) 0.65 
Severe anaemia‡  5/298 1.7 5/288 1.7 0.97 (0.28,3.30) 0.96 
Incidence during all time at risk after recruitment 
 
Events 
/PYAR 
Incide
nce 
Events 
/PYAR 
Incide
nce 
Incidence Rate 
Ratio 
p-
value 
First malaria episode 46/240.4 0.19 37/242.1 0.15 1.25 (0.81,1.93) 0.31 
First mild anaemia episode 50/241.2 0.23 45/241.3 0.19 1.11 (0.74,1.66) 0.61 
1: weight for age z-score, 2: height for age z-score, 3: weight for height z-score, 
†Packed Cell Volume <33%, ‡Packed Cell Volume <25%, PYAR-person years at 
risk 
6.5 Discussion 
This double-blind randomised controlled trial has shown that supplementation of 
mothers with a second dose of 200,000IU of vitamin A, and their infants with 
50,000IU at the time of routine vaccinations at approximately 1, 2 and 3 months of 
age, was safe but not efficacious compared to a lower dose regimen. Biochemical 
markers of vitamin A status were similar in infants in both arms at 6 and 9 months of 
age, as were mean breast milk retinol concentrations. Clinical endpoints detected 
passively and actively did not suggest any consistent clinical benefits of the higher 
dose regimen.  
 
These results are not what had been expected (Humphrey & Rice 2000) and it is 
important to consider all possible explanations. The degradation of vitamin A 
capsules, which was most marked in the 50,000IU capsules, is a prime concern. 
However, the analyses excluding children who may have been dosed with lower 
amounts of vitamin A than intended reassured us that the deterioration of the 
capsules was not the reason for the lack of efficacy of the intervention. This finding 
shows the importance of the quality control assessments that were included in this 
clinical trial, and emphasises the importance of such checks both in future clinical 
trials and in routine supplementation programmes.  
 
Another possibility is that the measures of VAD used in this study do not accurately 
reflect the vitamin A status of the very young African infants involved. Young infants 
are subject to major physiological changes and a high incidence of infectious 
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disease. The integrity of serum retinol as a measure of VAD may be compromised, 
for example, by elevated acute phase proteins resulting from infections, leading to an 
under-estimate of serum retinol concentration (Thurnham et al. 2003) and reducing 
the specificity of serum retinol as a marker of VAD. This would tend to downwardly 
bias efficacy estimates based on this measure. However, MRDR tests were used as 
the primary outcome measure and are not affected by sub-clinical inflammation 
(Tanumihardjo et al. 1996b;Wieringa et al. 2002). We collected blood samples for 
MRDR evaluation three hours after DRA dosing. However, it is now clear that 
samples should be collected at least four hours after supplementation as earlier 
sampling reduces the sensitivity of the test. Although this would reduce the power of 
our study, we nevertheless found a high prevalence of VAD and thus conclude that 
the timing of MRDR blood sample collection is unlikely to explain the lack of efficacy 
in this study. The gold standard measure of vitamin A status requires a liver biopsy, 
an investigation too invasive for a trial such as this. The MRDR test is the most 
appropriate indicator of vitamin A status and has been shown to work well in older 
populations when the test is tightly controlled and care taken with its interpretation. 
However, its use in field settings involving young African infants merits further 
investigation. 
 
The study was not placebo controlled because it was not considered ethical to 
randomise some infants to placebo when the lower dose regimen had been shown to 
have a marginal beneficial effect in a previous trial. Hence, our efficacy estimate may 
be slightly lower than would have been the case had this been a placebo-controlled 
trial. Nevertheless, the prevalence of VAD in the two arms was high and very similar: 
it seems unlikely that we missed a substantial effect of the higher dose regimen.  
 
The study benefited from the availability of a Clinical Surveillance System (CSS) 
which generated detailed clinical safety and efficacy information. The data generated 
by this passive case detection system was qualitatively different from that generated 
by the active case detection used to detect any immediate, short term side effects of 
the supplementation. The CSS documented episodes of illness that were severe 
enough for a child to be brought to the clinic, and covered the whole nine months of 
follow up for each infant rather than just two days after supplementation. The fact 
that there was no increase in either the short term side-effects or passively detected 
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illnesses, including bulging fontanelle, provides reassurance that the higher dose 
regimen was as safe as the lower dose regimen. However, the lack of any decrease 
in incidence of illnesses detected through the CSS suggests that the higher dose 
regimen did not confer any important absolute effect on morbidity.  
 
The best approach to improve the vitamin A status of young infants remains unclear. 
It may be that even higher doses of vitamin A at the time of routine vaccinations, 
and/or to mothers of young children, would have an impact. Alternatively, given the 
success of immunisation campaigns to raise vitamin A supplementation coverage, it 
may be useful to assess the effects of these on vitamin A status and to consider 
supplementing children aged less than six months in such campaigns. Another 
approach would be to further evaluate the effects of early neonatal supplementation.  
 
The higher dose supplementation regimen we evaluated has already been 
recommended by the International Vitamin A Consultative Group (International 
Vitamin A Consultative Group (IVACG) 2002). Although not previously tested in a 
clinical trial, the recommendation was based on theoretical calculations of its likely 
effect on infants’ vitamin A status, the potential for reductions in infant morbidity and 
mortality and a low probability of any important toxic side effects. Our results do not 
support this current IVACG recommendation. This highlights the difficulties inherent 
in balancing the urgency of reducing high infant mortality rates by implementing 
interventions that seem likely to be beneficial, against the time taken to conduct 
appropriate studies to gain empirical evidence of their efficacy. However, the EPI 
offers unparalleled opportunities to deliver health interventions to infants, the age 
group of children who suffer the highest mortality rates, and it is essential that the 
safety and efficacy of any potential intervention are tested in carefully conducted 
clinical trials before being implemented.  
 
In conclusion, higher dose vitamin A supplementation was well tolerated by mothers 
and infants, but failed to improve the vitamin A status or the incidence of illness 
episodes in trial participants. The stability of the vitamin A capsules is of great 
concern and draws attention to the need for quality assurance checks on such 
capsules in clinical trials and routine supplementation programmes. Specific 
validation of the biochemical indicators of vitamin A status may be useful in very 
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young infants. This study highlights the potential dangers of basing policy 
recommendations on theoretical calculations and plausible extrapolation from 
existing empirical data.  
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7.1 Abstract 
Background 
Efficient delivery strategies for health interventions are essential for high and 
sustainable coverage. We report impact of a change in programmatic delivery 
strategy from routine delivery through the Expanded Programme on 
Immunization (EPI+) approach to twice- yearly mass distribution campaigns 
on coverage of vitamin A supplementation in Tanzania 
 
Methods 
We investigated disparities in age, sex, socio-economic status, nutritional 
status and maternal education within vitamin A coverage in children from two 
independent household level child health surveys conducted:  1) prior to the 
introduction of twice-yearly mass distribution campaigns (1999); and 2) three 
years later (2002). A representative cluster sample of approximately 2,400 
rural households was obtained from Rufiji, Morogoro Rural, Kilombero and 
Ulanga districts. A modular questionnaire about the health of all children 
under the age of five was administered to consenting heads of households 
and caretakers of children. Information on the use of child health interventions 
including vitamin A was asked. 
 
Results 
Coverage of vitamin A supplementation among 1- 2 year old children 
increased from 13% [95% CI 10-18%] in 1999 to 76% [95%CI 72-81%] in 
2002.  In 2002 knowledge of two or more child health danger signs was 
negatively associated with vitamin A supplementation coverage (80% versus 
70%) (p=0.04). Nevertheless, we did not find any disparities in coverage of 
vitamin A by district, gender, socio-economic status and DPT vaccinations. 
 
Conclusions 
Change in programmatic delivery of vitamin A has been shown to achieve a 
major improvement in coverage in Tanzania that has been sustained by 
repeated campaigns for at least three years. There is a need to monitor the 
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effect of such campaigns on the routine health system and on equity of 
coverage. Documentation of vitamin A supplementation campaign contacts on 
routine maternal and child health cards would be a simple step to facilitate this 
monitoring. 
 
7.2 Background 
Vitamin A supplementation is one of the best proven, safest and most cost-
effective interventions in public health (World Bank 1993). In populations 
where vitamin A deficiency is of public health importance (WHO 1998), 
vitamin A supplements are recommended as prophylaxis and as treatment for 
at-risk groups and sick individuals respectively. Approximately two- thirds 
(Jones et al. 2003)  of the 10.8 million child deaths (Ahmad, Lopez, & Inoue 
2000) that presently occur can be prevented by available interventions of 
which vitamin A supplementation (VAS) is one. A meta-analysis of several 
large vitamin A trials has shown that  improving vitamin A status reduces 
mortality rates between 23-34%  among children six months to five years of 
age if vitamin A supplementation is given at least twice per year at coverage 
rates of at least eighty percent (Beaton et al. 1993;Fawzi et al. 1993).  
 
In Tanzania, efforts to combat vitamin A Deficiency (VAD) through 
supplementation started through a disease-targeted approach in 1987. This 
was not very successful because it was confined to government-owned 
primary health care facilities and targeted therapeutically to children between 
6-59 months suffering from xerophthalmia or diseases precipitating VAD. 
Consequently, many young children at risk of VAD in Tanzanian communities 
were not supplemented with vitamin A through this approach. In 1997, Vitamin 
A supplementation was introduced through the routine Expanded Programme 
on Immunization (EPI) for post partum mothers’ and children at 9 months 
together with measles vaccination.  
 
During measles vaccine campaigns in late 1999 and 2000, children between 
6-59 months from 30 and 52 districts respectively of mainland Tanzania also 
received vitamin A supplements. Post campaign Vitamin A supplementation 
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coverage levels in these pilot campaigns were estimated at 94% and 99% in 
1999 and 2000 respectively (Mugyabuso JKL. paper presented at the Annual 
EPI evaluation meeting 2002). Based on these results and similar lessons 
from the Philippines (Fiedler et al. 2000), UNICEF initiated and supported the 
national bi-annual implementation of VAS in children 6 months to 5 years in 
Tanzania starting in 2001. Advocacy, social mobilization and campaigns 
through national mass media agencies were used to create awareness in 
communities. The estimated coverage for targeted children in June and 
December 2001 from routine statistics was 80% and 91% respectively 
(Mugyabuso JKL, paper presented at the Annual EPI evaluation meeting 
2001).   
 
Here we describe the effect of the change in programmatic delivery strategy of 
vitamin A supplementation on coverage as documented through two 
independent household-level child health surveys carried out prior to the 
introduction of the twice-yearly mass distribution strategy (1999) and three 
years later (2002). We also describe factors associated with access to the 
intervention. 
 
7.3 Methods 
This study was part of a larger evaluation of the effectiveness and cost of 
health system and facility-based Integrated Management of Childhood Illness 
(IMCI). Details of the study area have been described elsewhere (Armstrong 
Schellenberg et al. 2003). In brief, Rufiji and Kilombero districts are low-lying 
and much of the land has fertile alluvial soil of the Rufiji and Kilombero River 
plains respectively. Morogoro Rural and Ulanga are mountainous with some 
low-lying areas. The main economic activities of the population are 
subsistence farming and fishing. The four districts have an estimated total 
population of about 1.2m people (Tanzania National Bureau of Statistics 
2003). Morogoro Rural district participated in the 1999 but not the 2000 
measles campaign which also included pilot vitamin A supplementation. 
Kilombero district participated only in 2000 measles campaign. Rufiji and 
Ulanga districts were not part of either pilot campaign. 
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A representative cluster sample of approximately 2,400 rural households was 
obtained from the four districts. In 1999, 30 clusters were selected from each 
of three districts and 35 clusters from Kilombero District. Villages (clusters) 
were selected with probability proportional to size, and one kitongoji (sub-
village with approximately 100 households) was selected at random from each 
selected village. 20 households were selected using a modified EPI-type 
scheme (Bennett et al. 1991) that guaranteed an equal probability of selection 
for every household. In 2002, the same villages were selected but the 
sampling of sub-villages and households was repeated with replacement. The 
chances of visiting the same households were small. Ifakara town in 
Kilombero district is the largest urban area in the survey; ten additional 
clusters from this town have been omitted from the analysis described here, 
so that all results refer to rural areas. 
 
A structured questionnaire about the health of all children under the age of 
five years was administered to consenting heads of the households. We 
documented background information of all children in the household, 
information on proxy indicators of household socio-economic status such as 
household ownership of a radio, a tin roof, a bicycle, educational level and 
occupation of the head of household. Mothers or caretakers of children were 
interviewed about their educational level and knowledge of child health danger 
signs (fast breathing, difficult breathing, fits or convulsions, very sleepy, 
vomiting all ingested material or inability to drink or breastfeed). Vaccination 
history was recorded from health cards or mother’s record books for those 
who had one. Where there were no records or none could be found, mothers 
or caretakers were asked whether the child had DPT immunizations and the 
number of doses received. Mothers or caretakers of the children were shown 
a vitamin A capsule and were asked whether their children had ever received 
a similar one, and if so, the month and year of the most recent dose. 
 
Data analysis 
Data were double-entered and verified using FoxPro (version 2.6, Microsoft 
Corporation, Seattle, WA, USA) at Ifakara Health Research and Development 
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Centre (IHRDC). Range checks and internal consistency were performed 
before analysis in Stata (version 8.2, Stata Corporation, College Station, TX, 
USA).  
 
The analysis took into account the clustered nature of data. We used standard 
STATA svytab command to produce design-based F-tests. Vitamin A 
supplementation coverage was defined as the number of children between 1 
and 2 years of age receiving vitamin A in the six months prior to the date of 
the survey divided by the total number of children between 1 and 2 years in 
the survey (Victora, Bryce, & Lambrechts 1998). A relative index of socio-
economic status was constructed by combining documentation of household 
characteristics, assets, income sources and education. We used principal 
components analysis to estimate the appropriate weights or “scores” for the 
index (Filmer & Pritchett 2001). Quintiles of children were developed based on 
their household socio-economic score.  
 
7.4 Results 
A total of 385 and 388 children aged between 1 and 2 years who had 
complete data on vitamin A supplementation were sampled from 2,131 and 
2,027 households in 1999 and 2002 surveys respectively. Table 1 shows 
selected background of the study subjects from the two surveys. 
Approximately 1% (1999) and 0.4% (2002) of the households refused to 
participate in the surveys.  
 
Overall coverage of vitamin A increased from 13.2% [95% CI: 9.8-17.7%] in 
1999 to 76.3% [95% CI: 71.5-80.5%] (Table 2). As expected, maternal 
education was associated with VAS coverage, although the difference 
reached conventional statistical significance only in 1999 (p=0.02), and not in 
2002 (p=0.08).  Coverage of VAS was similar in the two surveys for both boys 
and girls and did not vary by vaccination status. However, in the 2002 survey, 
maternal knowledge on child health danger signs was found to be negatively 
associated with VAS coverage, which was about 10 percentage points lower 
in mothers who knew at least two danger signs than in those who did not. The 
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VAS achieved a major increase in coverage without any decrease in equity: 
coverage was uniformly distributed by socio-economic status before and after 
the campaigns, as well as across the districts. 
 
 
7.5 Discussion 
This study has revealed that a change in the delivery strategy of interventions 
in a health system can have important effects on coverage without 
compromising equity. Our data has shown that, vitamin A supplementation 
coverage in children between 1 and 2 years of age increased from 13% in 
1999 to 76% in 2002. National coverage figures from the 1999 Tanzania 
Reproductive and Child Heath Survey (TRCHS) were similar (14%) (Tanzania 
National Bureau of Statistics & Macro International Inc.Calverton 2000) to 
what we observed in study districts. However, more recent national coverage 
estimates from the 2004/2005 DHS, which include around 7,000 children 
(Tanzania National Bureau of Statistics & Macro International Inc.Calverton 
2005), are rather lower, at (46%), than we found in our 2002 survey, possibly 
due to geographic variations in coverage or to a drop between 2002 and 
2004. In contrast, 85% and 90% coverage at national level have been recently 
reported by two other sources (Ndossi, G.D. 2004 and Helen Keller 
International, 2004), the second of which was population based assessment in 
12,000 children from 21 regions of mainland Tanzania. The most likely 
explanation for the discrepancies between the 2004/05 DHS and HKI survey, 
both of which cover the entire country are a combination of survey timing and 
differences in questionnaires wording and implementation. The HKI survey 
was conducted during early to end of August 2004, and had a short recall 
period, as it was little more than a month after the June 2004 VAS campaign. 
The DHS was conducted from October 2004 to January 2005. Further, the 
HKI survey question on VAS had a specific point reference of June 2004 
whereas the DHS question referred to a 6 month period prior to the survey 
(giving the scope to capture VAS provided through EPI+ as well as disease 
targeted approaches, which would have increased coverage estimates).  
Interview techniques, whether or not mothers were actually shown the 
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capsules, and whether the capsules were of the right colour, could explain the 
differences observed (Mugyabuso, report in preparation). Sampling 
methodology also differed between the surveys. 
 
We found no worsening of inequities in vitamin  A supplementation between 
1999 and 2002, despite the major increase in coverage, unlike what has been 
reported elsewhere (Choi, Bishai, & Hill 2005). Introduction of new health 
interventions is often embraced by richest first and followed gradually by the 
poorest (Victora et al. 2000). As our data shows one would expect equity to 
get worse as coverage increases, before it can get better. Here we found the 
opposite and highlights the need for devising ways to maintain these 
achievements (Mills 2005). We did not find any evidence of gender or district 
differentials in VAS coverage. A negative association between vitamin A 
supplementation and maternal knowledge of child health danger sign was 
rather unexpected. We think this to be more of a chance finding than a real 
difference.  
 
Vitamin A supplementation campaigns in Tanzania have been concerted 
efforts by the Government and stakeholders from the health sector. To 
maximize coverage, activities were strategically integrated into 
commemoration of the Day of the African Child and World AIDS Day events. 
During implementation, partnerships were forged between the Presidents 
Office for Regional Administration and Local Government (PORALG), Ministry 
of Health and the Tanzania Food and Nutrition Centre (TFNC). Funding 
support came primarily from UNICEF and vitamin A supplies from Canadian 
International Development Agency (CIDA). Other agencies and Non 
Governmental Organizations such as USAID and Plan International also 
joined these efforts, albeit in later rounds.  
This study had two potential limitations.  First, we depended largely on the 
mothers’ or caretakers’ accounts of the vitamin A supplementation status of 
their children. We also checked the child’s MCH card or notebook for 
information about vitamin A supplementation but this had limited use as the 
campaign staff were trained not to record the vitamin A dose on the children’s 
health cards. Secondly, neither the 1999 nor the 2002 household surveys 
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were designed solely to evaluate the change in delivery strategy or policy, but 
were rather designed to measure coverage of various interventions for 
children under five, vitamin A supplementation being one, as recommended 
by UNICEF and WHO (Victora, Bryce, & Lambrechts 1998). 
  
Although the bi-annual campaign-based strategy for vitamin A delivery 
resulted in a major increase in coverage, it remains important that this 
approach sustains universal coverage while not undermining routine health 
programs (Schreuder & Kostermans 2001). 
  
One among the many obstacles for health systems in low-income countries is 
fragmented health information systems. Reliable and timely health information 
is an essential foundation for public health action. Such systems are vital for 
informing decision-makers to enable them to identify problems and needs, 
track progress, evaluate the impact of interventions, and make evidence-
based decisions on health policy and effect policy change. Routine health 
programs may be weak due to poor motivation, often overburdened health 
staff with excessive data and reporting from multiple data collection systems 
and lack of supervision. The VAS coverage rates that we have observed so 
far in Tanzania need to be sustained and monitored regularly if we are to 
reach the MDGs in 2015. The MCH “Road to Health” cards offer a practical 
opportunity to capture information on interventions that children actually 
receive through routine systems or campaigns. 
 
During the mass distribution campaigns, vitamin A supplementation was not 
recorded on the health card. If campaigns are going to continue, monitoring of 
progress would be greatly simplified if planners ensure that information for 
each individual child is recorded. To our knowledge, vaccines or vitamin A 
supplementation campaigns that are outside routine EPI are not generally 
registered on children’s health cards. 
 
Coverage figures of the campaigns since 2001 have been recorded on tally 
sheets and subsequently summary sheets that were later collated by 
Tanzania Food and Nutrition Centre.  The problem with this approach is the 
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potential to over-estimate coverage because of lack of proper denominators, 
or inflated numerators due to multiple doses to the same children. 
Documenting any extra contacts such as National Immunization Days (NID) or 
other related health events on health cards not only offers a useful opportunity 
to reliably estimate coverage figures, but also creates a less demanding and 
more integrated health information system. In our study, we used information 
provided by mothers as well as that written on health cards to estimate 
coverage figures.  This source of information is also open to error but is likely 
to be a conservative estimate, and has the advantage of being household-
based (Murray et al. 2003).  
 
Social mobilization campaigns are good for catch-up coverage over a short 
period of time. This coverage has been sustained for at least three years. In 
spite of the campaigns, National VAS coverage has dropped to 46% in 2004 
(Tanzania National Bureau of Statistics & Macro International Inc.Calverton 
2005). Given the evidence on the cost per death averted in Tanzania (MOST 
& USAID Micronutrient Program 2005) and the role vitamin A can play in 
reducing child mortality, allocation of resources required to implement such 
child health interventions need to be maintained.  
 
We conclude that, since routine services at present are not geared towards 
monitoring vitamin A supplementation campaign contacts, deliberate efforts 
must be taken to enable capturing of such information at both routine contacts 
and campaigns. This will facilitate the monitoring of the effect of campaigns on 
routine health systems, equity of coverage and tracking progress on child 
survival.
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      Table 5: Distribution of selected characteristics in 1999 and 2002 survey 
Survey year Characteristics 
1999 2002 
Sex (N=385 in 1999, 388 in 2002)     
  Female 197 51.2 183 47.2 
  Male 188 48.8 205 52.8 
Age distribution‡     
  6-11 months 467 25.2 401 21.3 
  1-2 years 385 20.7 388 20.6 
  2-3 years 353 19.0 406 21.6 
  3-4 years 348 18.7 356 19.0 
  4-5 years 304 16.4 330 17.5 
DPT vaccination (N=385 in 1999, 387 in 
2002)     
  Not vaccinated 105 27.3 91 23.5 
  Vaccinated 280 72.7 296 76.5 
Mothers education (N=385 in 1999, 388 in 
2002)     
  None 129 33.5 100 25.7 
  Primary 243 63.1 280 72.2 
  Secondary/Higher 13 3.4 8 2.1 
Knowledge of ≥2 danger signs (N=353 in 
1999, 375 in 2002)     
  No 281 79.9 244 65.1 
  Yes 71 20.1 131 34.9 
Wealth quintiles (N=350 in 1999, 376 in 
2002)     
  Poorest  60 17.1 73 19.4 
  Second poorest  56 16.0 77 20.5 
  Middle 80 22.9 70 18.6 
  Second richest 73 20.9 82 21.8 
  Richest 81 23.1 74 19.7 
District (N=385 in 1999, 388 in 2002)     
  Morogoro 79 20.5 95 24.5 
  Rufiji 99 25.7 108 27.8 
  Ulanga 111 28.8 114 29.4 
  Kilombero 96 25.0 71 18.3 
    
  ‡
 All children under five year included here 
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Table 6: Vitamin A supplementation coverage in children (12-23) months by selected 
characteristics 
1999 Survey 2002 Survey 
Characteristics 
n N % 95%CI p 
valuea n N % 95%CI 
p 
valuea 
VAS coverage           
  All districts 51 385 13.2 9.8-17.7  296 388 76.3 71.5-80.5  
Sex           
  Male 27 188 14.4 9.8-20.5 161 205 78.5 71.9-83.9 
  Female 24 197 12.2 7.9-18.4 
0.53 
135 183 73.8 66.8-79.7 
0.28 
DPT vaccination           
  Vaccinated 37 280 13.2 9.5-18.1 229 296 77.4 71.6-82.3 
  Not vaccinated 14 105 13.3 7.6-22.3 0.97 66 91 72.5 63.2-80.2 0.34 
Maternal 
education           
  No 10 129 7.8 4.2-13.8 70 100 70.0 60.2-78.3 
  Primary 37 243 15.2 11.2-20.3 218 280 77.9 72.4-82.5 
  Secondary 4 13 30.8 12.0-59.1 
0.02 
8 8 100.0 - 
0.08 
Knowledge of ≥2 
danger signs           
  No  35 282 12.4 9.1-16.8 195 244 79.9 74.4-84.5 
  Yes 14 71 19.4 11.5-31.8 
0.09 
91 131 69.5 60.0-77.6 
0.04 
Socio-economic 
status           
  Poorest 5 60 8.3 3.7-17.8 56 73 76.7 67.5-84.0 
  Very Poor 10 56 17.9 9.6-30.9 59 77 76.6 65.5-85.0 
  Poor 9 80 11.3 5.7-21.1 49 70 70.0 56.7-80.6 
  Less Poor 10 73 13.7 6.7-26.0 65 82 79.3 68.7-86.9 
  Least Poor 12 81 14.8 8.1-25.5 
0.64b 
58 74 78.4 67.6-86.3 
0.68b 
District           
  Morogoro 12 79 15.2 8.2-26.5 73 95 76.8 66.9-84.5 
  Rufiji 13 99 13.1 6.6-24.3 81 108 75.0 65.3-82.7 
  Ulanga 16 111 14.4 8.4-23.6 89 114 78.1 69.3-84.9 
  Kilombero 10 96 10.4 5.5-18.9 
0.85 
53 71 74.6 61.6-84.4 
0.94 
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8.1 Summary  
Background 
The Integrated Management of Childhood Illness (IMCI) strategy is designed 
to address major causes of child mortality at community, health facility, and 
health system levels. We aimed to evaluate the effectiveness of facility-based 
IMCI in rural Tanzania.  
 
Methods 
We compared 2 districts with facility-based IMCI and 2 neighbouring 
comparison districts without IMCI, from 1997 to 2002, using a non-randomised 
study. We assessed quality of case-management for child illness, drug and 
vaccine availability, and supervision involving case-management, through a 
health facility survey in 2000. Household surveys were used to assess child 
health indicators in 1999 and 2002. Child survival was tracked through 
demographic surveillance over a pre-defined 2-year period from mid-2000. 
Additional information on contextual factors was gathered through interviews 
and record review. The economic cost of child health care in IMCI and 
comparison districts was estimated through interviews and record review at 
national, district, facility and household levels. 
 
Findings 
During the IMCI phase-in period, under-five mortality rates were almost 
identical in IMCI and comparison districts.  Over the two following years, 
mortality levels were 13% lower in IMCI than comparison districts (95% CI –
7%, 30% or 5%, 21%, depending on how adjustment is made for district-level 
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clustering), with  a rate difference of 3.8 fewer deaths per 1000 children per 
year. Contextual factors, such as mosquito net use, all favoured the 
comparison districts. Costs of child health care were comparable or lower with 
IMCI than with case-management without IMCI.  
 
Interpretation 
Our findings support going to scale through widespread implementation of 
facility-based IMCI in the context of health sector reform, basket funding, good 
facility access and high utilization of health facilities.  
 
 
8.2 Introduction 
Every year, more than ten million children worldwide die (Black, Morris, & 
Bryce 2003), and 95% of these deaths occur in just 42 less developed 
countries. The inequity in children’s survival between rich and poor countries 
is unacceptably vast, as are the differences in survival between richer and 
poorer children within most countries (Victora et al. 2003). Although children’s 
survival worldwide has improved over the past 30 years, the rate of increase 
peaked around 1980 and there has been virtually no further improvement 
since then in sub-Saharan Africa. In some countries, children’s survival has 
even declined, and HIV/AIDS is only a partial reason (Walker, Schwartlander, 
& Bryce 2002). The main causes of death of children worldwide are neonatal 
disorders, diarrhoea, pneumonia, and malaria, although HIV/AIDS accounts 
for at least 10% of deaths in some African countries (Black, Morris, & Bryce 
2003). Undernutrition is a major underlying cause and has been estimated to 
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contribute to more than half of all deaths in children (Black, Morris, & Bryce 
2003).  
 
Effective interventions are available that could prevent more than 60% of all 
deaths in children (Jones et al. 2003). Yet mothers and children are not 
receiving these interventions: coverage remains unacceptably low (Bryce et 
al. 2003). The Integrated Management of Childhood Illness (IMCI) is a 
strategy for improving children’s health and development through the 
combined delivery of essential child-health interventions. Originally, IMCI 
consisted of case management guidelines for sick children in peripheral first-
level health facilities, to be adapted for each country (Gove 1997). Later, the 
strategy expanded to include guidelines from WHO and UNICEF for delivering 
interventions to increase children’s survival at household, community, and 
referral levels, with three components: improvements in case-management; 
improvements in health systems; and improvements in family and community 
practices. By the end of 2003, the first two components of IMCI were in the 
early implementation or expansion phase in 108 less developed countries, 
including virtually all African countries south of the Sahara (WHO 2004). The 
Multi-Country Evaluation of IMCI seeks to generate information on the 
effectiveness, cost, and impact of IMCI that can be used to strengthen the 
delivery of child-health interventions and the implementation of the IMCI 
strategy; it includes in-depth studies in Bangladesh, Brazil, Peru, Tanzania, 
and Uganda (Bryce et al. 2004). In Tanzania, the mortality among children 
younger than 5 years is 147 per 1000 births, resulting in almost 250 000 
deaths each year (National Bureau of Statistics & Macro International Inc 
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2000). The country has a gross domestic product of US$501 per head (UNDP 
2001) and is undergoing health-sector and local-government reforms. As 
districts gain more control over their health budgets, IMCI is one of the 
strategies recommended by the Ministry of Health to address major children’s 
health problems such as malaria, pneumonia, malnutrition, and diarrhoea, 
which together account for more than 83% of postperinatal deaths before the 
age of 5 years (unpublished data from the Tanzania Essential Health 
Interventions Project). Here, we report the effectiveness of facility-based IMCI, 
by which we mean the first two components of the strategy, on children’s 
health and survival in rural Tanzania. 
 
 
Figure 7: Timing of implementation of IMCI and the different components of this study 
 
We compared children’s health, behaviours at household level relating to 
children’s health, and children’s survival in two districts with facility-based 
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IMCI and two neighbouring comparison districts without IMCI over the period 
from 1997 to 2002. 
 
8.3 Methods 
Design 
We used a non-randomised controlled trial, or “plausibility” design (Habicht, 
Victora, & Vaughan 1999), in which there is monitoring of process measures 
to improve the internal validity of the study and of contextual factors to check 
whether any apparent effect of the intervention is due to other factors. We 
compared children’s health and survival in four neighbouring rural districts of 
Morogoro and Coast Regions, southern Tanzania, in 1999 and 2002. The two 
IMCI districts, Morogoro Rural and Rufiji, started to implement IMCI in 1997–
98, and the two comparison districts, Kilombero and Ulanga, started 
implementation in 2002. The two comparison districts were chosen for several 
reasons: they were geographically contiguous though separated from the 
intervention districts by an uninhabited game reserve, so there is negligible 
population movement between intervention and comparison areas; they had 
continuing demographic surveillance; they had similar or lower mortality rates; 
and they had no immediate plans to implement IMCI. Figure 1 shows the 
timing of implementation of IMCI and each of the five main study components. 
We first assessed the quality of case-management for illness in children, 
availability of drugs and vaccines, and supervision involving case-
management, through a cross-sectional survey in a sample of health facilities 
from all four districts in August, 2000: detailed methods and findings were 
reported elsewhere (Armstrong Schellenberg et al. 2004). Second, household 
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surveys were used to assess indicators of children’s health in a probability 
sample of children from all four districts13 in July–August, 1999, early in the 
implementation phase, and again in July–August, 2002. Third, survival in 
children in a part of each district was tracked through demographic 
surveillance (INDEPTH Network 2002) throughout the study, with particular 
emphasis on a predefined (selected a priori rather than after examining the 
results) 2-year period from mid 2000, by which time IMCI implementation was 
thought to have reached sufficiently high coverage for a sufficiently long 
period for an effect on survival to be measurable. Fourth, information on 
contextual factors (programmes and issues other than IMCI that might have 
affected children’s health in the four districts during the study period) was 
gathered through interviews with all health contributors (i.e., groups active in 
health issues) in the study districts and desk review of plans, budgets, and 
reports, together with data from the child-health surveys. Fifth, we estimated 
the economic cost (including the value of donated goods, volunteer staff time, 
and replacement costs of assets such as buildings) of children’s health care in 
IMCI and comparison districts through interviews and record review at 
national, district, facility and household levels; detailed methods and findings 
are reported elsewhere (Adam et al. 2003;Adam et al. 2004). 
 
Study setting 
Kilombero, Morogoro Rural, Rufiji, and Ulanga Districts are in southern 
Tanzania and have a total population of about 1·2 million people, of whom 200 
000 are younger than 5 years (http://www.tanzania.go.tz/census; accessed 
Nov 16, 2003). Rufiji (IMCI) and Kilombero (comparison) are low-lying, and 
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much of the land is in the fertile flood plain of the Rufiji and Kilombero rivers. 
Morogoro Rural (IMCI) and Ulanga (comparison) have mountainous areas as 
well as low-lying plains. There are two main rainy seasons, October–
December and February–May. There is a broad mix of ethnic groups, 
although Swahili, the national language, is widely spoken. Most people are 
subsistence farmers. Most dwellings have wood-framed mud walls with 
thatched or corrugated metal roofs. Rural roads are generally unpaved, and 
transport can be difficult in the rainy seasons. The public-health system has a 
network of hospitals, health centres, and dispensaries, with 3300 to 7000 
people served by each facility. Over 70% of the populations live within 5 km of 
a health facility. Rates of use of health facilities are high; routine reports by the 
Health Management Information System suggest 3·0 visits per child under 5 
years old per year for curative care in 1999. Malaria, pneumonia, and 
waterborne diseases such as cholera and diarrhoea are the main health 
problems of the area as reported through the health services and as 
perceived by local people. Seasonal food shortages are common, and a 
famine affected much of the country in early 1999. For Tanzania as a whole, 
expenditure per person on health was US$11·37 in 1999–2000, including 
private, out-of pocket expenses (Ministry of Finance 2001). Monthly total 
household consumption and expenditure per person in 2001 was around 
US$10, of which around 70% was for food (Tanzania National Bureau of 
Statistics 2003). 
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IMCI implementation 
Implementation of IMCI in Tanzania has been described elsewhere 
(Armstrong Schellenberg, Bryce, de Savigny, Lambrechts, Mbuya, Mgalula, & 
Wilczynska 2004). Briefly, the Tanzanian Ministry of Health began IMCI 
implementation in 1996, and adapted generic IMCI case-management 
guidelines to reflect national child-health policies (eg, first-line and second-line 
treatments for malaria and pneumonia) and local terms for illness symptoms 
and providers. All materials were translated into Swahili and used as the basis 
for preparation of national and district-level trainers. The target audience for 
the 11-day training was all health workers in first-level health facilities who 
provide case-management to children. Most of these health workers have 2–3 
years’ training in clinical medicine after primary education; around 25% have 
public-health training after primary education. Through local-government and 
health-sector reforms, local councils have increased autonomy and control 
over their own health budgets and plans, and they have access to a limited 
amount of donor-supported “basket” funding from the health-sector-wide 
approach (Cassels 1997), whereby the Ministry of Health and partners (the 
World Bank, the UN Population Fund, and the governments of Denmark, 
Ireland, the Netherlands, Switzerland, and Germany) pool resources in a 
common kitty from which funds are then directly disbursed to districts through 
special accounts of the council health management teams (CHMT; “council” 
refers to the local government of both rural districts and urban municipalities). 
The CHMT of Morogoro Rural and Rufiji Districts decided to adopt IMCI and to 
give highest priority to its introduction and implementation, on the basis of 
evidence available to them from a sentinel burden-of disease information tool 
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and a district-health-budget mapping tool developed by the Tanzania 
Essential Health Interventions Project (TEHIP) (de Savigny et al. 2004). 
TEHIP also provided financial resources to districts of about US$0·92 per 
person per year to simulate sector-wide basket funding (Cassels 1997) 3 
years in advance of the actual start of basket funding. The CHMT of Morogoro 
Rural and Rufiji reported that over 80% of health-workers managing children 
in first-level facilities had been trained in IMCI by mid 2000 in an 11-day 
course with about 30% of the training time spent in clinical practice. TEHIP 
tools were not available in either of the two comparison districts. 
 
Health-facility survey 
We selected a representative sample of 75 health facilities from government 
dispensaries and health centres (Armstrong Schellenberg, Bryce, de Savigny, 
Lambrechts, Mbuya, Mgalula, & Wilczynska 2004). Within chosen health 
facilities, the individuals eligible for inclusion in the survey were the first six 
sick children aged 2–59 months who attended on the day of the survey for an 
initial visit for any illness and whose mother consented to take part. Through 
observation of case-management, exit interviews with carers, reexamination, 
and interviews with health-care providers, we collected information on 29 
indicators relating to assessment, classification, and treatment of the child, 
counselling and communication with the mother, and health-systems support. 
We could not do a before-IMCI health-facility survey because implementation 
of IMCI had already started before this study began in 1999. 
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Household surveys 
Detailed information on the 1999 survey is given elsewhere (Armstrong 
Schellenberg et al. 2003). Briefly, we took a representative cluster sample of 
about 2300 rural households from the four districts in July–August, 1999. We 
chose 30 rural clusters each of 20 households from three of the four districts, 
and 25 rural clusters of 20 households from the fourth district, Kilombero, by 
use of a modified scheme similar to the Expanded Programme of 
Immunizations scheme (Bennett et al. 1994) that ensured an equal probability 
of selection for every household. A modular questionnaire about the health of 
all children under 5 years was administered to consenting heads of 
households, generating information on household-level child-health indicators 
as agreed by an inter-agency working group on IMCI including representatives 
from WHO, UNICEF, the US Agency for International Development (USAID), 
the US Centers for Disease Control and Prevention, and the USAID-funded 
BASICS Project. Information on proxy markers of household socioeconomic 
status was collected, such as household ownership of a radio, a tin roof, a 
bicycle, and the education and occupation of the household head. Mothers or 
carers (we use “mother” to denote the main carer) of all children under 5 years 
old were interviewed about their educational attainment, whether or not the 
child was currently breastfed, and if so what other food or drink the child had 
received during the previous 24 h. Information on routine vaccinations was 
collected directly from health cards or, if no health card or other written record 
was available, according to the mothers’ recall. Mothers were asked whether 
the child had received vitamin A supplementation and, if so, how long ago. 
Mothers were then asked about any illness each child had during the 2 weeks 
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before the survey and what action had been taken. For children who had been 
sick, further modules elicited detailed information about use of appropriate 
(non-traditional) health-care providers including village health workers, 
dispensaries, health centres, hospitals, or private doctors. Information was 
collected on the care the child received from each such provider and any 
other treatments the child had taken. Special attention was given to the care 
of children with danger signs: fast or difficult breathing, seizures or 
convulsions, extreme sleepiness, excessive vomiting, or inability to drink or 
breastfeed (Armstrong Schellenberg, Bryce, de Savigny, Lambrechts, Mbuya, 
Mgalula, & Wilczynska 2004). Children were invited to attend a measuring 
station in the middle of the village, where they were weighed on digital scales 
(Seca Vogel and Halke GmbH, Hamburg, Germany) and their height (if 2 
years or older) or length (under 2 years) was measured with purpose-made 
instruments. A generic version of the questionnaire is available from the 
authors on request. In July–August, 2002, we did a similar follow-up survey. 
Households were selected from the same villages (clusters) as in 1999. Within 
selected villages, the chance of visiting the same household was small: a 
single subvillage (kitongoji) was chosen randomly and 20 households 
selected. We took care to ensure that no survey staff visited a village that they 
had worked in during the earlier survey. The questionnaire was translated to 
Swahili, back translated, pre-tested, and pilot tested. Quality-control measures 
in each cluster included supervisors accompanying one to three interviews; 
households reported to be empty being visited by a supervisor; re-interviewing 
by a supervisor of a maximum of two mothers bringing their children to be 
weighed and measured, with information from the two interviews compared 
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and discrepancies discussed and resolved with the original interviewer; and 
weight and height measurements being repeated for up to two children. 
Repeat measurements were done in most of the clusters, but we could not do 
them in every cluster because the supervisors also had to select clusters for 
the next day’s work. For some areas these were up to 5 h travel away by car, 
boat, bicycle, or foot, and in other areas the sensitization of the communities 
and selection of households took many hours, limiting the time available for 
quality control. Weight-for-age, height-for-age, and weight-for-height Z scores 
were calculated with reference to the standards of the US National Centers for 
Health Statistics by use of the EPINUT module of EPI-Info version 6.0. Low 
weight for age, stunting, and wasting were defined respectively as weight-for-
age, height-for-age, and weight-for-height Z scores of less than –2, with 
exclusion of outliers (Z score of less than –5 or more than 3). Because 
stunting is most prevalent at ages 24–59 months and wasting at 12–23 
months (WHO 1995), analyses were done for these subgroups. Data were 
processed in FoxPro (version 2.6) and analysed in Stata (version 6), following 
an analytical plan previously agreed by the investigators. All analyses were 
adjusted for clustering by use of standard Stata commands such as svymean 
and svylogit. Probability values should be interpreted with caution given the 
nonrandomized study design and the large number of tests. We did 
significance testing to look for evidence of four types of differences: between 
IMCI and comparison districts in each of the two surveys; between 1999 and 
2002 for all four districts combined; between IMCI and comparison areas with 
1999 and 2002 data combined; and for an interaction between IMCI and 
time—i.e., whether the difference between IMCI and comparison districts 
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changed on average between 1999 and 2002. The latter effects are potentially 
attributable to IMCI, provided that there were no contextual factors that 
explained them. 
 
Demographic surveillance 
Because routine registration of births and deaths in Tanzania is rare, we used 
demographic surveillance systems (DSS) to measure children’s survival in a 
part of each of the four districts. In Kilombero and Ulanga districts, the DSS 
started in 1996 with a baseline census in a population of 52 000, covering six 
contiguous villages of Kilombero district (10% of the district population) and 12 
contiguous villages of Ulanga (16%). These areas are not a representative 
sample of either district. Since January, 1997, an interviewer (one of about 40 
full-time staff) has visited each household every 4 months and collected 
information on pregnancies, births, deaths, and migrations, using the 
household registration system (Binka et al. 1999). Births and deaths are also 
reported continuously by key informants based in each kitongoji. Extensive 
quality control measures include repeat interviews in a randomly selected 
10% of households. Data from each week’s work are used to update the 
household registration system database before a weekly field meeting. 
Checking programs are run and queries referred back to the field team for 
correction within 2 weeks of the original interview. In Rufiji district, field 
procedures, quality control, and data management are similar to those in 
Kilombero and Ulanga DSS. Rufiji DSS started in 1998 with a baseline census 
in a population of about 70 000 people covering 32 villages (44% of the district 
population). In Morogoro Rural district, demographic and mortality surveillance 
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began in 1992 with an initial census, which has since been repeated annually 
in about 85 000 people in 50 villages (16% of the district population). 
Continuous mortality surveillance provides information on numbers and 
probable causes of death by use of the verbal autopsy method. About 70 
villagers act as enumerators for the annual census update and as key 
informants for reporting deaths, each of which is followed up by one of four 
clinical officers from the CHMT. Data entry uses a tailor-made FoxPro 
database system. Data quality is ensured by checks in the field, during and 
after data entry. Supervisors visited a random sample of households to verify 
entries on the census forms and to check that all households visited have 
been included in the census and that no non-existent households have been 
included. After each census, re-interviews are done for a sample of 
households for each enumerator.  
 
Analysis of mortality 
Our primary focus was to compare mortality over the 2-year period starting in 
mid 2000, by which point IMCI implementation was thought to have reached 
sufficient sustained coverage for any effect on children’s survival to be 
measurable, as judged by an independent review panel. Following an agreed 
analytical plan, we compared mortality rates per 1000 children under 5 years 
per year between IMCI and comparison areas from mid 2000 to mid 2002, 
checking for any differences in 1999, which served as a baseline for the 
mortality analysis. Note that the widely used children’s survival measure of 
5q0 is about 4·4 times these rates, because the 5q0 is a cumulative 
probability of survival to age 5 years and not an annual rate. Adjustments for 
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age (<1 year and 1–4 years) and rainfall (estimated from remote sensing 
data) were made with Poisson regression models, and the between-district 
differences compared by t-test-based methods of adjusted residuals, as 
appropriate for clustered data with a small number of clusters (Hayes & 
Bennett 1999). With only four districts, p values from this approach are likely 
to be conservative. We also calculated p values from Poisson regression 
ignoring between-district variation. Secondary analysis made use of all 
available DSS data to summarise longer-term trends in children’s survival in 
relation to IMCI. We used Poisson regression for the data from each DSS 
area separately, testing for the size and statistical significance of the trend in 
mortality rates over time. Owing to difficulties with data completeness, 
analysis was repeated with and without Morogoro data for the year 2000. 
 
Contextual factors 
We summarised factors other than IMCI that might have affected child health 
in the four districts, with emphasis on those that might have changed over the 
study period, including geographical, environmental, and demographic 
features, health-care infrastructure and activities, and other health-related 
programmes, activities, or events (including disasters and famines). These 
factors were related to quantifiable indicators from the household surveys. In 
addition to using data from the household surveys, we contacted around 40 
health contributors in the four study districts, including CHMT, TEHIP, non-
governmental organisations, religious missions, and bilateral and multilateral 
aid organisations. Information on delivery of routine health care and other 
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relevant activities was systematically collated from written reports and 
interviews with key informants. 
 
Economic costs 
Detailed methods are given elsewhere (Adam, Manzi, Kadundwa, Armstrong 
Schellenberg, Mgalula, de Savigny, Mbuya, & Wilczynska 2003;Adam, Manzi, 
Armstrong Schellenberg, Mgalula, de Savigny, & Evans 2004). Briefly, cost 
data were collected for the start-up period of implementing IMCI (1996 to 
1997) and for maintaining health services for children under 5 years including 
IMCI subsequently. Costs were estimated from the societal perspective and 
were collected from the levels of nation, district, hospital, primary health 
facility, and household. Among the costs included were those for drugs and 
vaccines; training costs attributable to care of children under 5 years, 
including but not restricted to IMCI; the annualised cost of capital items; and 
the opportunity cost of staff time spent in consultation with children under 5 
years (assessed through a time-and motion study) and time spent attending 
meetings and undertaking supervision visits. 
 
 
 
 
 
 
 
 
 
Table 8: Selected indicators showing quality of care and health-system support in IMCI 
and comparison districts in August, 2000 
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 IMCI Comparison p* 
Child checked for presence of cough, diarrhoea, 
and fever 
219/231 (95%) 67/188 (36%) <0.0001 
Child correctly classified 139/219 (63%) 66/176 (38%) <0.0001 
Child needing oral antibiotic or oral antimalaria 
given correct prescription 
159/219 (73%) 63/178 (35%) <0.0001 
Carer of child prescribed an oral medication 
reports correctly at facility exit how to give the 
treatment  
163/225 (72%) 100/179 (56%) 0.02 
Mean index of availability of essential oral 
treatments 
0.93 (n=39) 0.95 (n=35) 0.47 
Health facility received at leas tone supervisory 
visit that included observation of case 
management during the previous 6 months 
19/37 (51%) 7/34 (21%) 0.007 
F-tests comparing area with and without IMCI unless otherwise stated. ORS, 
oral antibiotic, oral antimalarial, or a combination of these medications 
 
 
Household costs included travel and out-of-pocket expenditures to obtain care 
for children under 5 years but did not include a monetary value of time lost in 
seeking care. Costs at all these levels were summed to obtain the total cost to 
the district of providing care for children under 5 years. To allow comparison 
across districts, cost estimates were standardised to a district with a 
population of 50 000 children under 5 years. Estimates of the additional cost 
to the district of implementing IMCI were based on the difference in cost of 
care for children under 5 years between the standardised IMCI and 
comparison districts. 
 
Role of the funding sources 
The funding sources were not involved in the study design; collection, 
analysis, or interpretation of data; writing of the paper; or the decision to 
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submit the paper for publication. The corresponding author had full access to 
all the data in the study and had final responsibility for the decision to submit 
for publication. 
 
 
8.4 Results 
Quality of care 
The introduction of facility-based IMCI was associated with improved quality of 
care as measured through the health-facility survey in August, 2000, after the 
end of the IMCI phase-in (figure 1). More than twice as many children were 
checked for cough, diarrhoea, and fever in the IMCI facilities as in the 
comparison districts (p<0·0001; table 1).12 Sick children were 1·7 times more 
likely to be correctly classified in IMCI districts than in comparison districts 
(p<0·0001). Drug availability was reasonably good and similar in IMCI and 
comparison areas at the time of the survey (p=0·47; table 1). However, the 
proportion of sick children needing oral antibiotics, oral antimalarials, or both 
who were prescribed them correctly was two times higher in the IMCI districts 
than in comparison districts (p<0·0001). Of carers whose children had been 
prescribed oral rehydration solution (ORS), oral antibiotics, or oral 
antimalarials, a higher proportion in the IMCI districts than in comparison 
districts reported correctly at the facility exit how to give the treatment (rate 
ratio 1·3, p=0·02). Supervisory visits that included observation of case-
management were more common in IMCI districts than in comparison districts 
(p=0·007). Follow-up visits after IMCI training were not included in these 
Chapter 8: Effectiveness and cost of IMCI in Tanzania 
 - 136 - 
calculations. Overall, IMCI facilities were significantly better than, or similar to, 
comparison facilities for all but one indicator out of a total of 29. 
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DISTRICT P-values  
INDICATOR YEAR 
Morogoro 
Rural 
[IMCI] 
(number of 
observations) 
Rufiji 
[IMCI] 
(number of 
observation
s) 
Ulanga 
[No IMCI] 
(number of 
observations) 
Kilombero 
[No IMCI] 
(number of 
observation
s) 
IMCI 
vs 
comp-
arison 
areas 
Change 
over 
time 
1999 to 
2002 
Difference 
between 
IMCI and 
comparis
on 
Difference 
between IMCI 
and 
comparison 
changed over 
time 
UTILISATION & CARE  
1999 36% (239) 46% (273) 38% (273) 47% (229) 0.81 
 Appropriate care-seeking 
2002 32% (229) 45% (302) 35% (276) 31% (151) 0.17 0.02 0.45 0.36 
1999 51% (78) 55% (84) 62% (74) 74% (73) 0.02 
Care-seeking rate for children with danger signs 
2002 48% (64) 60% (78) 46% (71) 38% (42) 0.15 0.05 0.54 0.006 
1999 7% (450) 5% (545) 12% (570) 17% (406) 0.002 
Proportion of children admitted in last year* 
2002 9% (503) 6% (547) 11% (504) 13% (360) 0.06 0.45 0.002 0.002 
1999 13% (45) 38% (40) 15% (48) 6% (47) 0.03 
ORS use among children with diarrhoea 
2002 14% (42) 41% (54) 27% (55) 8% (26) 0.01 0.31 0.08 0.07 
HOME MANAGEMENT OF DISEASE 
1999 1% (136) 5% (125) 9% (140) 6% (107) 0.02 Sick child (today) receives increased fluids and 
continued feeding 2002 8% (133) 5% (117) 8% (149) 4% (76) 0.89 0.31 0.23 0.05 
CARETAKER KNOWLEDGE 
1999 24% (316) 19% (357) 21% (385) 26% (286) 0.54 Caretaker knows at least two signs for seeking 
care  immediately 2002 33% (384) 27% (400) 32% (379) 38% (284) 0.16 <0.0001 0.11 0.93 
FEEDING & NUTRITION 
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Table 9: Indicators of feeding, nutrition, carers' knowledge, home management of disease, use of health services, and care in 1992 and 2002 
1999 29% (429) 32% (518) 28% (559) 23% (344) 0.10 
Low weight for age 
2002 23% (483) 24% (518) 22% (494) 16% (331) 0.07 <0.0001 0.03 0.45 
1999 61% (233) 59% (264) 54% (303) 46% (180) 0.04 Stunting  prevalence in children aged 24-59 
months 2002 42% (289) 44% (296) 45% (282) 32% (195 0.45 <0.0001 0.07 0.07 
1999 17% (72) 9% (95 9% (115) 13% (85) 0.52 Wasting prevalence in children aged 12-23 
months 2002 5% (91) 8% (100 6% (110) 4% (67) 0.66 0.02 0.43 0.79 
1999 25% (52) 17% (59) 26% (42) 26% (27) 0.46 Child under 4 months of age is exclusively 
breastfed 2002 23% (30)  22% (36) 30% (30) 35% (23) 0.34 <0.0001 0.69 0.89 
1999 83% (30) 94% (49 98% (41 94% (32 0.17 Child aged 6-9m receives breastmilk & 
complementary feeding 2002 97% (38) 100% (43 97% (39) 100% (36) 0.96 0.008 0.23 0.26 
1999 2.6 (67) 2.8 (87 2.8 (98) 3.2 (82) 0.05 
Mean meal frequency for breastfed 1-year-olds  
2002 2.9 (81) 3.3 (98 3.1 (99) 3.2 (57) 0.61 0.01 0.06 0.03 
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Household surveys 1999 and 2002 
In 1999, data were available from 2006 children under 5 years of age living in 1321 
households with children of this age-group in the 120 rural clusters, representing 
93% of eligible households: residents of 137 (6%) were away and 21 (1·0%) refused 
to take part.13 In the 2002 survey, 1932 children were identified living in 1341 
households with children of this age-group within the same villages, representing 
94% of eligible households: residents of 142 (6%) were away and nine (0·4%) 
households refused to take part. The age profile of children involved in the two 
surveys was similar, with 24% and 21% of children being younger than 1 year in 
1999 and 2002, respectively. 
 
Around half of all children were reported by their carers as having been ill in the 2 
weeks before the surveys (1026/1968 [52%], data missing for 38 children in 1999; 
and 965/1914 [50%], data missing for 18 children in 2002). 42% of carers sought 
care from an appropriate health-care provider in 1999 compared with 36% in 2002 
(p=0·02; table 2). There was no evidence of any difference in care-seeking between 
IMCI and comparison districts (p=0·45) or of a differential change in care-seeking 
between IMCI and comparison districts over time (p=0·36). Care-seeking was 
generally more common for children reported as having had danger signs: in 1999, 
86 (53%) of 162 such children in IMCI districts and 100 (68%) of 147 in comparison 
districts had reportedly been taken to an appropriate provider. In the 2002 survey, 
the rate of care-seeking for children with danger signs had risen slightly in the IMCI 
districts (78/142 [55%]) and had fallen in comparison districts (49/113 [43%]; 
p=0·006 for the differential change overtime). Over 10% (200/1971) of children had 
been admitted to a health facility in the year before the 1999 survey, with admission 
being more common in the comparison districts than in the IMCI districts (p=0·002; 
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table 2). Although the difference persisted in the 2002 survey, it was much less 
striking because the rate of hospital admissions had risen by 1% on average in the 
IMCI districts and fallen by 3% in the comparison districts (p=0·002 for the differential 
change between IMCI and comparison areas).  
 
Among children sick with diarrhoea in the 2 weeks before the survey, the rate of use 
of ORS showed large variations between the districts, from 6% to 38%. 
Nevertheless, use of ORS was more common on average in IMCI than in 
comparison areas in both surveys (p=0·03 in 1999 and p=0·01 in 2002). The rate of 
appropriate home  management of disease, measured partly by the proportion of 
children sick on the day of the survey who had received increased fluids and 
continued feeding, was under 10% in all districts and both surveys. Nevertheless, 
there was evidence of differential improvement between the IMCI and comparison 
districts (p=0·05), with the proportion in IMCI districts increasing by 4% on average 
between 1999 and 2002 and that in comparison districts decreasing by 1%.  
 
In 1999, more than a fifth of carers knew at least two signs for seeking care 
immediately, and the proportion with such knowledge increased in all districts by 
2002 to around a third (p<0·0001 for the average change over time). There was no 
evidence of a differential change in such knowledge between IMCI and comparison 
districts (p=0·93). 
 
Anthropometric indicators of nutritional status were available for 1852 (92%) of 2006 
children in the 1999 survey and 1826 (95%) of 1932 children in the 2002 survey. 
Outliers (extreme Z scores) were omitted for 100 (5%) children in 1999 and for 57 
(3%) in 2002. Low weight for age is common in the study area, with 29% (528/1852) 
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of all children affected in 1999. The prevalence of low weight for age had decreased 
in all districts by 2002, to 22% (395/1826; p<0·0001). Low weight for age affected 4–
5% more children in the IMCI districts than in the comparison districts in both years 
(p=0·03). Wasting was found in 11% of children aged 12–23 months in 1999 
(42/367), a few months after a famine, and the rate had fallen to 6% (23/368) in 2002 
(p=0·02), with no evidence of differences between IMCI and comparison areas 
(p=0·43) or a differential change over time (p=0·79). Stunting affected 60% (297/497) 
of children aged 24–59 months in IMCI districts in 1999, about 10% more than in 
comparison areas (51%;247/483; p=0·04). By 2002, however, children in IMCI areas 
had “caught up”, and rates of stunting were similar in IMCI and comparison areas 
(249/585 [43%] vs 191/477 [40%]; p=0·07 for the differential change over time). 
When expressed as a mean height-for-age Z score in children aged 24–59 months, 
the differential change between IMCI and comparison districts reached conventional 
statistical significance, although we emphasise that all p values should be interpreted 
with caution (p=0·05, data not shown). 
 
Exclusive breastfeeding in children under 4 months of age was practised by 23% 
(41/180) of mothers in 1999 and 27% (32/119) by 2002 (p<0·0001). For children 
aged 6–9 months, 93% (141/152) were receiving breast milk and complementary 
feeding in 1999 and 99% (154/156) in 2002 (p=0·008). Neither of these 
breastfeeding indicators showed evidence of a difference between IMCI and 
comparison districts (p=0·69, p=0·23), nor of a differential change over time (p=0·89, 
p=0·26). In 1999, breastfed 1-year-old children received an average of 2·7 meals per 
day in IMCI districts and 3·0 in comparison areas (p=0·05). By 2002, these 
differences were no longer evident (p=0·03 for the differential change over time). 
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              Table 10: Mortality rates from July, 1999 to, June 2002 
 Deaths Child- years 
Death rate 
per 1000 
child-year 
July,1999, to June 2000 
 Morogoro 252 11,303 22.3 
 Rufiji 387 12,212 31.7 
Total IMCI districts 639 23,516 27.2 
 Kilombero 146 4,687 31.1 
 Ulanga 96 4,289 22.4 
Total comparison districts 242 8,977 27.0 
July,2000, to June 2002    
 Morogoro 522 23,985 21.8 
 Rufiji 698  25,979 26.9 
Total IMCI districts 1,220 49,964 24.4 
 Kilombero 362 12,685 28.5 
 Ulanga 257 9,280 27.7 
Total comparison districts 619  21,965 28.2 
 
 
Survival 
Mortality rates in children younger than 5 years, from the area of each district under 
demographic surveillance, are shown in table 3. In the period from July, 1999, to 
June, 2000, during the phase-in of IMCI, mortality in children younger than 5 years 
was 27·2 per 1000 child years in IMCI districts and 27·0 per 1000 child-years in 
comparison districts, giving a rate ratio of 1·01 and a rate difference of 0·2 deaths 
per 1000 child-years. Note that these rates are equivalent to a 5q0 of around 0·12 
(120 per 1000 live births). Over the next 2 years, from July, 2000, to June, 2002, 
mortality rates were 13% lower in the IMCI districts than in the comparison districts 
(rate ratio 0·87), corresponding to a rate difference of 3·8 fewer deaths per 1000 
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child-years. Adjustment for the difference between the areas in 1999 gives a rate 
ratio of 0·86, almost identical to the unadjusted value. Adjustments for age (<1 year 
and 1–4 years) and estimated rainfall were made with Poisson regression models 
but had no effect on the estimated rate ratio (data not shown). With allowance for 
variation between districts and use of a normal approximation based on the log rate 
ratio, the 95% CI was –7 to 30 (p=0·28 by t test). If we ignore between-district 
variation, the 95% CI for the 13% reduction in mortality associated with IMCI was 5 
to 21 (p=0·004 from likelihood-ratio _2 test). 
 
Additional mortality data were available from some of the DSS sites from January, 
1997, until December, 2002 (figure 1). We used all available data from complete 
years to assess trends over time in each district. This analysis found no evidence of 
a change over time in mortality among children under 5 years old in one of the two 
comparison districts, Kilombero, over the 6 years; there was an estimated 2% annual 
increase in mortality rate (95% CI –2 to 6; p=0·23). In the second comparison district, 
Ulanga, there was an annual decrease in mortality of 6% (2 to 10; p=0·002; figure 2). 
In districts with IMCI, mortality data were less complete, but analysis of all available 
data for whole calendar years showed an annual decrease of 11% in mortality in 
Rufiji district between February, 1999, and December, 2002 (95% CI 7 to 16; 
p<0·0001) and an annual decrease of 14% from January, 1997, to December, 2001, 
in Morogoro Rural district (95% CI 11 to 17; p<0·0001). Owing to data 
incompleteness, the Morogoro Rural analysis was repeated without data from the 
year 2000; the annual decrease in mortality in children under 5 years was 11% (8 to 
15; p<0·0001).  
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 Figure 3: All-cause mortality in children under 5 year of age, 1997-2002 
 
 
 
Contextual factors 
The desk reviews of plans, budgets, reports, and expenditure and interviews with 
health contributors suggested several factors other than IMCI relevant to child health 
that differed between IMCI and comparison districts. We were especially concerned 
to identify those factors that might account for the observed differential changes in 
survival between IMCI and comparison districts—ie, factors that changed rapidly and 
differentially during the study period. The factors identified were limited to malaria-
control efforts, vaccination programmes, and coverage of vitamin A supplementation. 
Of children who had fever in the 2 weeks before the 1999 household survey, 42% 
had been given an antimalarial drug (table 4). In 2002, only 28% of such children 
had received an antimalarial drug (p<0·0001), with no evidence of differential change 
in IMCI and comparison districts (p=0·35). In 1999, most of these children (85%) 
received chloroquine, whereas in 2002, the most commonly used drugs were 
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sulfadoxinepyrimethamine (53%), quinine (24%), and amodiaquine (17%). A second 
malaria-control effort that differed between the districts was social marketing of 
treated mosquito nets, and we were also concerned that coverage of untreated nets 
purchased through the private sector might have changed differentially. Use of 
untreated nets the night before the 1999 household survey varied widely between 
districts, from 14% in Morogoro Rural district (IMCI) to 59% in Kilombero district 
(without IMCI). Use of nets increased strikingly in all four districts by 2002, reaching 
85% in Kilombero and 35% in Morogoro Rural. Although the increase in use was 
larger in IMCI districts than in comparison districts when measured as a ratio of 
2002/1999 rates (1·95 vs 1·57; p=0·03), use remained significantly higher in 
comparison districts than in IMCI districts in 2002 (66% on average in comparison 
districts and 41% in IMCI districts; p<0·0001). Use of nets that had been treated in 
the 6 months before the survey was rare in all districts in 1999, at less than 7%, and 
increased in all districts by 2002, by 4–14%, with no evidence of a differential change 
between IMCI and comparison areas over time (p=0·14). Although vaccine coverage 
was generally high (over 80%) in all districts and during both surveys, there was 
evidence of a small decrease in coverage of BCG vaccine between the two surveys, 
from 97% to 96% (p=0·02). We also found a differential decline in coverage of DPT 
vaccine from the 1999 value of 86%. In 2002, DPT coverage increased to 95% in the 
comparison districts but had fallen to 82% in the IMCI districts (p=0·03 for the 
differential change over time). Coverage of vitamin A supplementation was only 14% 
in 1999 and similar in IMCI and comparison areas. In 2002, coverage had increased 
greatly in all districts, to an average of 76% (p<0·0001), with no apparent difference 
between the districts (p=0·73) nor any evidence of a differential change over time 
(p=0·98). For vaccination coverage and malaria-control efforts, the higher coverage 
in comparison districts would have tended to negate any apparent effect of IMCI on 
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child survival. For vitamin A supplementation, the coverage was similarly low in all 
four districts in 1999, rose equally by 2002, and cannot therefore account for the 
greater drop in mortality in the IMCI areas over the study period. 
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Table 11:  Indicators reflecting programmes and issues other than IMCI that could have affected child health and survival during the study period 
DISTRICT P-values  
INDICATOR YEAR Morogoro 
Rural (IMCI) Rufiji (IMCI) 
Ulanga 
(comparison) 
Kilombero 
(comparison) 
IMCI vs 
comp-arison 
areas 
Change 
over 
time 
1999 to 
2002 
Difference 
between 
IMCI and 
comparis
on 
Difference 
between 
IMCI and 
compariso
n changed 
over time 
1999 67/174 (39%) 80/199 (40%) 58/180 (32%) 95/164 (58% ) 0.23 Child with fever receives 
antimalarial drug 2002 54/177 (31% ) 54/217 (25%) 43/177 (24%) 37/107 (35% ) 0.86 
<0.0001 0.33 0.35 
1999 64/449 (14% ) 146/543 (27%) 174/565 (31%) 236/399 (59% ) <0.0002 
Child sleeps under net  
2002 175/500 (35% )      254/547 (46%) 268/504 (53%) 299/352 (85% ) <0.0001 
<0.0001 <0.0001 0.03 
1999 13/449 (3% ) 19/543 (3%) 28/567 (5%) 26/399 (7%) 0.10 
Child sleeps under treated net*  
2002 41/500 (8%) 87/547 (16%) 44/504 (9%) 74/352 (21% ) 0.54 
<0.0001 0.22 0.14 
1999 322/368 (87% ) 408/440 (93%) 435/499 (87% ) 
293/333 (88% 
) 0.23 Anemia in children >=6m (Hb<11.0 
g/dL) 
 2002 353/434 (81% ) 409/477 (86%) 478/452 (84%) 214/309 (69% ) 0.06 
<0.0001 0.07 0.67 
1999 80/81 (99%) 94/100 (94%) 112/115 (95%) 98/99 (99%) 0.97 BCG vaccine coverage (informed 
or registered) 2002 91/96 (95%) 104/108 (96%) 108/114 (95%) 69/71 (97%) 0.97 
0.02 0.94 0.97 
DPT vaccine coverage (informed or 1999 67/80 (84%) 90/100 (90% ) 95/118 (81% ) 90/99 (91%) 0.68 0.40 0.15 0.03 
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registered) 
2002 72/96 (75%) 95/108 (88%) 108/114 (95% ) 68/71 (96%) 0.001 
   
1999 65/80 (81%) 86/100 (86%) 94/118 (80%) 87/99 (88%) 0.90 Polio vaccine coverage (informed 
or registered) 2002 57/93 (61%) 92/108 (85%) 97/114 (85%) 65/71 (92%) 0.007 
0.21 0.11 0.12 
1999 70/80 (88%) 89/100 (89% ) 99/118 (84%) 95/99 (96%) 0.83 Measles vaccine coverage 
(informed or registered)  2002 84/96 (88%) 96/108 (89%) 105/114 (92%) 67/71 (94%) 0.14 
0.51 0.33 0.72 
1999 12/95 (13%) 13/99 (13%) 14/111 (13%) 14/97 (14%) 0.71 Vitamin A supplementation 
coverage 
 
2002 73/95 (77%) 81/114 (75%) 89/114 (78%) 53/71 (75%) 0.84 
<0.0001 0.73 0.98 
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Economic costs of under-five care 
IMCI was not associated with higher economic costs than conventional care (care 
without IMCI). In fact, the reverse was found: the cost of care per child younger than 
5 years was estimated at US$11·19 in IMCI districts and US$16·09 in comparison 
districts (table 5).15,16 The major components of cost were at district, hospital, 
primary facility, and household levels, with the estimate of hospital-level costs in the 
comparison districts accounting for almost half of total cost of care per child (46%). 
Since we would not have expected IMCI to have affected hospital-level costs to such 
an extent, and because access to hospitals was better in comparison than in IMCI 
districts, we recalculated the cost of care per child younger than 5 years without the 
hospital component and found similar total costs per child in IMCI and comparison 
areas (US$8·30 in the IMCI districts, US$8·76 in the comparison areas). 
 
Table 12: Annualised cost of care per child younger than 5 years, standardised districts of 
50,000 children younger than 5 years with and without IMCI 
Cost in 
standardized 
districts with IMCI 
Cost in standardised 
comparison district 
 
  TZS (US$) 
% of total 
cost 
  TZS (US$) 
   % of 
total cost 
Level       
  National      129 (0.17) 1       55 (0.07) 0 
  District  1,784 (2.30) 21  2,605 (3.35) 21 
  Hospital 2,243 (2.89) 26  5,692 (7.33) 46 
  Primary-facility 2,455 (3.16) 28  2,283 (2.94) 18 
  Household  2,083 (2.68) 24  1,867 (2.40) 15 
Total 8,695 (11.19) - 12,503 (16.09) - 
Total excluding 
hospital costs 
6,452 
( 8.30) 
 
-   6,810 (8.76) - 
 TZS =Tanzania shillings. Data from 1999 
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8.5 Discussion 
Our effectiveness evaluation to estimate the impact of a programme that was 
selected and implemented by district health staff in rural Tanzania showed evidence 
that case-management was improved, the mortality rate in children younger than 5 
years was 13% lower in districts with IMCI than in comparison areas, and that costs 
of children’s health care with IMCI were similar to or lower than those with 
conventional case-management, suggesting that facility-based IMCI is highly cost 
effective. Our findings on mortality rates and trends in the presence of facility-based 
IMCI, although not supporting the same type of inference as a randomized controlled 
trial covering a large number of districts, support going to scale in Tanzania with this 
intervention in the context of health-sector reform, basket funding, good facility 
access, and high utilization of health facilities. 
 
Several design issues must be borne in mind in interpretation of our findings. We set 
out to evaluate the effectiveness of an integrated delivery strategy encompassing 
several interventions, such as antibiotics, antimalarials, and oral rehydration therapy, 
for which efficacy is already well documented (Bryce, Victora, Habicht, Vaughan, & 
Black 2004). Our objective was to estimate the impact of a programme that was 
managed by district health staff under routine circumstances, similar to a phase IV 
study of a drug or vaccine. Our study did not start until 1999, by which time IMCI 
implementation had started; thus we could not do a before-IMCI health-facility 
survey. However, we were reassured that before the study started children’s survival 
in the IMCI districts was similar to or worse than that in the comparison districts. A 
randomised design would not have been possible because implementation of IMCI 
had already started in two of the four districts that had demographic surveillance 
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systems. Therefore, we placed much emphasis on documenting and assessing the 
effect of contextual factors that might confound the observed results. We are 
reassured that the observed distribution of contextual factors would tend, if anything, 
to lead to an underestimate of the true impact of IMCI, but in a non-randomised 
design with a small number of units of analysis we cannot rule out their influence 
completely. 
 
The study was designed to detect a 20% reduction in mortality, which seemed 
feasible given that IMCI includes several life-saving interventions, and that baseline 
mortality rates were high. We found a smaller effect than we had expected, and the 
95% CI for this estimate included the value of zero, corresponding to no effect. 
Nevertheless, in many large-scale public-health evaluations the number of available 
units of analysis is small, and even if the result had been statistically significant it 
would be hard to interpret in strict probabilistic terms. For this reason, we tried hard 
to document intermediate changes that could be ascribed to IMCI implementation 
and also contribute to reducing mortality, thus strengthening the plausibility (Victora, 
Habicht, & Bryce 2004) of an effect on mortality. For example, health-worker 
performance, including prescription of life-saving drugs, improved substantially; key 
indicators that could be ascribed to IMCI implementation (such as home 
management of disease and some care-seeking and feeding practices) showed 
improvements, although most were still well below what would be desirable; and 
mean height for age, a good indicator of overall health of children that could be a 
result of improved disease management and feeding practices (WHO 1995), was 
significantly improved. Taken together, these results support the hypothesis that 
IMCI implementation led to a mortality reduction. 
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We identified several areas within facility-based IMCI that deserve careful attention, 
with a view to the rethinking of parts of this strategy. Results from Uganda suggest 
that supportive supervision is associated with improved quality of care (unpublished). 
We found that although general visits from supervisory teams were frequent, many 
such visits did not involve case management. Supportive supervision involving case 
management observation was more common in the districts with IMCI than in 
comparison areas, yet there was still room for improvement, with a fifth of such staff 
not having had such a visit in the previous 6 months. Despite many attempts to 
develop an “IMCI supervision checklist”, implementation has proved impossible 
owing to the many duties that supervisors are expected to do. An integrated 
approach might help and is under consideration in Tanzania. We also found that less 
than a fifth of children needing referral were actually referred (17%; 95% CI 0 to 41; 
n=12) (Armstrong Schellenberg, Bryce, de Savigny, Lambrechts, Mbuya, Mgalula, & 
Wilczynska 2004), despite an expectation that IMCI guidelines would lead to a 
massive increase in referrals (Font et al. 2002). More than 60% of first-level health 
facilities are over 2 h travel time from their closest referral facility (data not shown), 
and a lack of transport and money together with the need to care for other children 
often means that mothers are unable to travel such distances with a sick child 
(unpublished and Hausmann and colleagues (Muela, Mushi, & Ribera 2000)). Health 
workers are part of the communities they serve, and a possible explanation is that 
they do not refer children who are unlikely to be taken to a referral facility. The IMCI 
guideline on “Where referral is not possible”, which is part of the IMCI training course 
in Tanzania, goes some way towards supporting health workers to offer these 
children the best possible treatment. 
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The potential impact of IMCI is likely to depend largely on the efficacy and availability 
of appropriate treatment for malaria, which is the main cause of morbidity and 
mortality in the study area. Nationally, the first-line antimalarial drug changed in 2000 
from chloroquine to sulfadoxine-pyrimethamine, owing to widespread drug 
resistance. There were initially problems with quality control and delivery, which 
might have led to the decrease in treatment of fever with antimalarials, from 42% to 
28% in children sick in the 2 weeks before each survey. Despite increased efficacy, 
the newly introduced sulfadoxine-pyrimethamine was apparently neither so widely 
available nor as popular as chloroquine had been in 1999 and this is likely to have 
reduced the potential effectiveness of IMCI in the timeframe of this study. 
 
From its origins as a case-management strategy, IMCI later developed into three 
linked components: case management, health-facility support, and household and 
community support. The third component, often known as “community IMCI”, 
consists of health education messages and programmes in support of 17 key family 
practices, focused around growth promotion and development, disease prevention, 
care-seeking, and compliance with health-workers’ advice. This package has not 
been implemented in our study area. Nevertheless, many of the activities with high 
coverage in all four districts are compatible with community IMCI, including the use 
of treated mosquito nets and vitamin A. Tanzania has a long history of community 
based activities and programmes: for example, all villages in Morogoro Region had 
two village health workers trained in the 1980s, and in a few villages these people 
remain active in health promotion, including growth monitoring of children, 
supplemental feeding of those identified to be at risk, and village health days to 
promote vaccination. The potential gains from such outreach are clear, but there is 
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currently no mechanism by which such community-based health workers can be 
motivated, supervised, and supported on a large scale. Given the difficulties in 
providing support and supervision to peripheral-facility-based health workers, how a 
much larger force of unsalaried lower-level workers could be managed and 
sustained remains unclear. 
 
The finding that economic costs of IMCI were similar to or less than those of 
conventional children’s health care was unexpected. The explanation is that 
substantial amounts of money were spent on care for children in comparison 
districts, and that this roughly equaled the cost of IMCI. There is no evidence that 
these districts are atypical of rural Tanzania: as is often the case, there was 
continuing donor investment in health programmes including from multilateral 
agencies such as UNICEF, from bilateral agencies such as the Swiss Agency for 
Development and Cooperation, and from nongovernmental organisations such as 
Plan International. Estimated funding for health from major donors such as the Swiss 
Agency for Development and Cooperation and Development Cooperation Ireland 
was around US$0·80 per person in the comparison districts, not very different from 
the TEHIP funding of US$0·92 per head. Furthermore, IMCI was implemented at a 
financial cost within the basket funding available to all districts through health-sector 
reform. For example, the cost of training 48 health workers would use between 1% 
and 6% of current basket funding allocated to each district. Implementation in the 
comparison districts started in 2002. 
 
More than 10 years ago, an early estimate of the likely cost-effectiveness of IMCI 
reported that “implementation of the integrated cluster of treatments, including 
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hospital services, would cost between $30 and $100 per DALY saved”(World Bank 
1993). Furthermore, there was an expectation that, if health services were well used, 
child mortality rates might be reduced by 50–70%. With the benefit of hindsight, 
these expectations were somewhat optimistic. Implementation of IMCI has proved to 
be far more challenging than was first thought: although virtually every country in 
Africa has started to implement the strategy (WHO 2004), not one country yet has 
high enough national level coverage to achieve a measurable effect on mortality. 
This lack of high-level coverage, and an intervention perceived to be very expensive 
by many donors, might have led to a general feeling among international policy-
makers that IMCI has no effect on children’s survival. Our data suggest that high 
coverage of facility-based IMCI leads to lower child mortality and that the reduction is 
achievable within existing health budgets. In our setting, simple, practical planning 
and management tools, developed by TEHIP, for strengthening the capacity of 
district health systems were the essential first step to achieving this impact. 
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9.1 Summary 
 
We examined the impact of the Integrated Management of Childhood Illnesses 
(IMCI) strategy on the equality of health outcomes and access across socio-
economic gradients in rural Tanzania, by comparing changes in inequities between 
1999 and 2002 in two districts with IMCI (Morogoro Rural and Rufiji) and two without 
(Kilombero and Ulanga). 
 
Equity differentials for six child health indicators (under weight, stunting, measles 
immunization, access to treated and untreated nets, treatment of fever with 
antimalarial) improved significantly in IMCI districts (p<0.05) compared to 
comparison districts, while four indicators (wasting, DPT coverage, care takers’ 
knowledge of danger signs and appropriate care seeking) improved significantly in 
comparison districts (p<0.05) compared to IMCI districts. The largest improvements 
were observed for stunting among children between 24-59 months of age. The 
concentration index improved from -0.102 in 1999 to -0.032 in 2002 for IMCI while it 
remained almost unchanged -0.122 to -0.133 in comparison districts. IMCI was 
associated with improved equity for measles vaccine coverage, whereas the 
opposite was observed for DPT antigens.  
 
This study has shown how equity assessments can be incorporated in impact 
evaluation at relatively little additional cost, and how this may point to specific 
interventions that need to be reinforced. The introduction of IMCI led to 
improvements in child health that did not occur at the expense of equity. 
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9.2 Introduction 
 
Very few studies have assessed trends in socio-economic inequities in health, 
particularly in low and middle-income countries (Victora et al. 2000). Of these, most 
studies have addressed cross-sectional status of inequalities in child health and 
access to interventions (Gwatkin et al. 2000).  Earlier publications in Tanzania 
described inequities in child nutritional status, health care seeking and utilization 
(Armstrong Schellenberg et al. 2003;Mwageni et al. 2004) 
 
This study is part of the Multi-Country Evaluation of the Integrated Management of 
Childhood Illnesses (IMCI) strategy. IMCI combines prevention and treatment of 
common childhood illnesses into simple guidelines and messages for use in first-
level health facilities and communities. Primary care alone may not be sufficient for 
improving health equity (Bishai et al. 2005). Policies that emphasize a primary health 
care strategy can potentially worsen health inequalities temporarily mainly because 
new public health interventions and programmes tend to reach those in higher socio-
economic status first and later those in lower socioeconomic status (Victora, 
Vaughan, Barros, Silva, & Tomasi 2000). In addition to assessing the overall impact 
of IMCI (Armstrong Schellenberg et al. 2004a), the Multi-Country Evaluation also 
aimed to assess the impact of IMCI on health equity. 
In this paper we examine the impact of the IMCI strategy on the equality of health 
outcomes and access across the socio-economic gradient in rural Tanzania, by 
comparing changes in inequities between 1999 and 2002 in two districts with IMCI 
(Morogoro Rural and Rufiji) and two comparison districts (Kilombero and Ulanga). 
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9.3 Methods 
A population-based survey was carried out between July and August 1999 in rural 
areas of four districts (Kilombero, Ulanga, Rufiji and Morogoro) in South East 
Tanzania. The study area has been described in detail elsewhere (Armstrong 
Schellenberg, Victora, Mushi, de Savigny, Schellenberg, Mshinda, & Bryce 
2003;INDEPTH Network 2002). The districts are located at 6-8° south, 36-39° east 
and had a total population in 2002 of approximately 1.2 million people 
(http://www.tanzania.go.tz/census). The details of the design of the study are 
described elsewhere (Armstrong Schellenberg, Adam, Mshinda, Masanja, Kabadi, 
Mukasa, John, Charles, Nathan, Wilczynska, Mgalula, Mbuya, Mswia, Manzi, de 
Savigny, Schellenberg, & Victora 2004a).  Briefly, a probability cluster sample of 
approximately 2,300 households was selected from the four districts. Thirty rural 
clusters, each of 20 households, were chosen from three of the four districts and 25 
clusters were chosen from Kilombero District. Villages were selected with probability 
proportional to estimated population size, and one kitongoji (sub-village, with 
approximately 100 households) was chosen at random from each selected village. 
Twenty households were chosen from each kitongoji using a modified EPI-type 
sampling scheme (Bennett et al. 1991) that ensured an equal probability of selection 
for every household in the sub-village. 10 additional peri-urban clusters in Ifakara 
town (in Kilombero District) have been omitted from the analysis described here so 
that all results refer to rural areas. Fieldwork was carried in July and August 1999, 
and a second survey using exactly the same methodology was carried out in July-
August 2002. Households were selected from the same villages (clusters) as in 
1999. The chance of visiting the same household was small: in each village, a single 
sub-village (kitongoji) was randomly chosen and 20 households included. No survey 
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staff visited a village that they had worked in during the 1999 survey. Quality control 
measures are reported elsewhere (Armstrong Schellenberg, Adam, Mshinda, 
Masanja, Kabadi, Mukasa, John, Charles, Nathan, Wilczynska, Mgalula, Mbuya, 
Mswia, Manzi, de Savigny, Schellenberg, & Victora 2004a). 
 
A modular questionnaire about the health of all children under five years of age was 
administered to consenting heads of households. We obtained information for proxy 
markers of household socioeconomic status such as household ownership of assets, 
housing characteristics, education, and occupation of the household head, 
household head and mother or caretakers source of income. Caretakers of all 
children under five years of age were asked about their level of education and any 
reported child illness during the two weeks before the survey, including action taken. 
We also collected indicators for morbidity (two week period prevalence of history of 
fever), nutritional measurements (weight and length or height), coverage of 
interventions (DPT, measles and polio vaccines both registered and informed, 
children sleeping under nets  treated with insecticide in the last 6 months, and 
children sleeping under any net), care taker knowledge of care seeking (knowledge 
of at least two child health danger  signs and knowledge of feeding during illness) 
and home management of illness (children with fever receiving appropriate 
treatment). Additional information on indicators is available elsewhere 
(www.who.int/imci-mce).  
 
Children were weighed on digital scales (Seca Vogel & Halke GmbH & Co, 
Hamburg, Germany) and their height (≥2 years) or length (<2 years old) was 
measured using locally-made instruments. For convenience, both length and height 
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will be referred to as height. Weight for age and weight for height Z-scores were 
calculated with reference to the US National Centers for Health Statistics (NCHS) 
standards using the EPINUT module of EPI-Info v6.0 (CDC Atlanta, Georgia, US). 
Underweight, stunting and wasting were defined respectively as weight-for-age, 
height-for-age and weight-for-height z-scores of less than –2, excluding outliers (z-
score of <-5 or >3).  Because stunting is most prevalent at ages 24-59 months, and 
wasting at 12-23 months, analyses were carried out for these subgroups (WHO 
1995). 
 
Data sets from the 1999 and 2002 surveys were double entered and checked for 
consistency in Foxpro for Windows. They were then transferred to STATA 8.0 for 
statistical analysis. Variables from the two data sets were individually coded, 
recoded and labeled appropriately. All analyses took into account the clustered 
nature of the data by employing svy procedures in Stata. 
  
We created an index of household wealth for each survey based on household 
characteristics, ownership of assets, household head and maternal income, and 
educational level of the head. Household level characteristics included ownership of 
the house and type of roofing. Household assets comprised ownership of radio, 
bicycle, nets, animals such as cows, goats, sheep, donkeys, and chicken and ducks. 
Household head and maternal income variables included whether they had income 
from any activities apart from farming such as masonry, petty business, fishing, 
driving or employment in other formal sectors. The numbers of years of schooling for 
both the head and mother or caretaker were categorized as none, one to seven for 
primary and eight or more for secondary education and above. The household 
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wealth index was the weighted sum of household characteristics, different consumer 
durables owned by the household, income and number of years of schooling. The 
weights for the assets in the index were generated by Principal Components 
Analysis (PCA) on the correlation matrix (Filmer & Pritchett 2001). In each survey, 
households were categorized into one of five equal sized groups from the most poor 
to the least poor.  
 
To assess whether the implementation of IMCI had reduced inequalities, we 
calculated concentration indices (Kakwani, Wagstaff, & Doorslaer 1997;Wagstaff, 
Paci, & van Doorslaer 1991) for a selected list of key coverage interventions and 
nutritional status and present all indicators as positive measures. The outcomes 
included anthropometric measures (not under weighted, not stunted and not wasted) 
and vaccine coverage, caretaker knowledge, care seeking, mosquito net use, and 
home management of illness. 95% confidence intervals for concentration indices are 
also presented. Differences between two concentration indices were tested using a t-
test (World Bank (undated)). 
 
Concentration indices take values between -1 and 1. A value of zero indicates that 
the health variable is equitably distributed across all wealth groups. A negative value 
indicates disproportionate concentration of the health variable among the poor.  
Health variables can be “goods” such as intervention coverage, or “bads”, such as 
mortality or malnutrition.  Hence a negative concentration index is pro-poor in terms 
of intervention coverage, or pro-rich in terms of undesirable health outcomes. 
(http://siteresources.worldbank.org/INTPAH/Resources/Publications/Quantitative-
Techniques/health_eq_tn07.pdf) 
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9.4 Results 
 
In 1999, data were available from 2,006 children under 5 years of age living in 1321 
households with children of this age-group in the 120 rural clusters. These 
represented 93% of eligible households: residents of 137 (6%) were away at the time 
of the survey and 21 (1%) refused to take part. In the 2002 survey, 1932 children 
under 5 years of age, living in 1341 households of the same villages were identified. 
These represented 94% of eligible households: residents of 142 (6%) were away 
and 9 (0.4%) households refused to take part. The age and sex distribution for these 
children was similar in the two surveys (Table 1). 
 
                Table 13: Age and sex distribution in 1999 and 2002 surveys 
Year of survey 
Characteristic 
1999 (N=2006) 2002 (N=1924) 
Sex  
Boys 1008 (50%) 980 (51%) 
Girls 998 (50%) 944 (49%) 
Age in years  
Less than 1 489 (24%) 405 (21%) 
1-2  401 (20%) 389 (20%) 
2-3  385 (19%) 413 (21%) 
3-4  390 (19%) 372 (19%) 
4-5  341 (17%) 344 (18%) 
 
Table 2 shows asset ownership in wealth quintiles in the two surveys. There were 
consistent patterns of assets ownership and socio-economic gradients between IMCI 
and comparison districts 
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Table 14: Asset ownership for households in IMCI and comparison districts 1999 and 2002 
    Assets, education, household and maternal income 
Year 
SES 
quintile 
No. of HHs 
(%) 
Mean 
asset 
score 
Rented 
house 
(%) 
Heads 
education 
(%) 
Mother 
education 
(%) 
HH 
income 
(%) 
Bicycle 
(%) 
Radio 
(%) 
Net 
(%) 
Animals 
(%) 
Fowls 
(%) 
Roof 
(%) 
Mother’s 
income 
(%) 
IMCI 
             
1999 Poorest 132 (22.3) -1.61 0 44 39 2 8 6 2 9 37 0 0 
 Very poor 105 (17.7) -1.01 0 67 62 4 19 26 7 20 70 4 3 
 Poor 119 (20.1) -0.32 2 76 65 24 41 53 14 10 52 8 7 
 Less Poor 119 (20.1) 0.59 3 83 79 52 36 61 35 14 58 31 18 
 Least Poor 117 (19.8) 2.45 29 92 83 74 68 77 74 19 55 71 35 
2002 Poorest 139 (20.1) -1.84 0 30 29 2 16 12 9 6 42 3 0 
 Very poor 139 (20.1) -0.88 4 65 53 9 24 35 24 13 56 11 5 
 Poor 137 (19.8) -0.15 1 80 72 16 31 64 49 13 68 18 3 
 Less Poor 138 (20.0) 0.72 7 81 72 41 47 75 70 11 65 41 11 
 Least Poor 138 (20.0) 2.18 16 97 91 72 54 86 82 14 59 67 48 
Non IMCI 
             
1999 Poorest 123 (20.2) -1.88 0 68 56 2 3 5 11 2 15 1 0 
 Very poor 144 (23.8) -0.92 1 94 81 8 16 15 49 3 63 2 0 
 Poor 98 (16.1) -0.22 4 91 78 22 40 41 59 8 60 18 5 
 Less Poor 123 (20.3) 0.69 9 94 90 40 52 59 81 7 54 28 14 
 Least Poor 120 (19.7) 2.51 27 98 97 73 68 77 88 10 59 86 39 
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2002 Poorest 139 (22.8) -1.88 0 73 57 1 6 3 49 4 40 1 1 
 Very poor 109 (17.9) -0.90 1 92 84 15 16 24 69 4 61 10 6 
 Poor 119 (19.5) -0.13 3 96 88 22 45 43 84 6 62 29 9 
 Less Poor 135 (22.1) 0.80 5 96 96 23 70 73 94 5 87 50 19 
 Least Poor 108 (17.7) 2.46 43 98 98 71 67 88 89 11 67 90 54 
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Table 3 shows the equity results. Six child health indicators (underweight, 
stunting, measles immunization, access to treated and untreated nets, treatment 
of fever with antimalarial) improved significantly in IMCI districts (p<0.05) in 
relation to comparison districts, while four indicators (wasting, DPT coverage, 
care takers’ knowledge of danger signs and appropriate care seeking) improved 
significantly in the comparison districts relative to IMCI districts. 
 
Most concentration indices for the anthropometric variables were negative, 
showing that the poorest were more likely to be malnourished. For underweight 
and stunting, inequities declined more markedly in IMCI districts than in 
comparison districts, that is, concentration indices were less negative in 2002 
than in 1999 (Figure 1 and Table 3). The largest improvement was observed for 
stunting among children between 24-59 months of age; the concentration index 
improved, from -0.102 in 1999 to -0.032 in 2002, while it remained nearly 
unchanged (-0.122 to -0.133) in comparison districts. These improvements can 
be observed in Figure 1, where the gap between the lines representing IMCI and 
non-IMCI districts increases over time.  
 
The prevalence of wasting was considerably lower than that of either 
underweight or stunting, and because the analyses were restricted to the children 
aged 12-23 months, sample sizes were considerably smaller with fewer than 100 
children per cell (Table 3). During the study period, wasting prevalence 
decreased among the poorest in the comparison districts; no cases were  
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Table 15: Selected outcomes according to socioeconomic quintiles and corresponding 
concentration indices in 1999 and 2002 for IMCI and comparison districts 
% of children by socio-economic quintiles 
Indicator or outcome measure IMCI Year 
Poorest 
Very 
Poor 
Poor 
Less 
poor 
Least 
poor 
Overall 
Concentration index 
(95% confidence 
interval) 
Anthropometric status 
  
1999 38 29 28 23 18 27 -0.136 (-0.144,-0.129) No 
IMCI 2002 30 21 15 17 13 19 -0.166 (-0.175,-0.157) 
1999 31 36 33 29 20 30 -0.071 (-0.080,-0.063) 
Low weight for age for 0-59 
months (Underweight) 
IMCI 
2002 28 18 24 26 16 23 -0.057 (-0.066,-0.048) 
1999 65 64 50 46 36 51 -0.122 (-0.130,-0.114) No 
IMCI 2002 50 43 43 45 18 40 -0.133 (-0.152,-0.115) 
1999 69 70 63 50 41 59 -0.102 (-0.110,-0.094) 
Low height for age prevalence in 
children 24-59 months (Stunting) 
IMCI 
2002 43 49 46 44 33 43 -0.032 (-0.040,-0.024) 
1999 10 15 11 8 12 11 -0.022 (-0.061,0.017) No 
IMCI 2002 0 8 6 3 9 5 0.217 (0.128,0.305) 
1999 14 19 13 14 7 13 -0.105 (-0.154,-0.056) 
Low weight for height prevalence 
in children 12-23 months 
(Wasting) IMCI 
2002 10 7 6 5 9 7 -0.053 (-0.112,0.007) 
Coverage of preventive interventions 
 
1999 86 89 90 88 93 89 0.012 (0.006,0.017) No 
IMCI 2002 94 88 91 98 94 93 0.008 (0.003,0.013) 
1999 90 76 91 88 93 88 0.015 (0.008,0.023) 
Measles vaccination (informed or 
registered) 
IMCI 
2002 91 91 87 88 86 89 -0.012 (-0.016,-0.007) 
1999 74 81 93 90 89 86 0.034 (0.025,0.042) No 
IMCI 2002 97 92 100 95 91 95 -0.011 (-0.015,-0.007) 
1999 90 86 76 90 93 87 0.011 (0.003,0.019) 
DPT vaccination (informed or 
registered) 
IMCI 
2002 74 88 82 86 89 83 0.030 (0.022,0.038) 
1999 3 3 6 3 13 6 0.302 (0.283,0.320) No 
IMCI 2002 5 14 11 14 24 14 0.247 (0.231,0.263) 
1999 1 0.6 5 5 8 4 0.399 (0.380,0.420) 
Child sleeps under a treated net in 
the last 6 months 
IMCI 
2002 5 11 9 19 20 12 0.260 (0.248,0.271) 
1999 24 27 44 46 65 42 0.197 (0.189,0.205) No 
IMCI 2002 48 64 66 73 82 67 0.098 (0.092,0.103) 
1999 11 5 23 29 39 21 0.294 (0.281,0.306) 
Child sleeps under a net 
IMCI 
2002 25 31 38 54 63 41 0.192 (0.185,0.198) 
1999 17 21 20 32 24 23 0.067 (0.057,0.077) No 
IMCI 2002 33 33 36 31 37 34 0.018 (0.011,0.024) 
1999 22 25 17 20 23 22 -0.011 (-0.02,-0.001) 
Caretaker knows at least 2 danger 
signs 
IMCI 
2002 29 28 30 30 29 29 0.005 (-0.001,0.106) 
1999 14 21 26 29 23 23 0.058 (0.046,0.071) No 
IMCI 2002 22 26 24 32 32 28 0.078 (0.071,0.085) 
Caretaker’s knowledge of feeding 
during illness 
IMCI 1999 31 28 22 22 27 26 -0.040 (-0.05,-0.031) 
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% of children by socio-economic quintiles 
Indicator or outcome measure IMCI Year 
Poorest 
Very 
Poor 
Poor 
Less 
poor 
Least 
poor 
Overall 
Concentration index 
(95% confidence 
interval) 
  2002 32 29 33 27 28 30 -0.029 (-0.034,-0.023) 
Management of illness at home or and the facility 
  
1999 27 40 39 53 64 45 0.148 (0.135,0.160) No 
IMCI 2002 18 29 21 30 45 28 0.158 (0.136,0.179) 
1999 31 40 33 36 53 38 0.074 (0.058,0.090) 
Child with fever receives 
appropriate treatment 
IMCI 
2002 24 31 27 25 32 27 0.029 (0.015,0.043) 
Care seeking 
          
1999 31 39 37 49 56 43 0.108 (0.010,0.117) No 
IMCI 2002 31 35 34 31 30 32 -0.016 (-0.026,-0.005) 
1999 35 44 32 46 45 40 0.047 (0.039,0.056) 
Appropriate care seeking 
IMCI 
2002 31 42 35 46 41 39 0.055 (0.045,0.064) 
 
observed in the poorest quintile in 2002, and the concentration index became 
positive. Equity also appeared to improve slightly in the IMCI districts. 
 
Table 3 presents the time trends in inequities in preventive indicators. Unlike the 
indicators of malnutrition, equity for these outcomes improved when 
concentration indices were reduced between 1999 and 2002.  Measles and DPT 
vaccine coverage were already fairly equitable in IMCI and comparison districts 
in 1999, with all concentration indices being very close to zero. Inequity in 
measles vaccine coverage in comparison districts showed little change (from 
0.012 to 0.008), but in IMCI districts the concentration indices changed from 
0.015 (slightly pro-rich) to -0.012 (slightly pro-poor).  
 
On the other hand, the overall coverage of DPT in IMCI districts fell from 87% to 
83% while it increased from 86% to 95% in the comparison districts (Table 3). 
The reduction in IMCI districts mostly affected the poorest quintile (among whom 
Chapter 9: Impact of IMCI on inequalities in child health in rural Tanzania 
 - 174 - 
coverage fell from 90% to 74%) and as a consequence the concentration index 
increased from 0.011 to 0.030. In comparison districts, equity improved (from 
0.034 to -0.011) and in fact DPT coverage became slightly pro-poor. 
 Table 16: Concentration indices: Difference in IMCI and comparison districts 
Concentration Indices 
After – before 
difference 
(2002 minus 1999) 
Indicator 
IMCI No IMCI 
Difference in 
differences* 
(IMCI minus 
no IMCI) 
Underweight -0.029 0.014 0.044 
Stunting (24-59 months) -0.011 0.070 -0.081 
Wasting (12-23 months) 0.239 0.052 0.187 
Measles coverage -0.027 -0.004 -0.023 
DPT coverage 0.019 -0.045 0.064 
Child sleeps under a treated net -0.139 -0.055 -0.084 
Child sleeps under a net -0.102 -0.099 -0.003 
Caretaker knows at least 2 danger signs 0.016 -0.050 0.066 
Caretaker knowledge of feeding during illness 0.020 0.011 -0.009 
Child with fever received appropriate treatment -0.045 0.010 -0.056 
Appropriate care seeking 0.008 -0.124 0.132 
* Negative values-indicate greater improvement in equity in IMCI than in non-
IMCI districts – are highlighted in bold. 
 
There were significant improvements in the equity of coverage of mosquito nets 
in both IMCI and comparison districts between 1999 and 2002 (Table 3). The 
increase was for both treated and untreated nets. 
 
Results on caretaker knowledge are also shown in Table 3. In comparison 
districts, equity in the proportion of caretakers who knew two or more danger 
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signs and required urgent health care improved, but no change was observed in 
IMCI districts where the concentration indices were already virtually zero and 
therefore highly equitable. Regarding knowledge on the need to continue feeding 
the child during an illness, there were no significant changes in equity in either 
set of districts. 
Figure 4: Concentration indices and confidence intervals for nutritional indicators 
 
In terms of case-management, appropriate treatment with antimalarials for 
children with fever fell between 1999 and 2002 in both IMCI and comparison 
districts (Table 3). In the former, but not in the latter, equity improved during the 
study period. The concentration index decreased significantly from 0.074 to 
0.029.  
Chapter 9: Impact of IMCI on inequalities in child health in rural Tanzania 
 - 176 - 
 
Lastly, equity in appropriate care seeking improved significantly in the 
comparison districts, but the overall care seeking rate fell from 43% to 32% in the 
period. In the IMCI districts, where care seeking rates were more stable, there 
was slight but non-significant increase in inequity from a concentration index of 
0.047 to 0.055 (Table 3).  
 
Table 4 summarises the equity findings by showing the change in concentration 
indices (expressed by the difference between the 2002 and 1999 indices) in IMCI 
and non-IMCI districts, as well as the difference between these two differences. 
Negative values of the difference in differences – indicating greater improvement 
in equity in IMCI than in non IMCI districts – were observed for underweight, 
stunting, measles vaccine, mosquito nets, and fever treatment.  
 
 
9.5 Discussion 
We have used concentration indices based on asset quintiles to measure 
inequities in childhood health indicators from two independent child health 
surveys in South East Tanzania. Previous studies have shown that an asset 
index generated from household assets is a robust proxy measure of wealth 
(Filmer & Pritchett 2001), and these are now being widely used in the equity 
literature (Victora et al. 2003).  
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The main results of the Tanzania MCE-IMCI are presented elsewhere 
(Armstrong Schellenberg, Adam, Mshinda, Masanja, Kabadi, Mukasa, John, 
Charles, Nathan, Wilczynska, Mgalula, Mbuya, Mswia, Manzi, de Savigny, 
Schellenberg, & Victora 2004a). There was an improvement in the quality of care 
provided in first-level facilities, improvements in some but not all coverage 
indicators, and a significant reduction in stunting in the IMCI districts compared to 
comparison districts. Under-five mortality was assessed through demographic 
surveillance in delimited areas within each district; baseline levels were similar in 
IMCI and comparison districts, but after two years, mortality was 13% lower in 
the IMCI districts, a difference that did not quite reach statistical significance.   
 
In a previous analysis of the 1999 survey data, we showed that there were 
important baseline inequities in nutritional status and in the coverage of key 
interventions within all four districts (Armstrong Schellenberg, Victora, Mushi, de 
Savigny, Schellenberg, Mshinda, & Bryce 2003). The question addressed in this 
paper was whether or not the effects of IMCI mentioned above were associated 
with higher or lower levels of inequity in short term follow-up.  
 
Stunting is a key indicator because it reflects the cumulative effects of nutritional 
and infectious factors (WHO 1995). Both stunting and underweight prevalence 
showed strong inverse associations with the wealth index, as would be expected. 
Wasting prevalence, on the other hand, tended to be much lower – as observed 
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in other African settings (Victora 1992), and the association with wealth was 
modest.  
 
Stunting prevalence declined faster in IMCI than comparison districts, and equity 
improved more markedly in the former. There were also positive changes with 
IMCI in terms of underweight. For wasting, baseline inequities were not so 
marked, and improvement was significantly greater in comparison (p=0.002) than 
in IMCI districts, particularly due to low prevalence among the poorest in these 
two districts. The possibility of survival bias cannot be ruled out, with wasted 
children poorest families showing high mortality in the non-IMCI districts where 
death rates were higher. Overall it seems that IMCI had a beneficial impact on 
equity in nutritional status.  
 
Results on vaccine coverage were mixed. IMCI was associated with improved 
equity for measles vaccine, whereas the opposite was observed for DPT. A 
potential caveat is that we relied both on information recorded on a vaccination 
card as well as on doses reported by the mother; nevertheless, the same 
procedure was used both in IMCI and non-IMCI districts. These results concur 
with earlier findings (Armstrong Schellenberg, Adam, Mshinda, Masanja, Kabadi, 
Mukasa, John, Charles, Nathan, Wilczynska, Mgalula, Mbuya, Mswia, Manzi, de 
Savigny, Schellenberg, & Victora 2004a): the introduction of IMCI was associated 
with a drop in DPT coverage of a few percentage points, of statistical rather than 
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public health significance. Nevertheless, these disparities highlight the need to 
reach the poorest children with this vaccine.  
 
In terms of mosquito nets, equity improved in all districts. The decline in inequity 
of coverage for children sleeping under a treated net was faster in IMCI districts 
compared to comparison. It should be noted that the two comparison districts 
(Kilombero and Ulanga) were covered by a social marketing programme of 
treated nets that started two years earlier than in the IMCI districts (Nathan et al. 
2004). 
  
For indicators on caretaker knowledge and care seeking behaviours, the picture 
was also mixed. IMCI districts did better in terms of the proportion of caretakers 
who knew child health danger signs and in management of fever with 
antimalarials. On the other hand equity improvements were greater in 
comparison districts for care seeking rates, but this was largely due to a 
reduction in appropriate care seeking rates in the two upper quintiles in these 
districts, rather than an improvement among the poor. Reasons for these 
reductions are unclear, although they may be due in part to the change of first-
line antimalarial drug from chloroquine, which was both popular and easily 
available to the rather less popular sulphadoxine-pyrimethamine, which was less 
widely available. 
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This study has shown how equity assessments can be incorporated in impact 
evaluations at relatively little additional cost, and how these may point to specific 
interventions that need to be reinforced. For example, whereas vaccine coverage 
is reasonably high and equitable, there remain important inequities in mosquito 
net coverage and in treatment of fever with antimalarials.   
 
In the study districts, IMCI consisted mainly of the training of health workers, in a 
context of support to district management by the Tanzania Essential Health 
Intervention Package (Armstrong Schellenberg et al. 2004b). One might fear that 
the absence of a strong community component for promoting IMCI at household 
and family level might lead to increased inequities, because access to health 
facilities was already inequitable when IMCI was introduced (Armstrong 
Schellenberg, Victora, Mushi, de Savigny, Schellenberg, Mshinda, & Bryce 
2003). Such apprehension was not confirmed by our data. Therefore, IMCI 
introduction led to improvements that did not occur at the expense of equity. 
These findings should be interpreted in the light of two important characteristics 
of rural Tanzania: the relatively high rates of utilization of government facilities 
(Victora et al. 2005) and the fact that no user fees are charged in the two districts 
implementing IMCI (Manzi et al. 2005). 
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CHAPTER 10: Discussion and Conclusions 
This chapter discusses the main findings of the collected work presented in this 
thesis (Chapter 2). Methodological strengths and weaknesses of studies conducted 
and their relation to other studies are also discussed. Implications of the study 
findings are summarized with a view to how they can inform policy and consequently 
improve child health and survival. Emerging questions and future work are also 
proposed. 
 
We are almost at the halfway mark since commitment was made by world leaders to 
resolve most pressing problems of humanity and it is therefore important to take 
stock of what we have achieved so far. Have we made reasonable progress with the 
coverage of technologies we have at present? What are the bottlenecks to achieving 
these goals?  Can we do better, for history not to condemn us for not meeting our 
obligations? This thesis is a compilation of studies that are aimed at addressing 
some of the information and knowledge gaps by tracking progress on causes of 
death, intervention and health systems evaluation, and impact and equity 
assessments of large interventions programmes.  
 
Burden of disease 
Since the publication of the Global Burden of Disease (GBD) study in 1993 (Murray 
& Lopez 1996) which quantified the causes of deaths and injuries and the associated 
risk factors in eight regions of the world, there have been increased investments led 
by the World Health Organization (WHO) on improving the conceptual, 
methodological and empirical basis of assessment of burden of disease and injury 
burden. 
 
There is also an increasing demand for cause specific mortality burden data by 
planners of health services for allocation of resources to different intervention 
strategies to maximize their impact. Further, international aid donors need this 
information for assigning priorities for support and for accountability. However, in 
countries where disease burden is greatest and resources available for health 
services are insufficient, less priority has been given to collecting morbidity and 
mortality data. Such data are often patchy in their coverage, and are usually related 
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to urban populations, consequently the planner of health services who is bestowed 
with the task of assigning resources to different interventions to maximize impact, 
lacks this basic quantitative information to guide him or her through this process. 
 
A very basic step in understanding the demographics of populations and their health 
in any country is the counting of births and deaths and understanding what its 
members die of and at what age. Such data, even without the associated morbidity, 
would present a huge step towards assessing disease burden in poorest 
communities. Efforts to improve the collection and harmonization of vital statistics in 
resource poor settings are being spearheaded by the International Network for 
Demographic Surveillance (INDEPTH) and the Health Metrics Network (HMN).  
 
A stepping stones approach to a vital statistics system has been proposed for 
countries without reliable vital statistics (HMN Figure).  Step one would use sentinel 
registration with a minimum of at least one urban and rural demographic surveillance 
site each. This will provide the number of births and deaths by age, sex and cause in 
a sentinel sample the population but would not be fully representative of the whole 
country. Quality ascertainment and adjustments of data would be an on-going 
process. Step two would add simple random cluster sampling methods with enough 
clusters for representative analysis of sub-national burdens of disease (e.g. state, 
regional or provincial level) once a country is ready to move on to a more costly 
approach.. It is envisaged that steps one and two would provide valuable interim vital 
statistics while waiting for routine civil registration systems to build up quality and 
coverage to the required level of at least 90% coverage.  At that time the sentinel 
and sample systems could be decommissioned. 
 
Demographic surveillance combined with mortality surveillance using verbal autopsy 
(VA) has the potential to provide useful mortality data in these settings where as 
much as 80% of the disease burden is due to years of life lost to premature death. In 
our study on cause specific mortality we have provided cause-specific mortality rates 
for more than two years period (2000-2002) for Kilombero and Ulanga districts. As 
more data on causes of death is becoming available, global burden of disease 
estimates have also been published and are expected to provide the necessary 
impetus of the interventions needed to reduce them. The major killers of children 
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younger than five years have remained the same. Malaria, pneumonia, diarrhoea, 
nutritional deficiencies and conditions arising during the perinatal period were the 
leading causes of death in Kilombero and Ulanga districts. Our results are consistent 
with two reports on global estimates by the WHO Child Health Epidemiology 
Reference Group (CHERG) (Bryce et al. 2005) and by Lopez and colleagues (Lopez 
et al. 2006) both showing similar findings that more than half of these deaths were 
from preventable or treated conditions.  
 
 
If the health related Millennium Development Goals (MDGs) and especially goal 
number 4: to reduce child mortality are to be meet, careful and well designed 
approaches are required to prevent and control these conditions. Experience from 
neighbouring districts of Rufiji and Morogoro Rural where similar demographic and 
mortality data were collected and integrated into resource allocation for health care 
have shown impressive results. Health services profiles introduced by the Tanzania 
Essential Health Interventions Project (TEHIP) were generated annually from cause-
specific mortality data and provided to members of the council health management  
     Figure HMN Stepping stone approach to vital statistics system 
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teams (CHMTs) during their annual planning.  The CHMTs used the burden of 
disease information to set intervention priorities, chose a shorter list of essential 
health interventions, and align resources to interventions that addressed the biggest 
share of the burden in their respective districts. 
 
In a recent global analysis, HIV/AIDS which accounted for only 2% of deaths in 1990 
is responsible for 14% of global mortality in 2001. HIV/AIDS was the leading cause 
of disease burden in Sub-Saharan Africa, where it was followed by malaria (Lopez, 
Mathers, Ezzati, Jamison, & Murray 2006). Our results though could be an 
underestimate of the actual burden, indicate an increasing problem due to HIV/AIDS 
especially in the most productive age group (15-49). With the exception of infants, 
HIV/AIDS was among the top ten leading causes for death in our study.  The global 
analysis referred to above, which is based on modelling a variety of source of 
information, suggests that in Africa, diarrhoea and malaria are equivalent 
components of the burden of disease, each with shares of about 18% of the total.  
However in the DSS data in Tanzania and elsewhere in Africa, diarrhoea is recorded 
much less frequently than 18% as a component in the burden of disease, while 
malaria is recorded much more frequently than 18% in every setting examined.  This 
calls into question the difference from directly measured empirical data as seen in 
DSS settings and the basis of the models currently used for Burden of Disease 
analysis by WHO. 
 
Health system access 
A central problem in establishing health care systems is to provide resources in 
locations that are close enough to be reached by the populations in need. Therefore, 
ensuring physical accessibility and provider-consumer links is of primary concern. 
Physical distance between provider and consumer has been recognized as an 
important barrier for several decades (King 1966) and studies have shown that most 
people will not travel further than 5km (one hour walking) to basic and curative care 
(Stock 1983) . The distance problem seriously affects women and their children in 
the uptake of health services. By virtue of their reproductive functions and the their 
role in children care, women are more likely to seek more frequent health care than 
males 
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 Results from our study show that, spatial patterns of access to health care for 
children younger than five years and pregnant women were very similar indicating 
use of health facilities close to their households. About 78% of this rural population 
were shown to be within 1 hour from a health facility. Average travel time to a health 
facility for both under five and maternal care was estimated as 36.5 and 36.8 
minutes respectively. In a similar setting in Kwazulu Natal, where the road network is 
fairly advanced 65% of the residents of homesteads travelled an average of 1 hour 
or more to attend the clinic (Tanser, Gijsbertsen, & Herbst 2006). Similarly, a study in 
four rural districts in Kenya estimated that 63% of the population were within 1 hour 
of the national access benchmark (Noor et al. 2006).  Tanzania therefore appears to 
have a much more physically accessible health system than these wealthier 
countries. 
 
Since independence, Tanzania’s policies have been geared towards improving 
social development which includes health. In the different waves of reforms that the 
country has gone through, proximity to health services in the rural areas where the 
majority of the population live has been one of the primary concerns of the 
government. The policy of ensuring that at least every village in the country had a 
primary health care facility was hence adopted. Due to the decline in physical 
infrastructure of the health system in the 1990’s it was important to obtain more 
accurate estimates of current access to health services as a crucial parameter for 
understanding coverage of different health interventions.  Such evidence is lacking in 
the current health information system in Tanzania. 
 
Attraction to government facilities as estimated by the distance usage index (DUI) 
was higher in government health facilities compared to the non-governmental 
mission dispensaries nearby. We did not collect information on quality of health 
services during this study and hence cannot claim the resulting attraction as due to 
quality. However, there was strengthening of case management and improvement in 
the health systems capacity to support IMCI implementation in the district before and 
during the period of our study. Quality of health care has also been shown in other 
studies to have more impact on utilization than physical access (Acharya & Cleland 
2000;Egunjobi 1983). 
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Health system interventions 
The Integrated Management of Childhood Illness (IMCI) is one among many 
strategies for improving child health that integrates several interventions, each of 
which have already been proven to be efficacious in randomized controlled trials. 
There was a need therefore of evaluating their combined delivery under routine 
implementation conditions. The Multi-Country Evaluation of Integrated Management 
of Childhood Illness MCE-IMCI is an evaluation of this strategy that included studies 
of the effectiveness, cost and impact of IMCI in Bangladesh, Brazil, Peru, Tanzania 
and Uganda (Bryce et al. 2004). The IMCI strategy is comprised of: 1) improving 
health systems to support IMCI;, 2), improving health workers skills to manage major 
causes of illness in children younger than five; and 3) improving family and 
community practices needed to prevent diseases and stimulate appropriate 
utilization. In our study, we studied districts that implemented the first two 
components of the strategy. Guidelines for implementing the third component were 
not available in the duration of the study. 
 
Evidence from our work shows that facility based IMCI improved quality of care 
(chapter 6) and was associated with a reduction in mortality (chapter 6). Mortality 
was 13% lower in the intervention than in comparison districts (Chapter 6). The costs 
of IMCI were similar or lower in intervention than in comparison districts (Adam et al. 
2004) and more important the introduction of IMCI led to improvements in child 
health that did not occur at the expense of equity (Chapter 8).  
 
In our study the presence of demographic surveillance systems in each of the four 
districts was used to define the population at risk and determine mortality events.  
This enabled us to define individual risks and made it possible to measure person 
time at risk.  With the exception of the study in Uganda where no evaluation on 
mortality was done, other MCE study sites used different methods to evaluate child 
survival. For instance in Peru (Huicho et al. 2005b) they used the birth histories from 
two demographic and health surveys (DHS), while in Brazil vital registration and 
community health workers demographic surveillance (Amaral et al. 2005) were used 
to calculate mortality rates. The study in Bangladesh which is expected to finish in 
2007 is expected to use similar methods to ours with mortality data provided by the 
Matlab DSS.  
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Demographic surveillance systems (DSS) allow the tracking of migrations. 
Migrations are very common at least in this part of Tanzania and their integration into 
the DSS makes it possible to define individual time at risk. Tracking of migration is 
also critical in longitudinal studies and vaccine trials. Such tracking and use of 
accurate person-time denominators means that rates and trends measured in DSS 
are much more reliable than other sources. This makes the DSS setting useful as a 
testing ground for impact and health systems evaluations such as done here for 
IMCI. 
 
Our results on improved quality of care are consistent with those from other four 
studies in Uganda (Gouws et al. 2004), Peru (Huicho et al. 2005a), Brazil (Amaral et 
al. 2004) and Bangladesh (el Arifeen et al. 2004) even though case management 
training in some the sites was of minimum standards of quality.   
In our study districts, the 11 and 16 day courses for clinicians and non-clinician 
respectively and follow up after training was critical in reinforcing the skills gained 
during the training. An integrated supervision approach which has been introduced is 
expected to improve quality and performance of health care provision. 
 
Among the contributing factors of success of our study was the presence of system 
strengthening activities in the study districts. From the onset of IMCI introduction in 
Tanzania, health system strengthening activities by TEHIP were already underway. 
TEHIPs system strengthening activities that included a set of simple, user-friendly 
tools to enable local-level health planners to plan on the basis of evidence (de 
Savigny et al. 2004), from which the districts chose to implement IMCI and other key 
interventions. 
 
One of the assumptions of the IMCI impact model was that improvements in child 
health and nutrition depended on improved quality of care in health facilities which in 
turn would improve care seeking and utilization or increased coverage rates of key 
family interventions. Utilization rates reported from one of our baseline studies 
indicated that 41% of all the children who reported an illness two weeks preceding 
the survey sought care from a public health facility (Armstrong Schellenberg et al. 
2003). These rates are higher than those reported from similar studies in Uganda 
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and Bangladesh where 8% and 13% of children reported to have sought care from a 
public health within two weeks preceding the survey respectively.. 
 
The biggest cost share in IMCI implementation goes to training of health workers. 
The total district-level financial cost is estimated at 20.5 million shillings per district, 
or a total of 2.5 billion shillings for the whole country excluding the costs of 
introduction of burden of disease and health mapping tools2, a sum most of the 
districts would not have afforded earlier. With decentralization, districts now have 
more autonomy and control over their health budgets and plans. More money is now 
available from Sector Wide Approach (SWAp) health basket funding and other 
sources such as the local government and revenue generated from cost-sharing.  
 
 There a number of challenges on how best to accelerate implementation of IMCI in 
the country. It has been observed that coverage is growing at a slower pace than 
anticipated. 43 out 121 districts of mainland Tanzania and 4 out of 10 districts in 
Zanzibar have not started implementing IMCI despite the districts receiving funding 
and orientation from the central level.  
 
Vitamin A supplementation 
Interventions, however effective, are not enough if they do not reach the poor 
children who need them most. Vitamin A supplementation is considered to be one of 
the most cost effective interventions that have been researched extensively both in 
terms of health and nutritional impact and in terms of ways to make supplementation 
programmes successful (Sommer & West, Jr. 1996).  During the IMCI evaluation, we 
documented an increase in vitamin A supplementation coverage from 13% to 76% in 
1999 and 2002 respectively that was sustained by repeated campaigns for three 
years without compromising equity (Chapter 7). Our results are similar to those 
reported in the Phillipines (Choi, Bishai, & Hill 2005) where they examined VAS in 
the last six months using DHS data in 1993 and 1998.  
 
                                            
2
 Evaluation of facility based IMCI in Rufiji and Morogoro Districts, Tanzania. Policy Brief, March 2004 
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Twice yearly mass campaigns were introduced since 2001 to catch up with the low 
coverage rates in children between 6-59 months of age supplemented through the 
routine EPI system. Under the routine system, children are scheduled to receive their 
vitamin A supplementation at the time of their measles vaccination at 9 months and 
at 15 and 21 months. Coverage rates during these routine contacts have been low, 
necessitating the initiation of twice yearly supplementation campaigns that are 
coupled with activities on the Day of the African Child in June and the World AIDS 
day in December. Moreover, routine supplementation did not consider children 
above 2 years of age but less than five years who would also benefit from such an 
intervention.  Reports on the benefits of VAS below 6 months of age have been less 
consistent than from those above 6 months old (Humphrey et al. 1996;Rahmathullah 
et al. 2003;WHO/CHD Immunisation-Linked Vitamin A Supplementation Study Group 
1998) resulting to varied consensus on the policy recommendations by the expert 
group on vitamin A supplementation. 
 
Kilombero Vitamin A supplementation study 
In our study to evaluate the safety and efficacy of two vitamin A supplementation 
schedules in infants in Kilombero district in southern Tanzania (Chapter 9) high dose 
vitamin A was found to be safe and well tolerated by both mothers and infants. 
However, this did not confer any benefit in terms of reducing the incidence of 
disease in infants in the higher dose group. The prevalence of vitamin A deficiency at 
6 months of age was 43% in the higher dose group and 47% in the lower group.  Our 
results are contrary to what was found before (Humphrey & Rice 2000) and it was 
necessary to consider all possible explanations. In general, vitamin A 
supplementation results from studies in children less than six months have been less 
consistent than those documented for supplementation later in life (Fawzi 2006). In 
similar studies in Indonesia (Humphrey, Agoestina, Wu, Usman, Nurachim, 
Subardja, Hidayat, Tielsch, West, Jr., & Sommer 1996) and India (Rahmathullah, 
Tielsch, Thulasiraj, Katz, Coles, Devi, John, Prakash, Sadanand, Edwin, & Kamaraj 
2003), large doses of VAS in neonates had beneficial effects in children of normal 
and low birth weight respectively. 
 
We noted a degradation in the quality of some vitamin A capsules and excluded 
these children in the analysis. The results however remained unchanged but pointed 
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the need to institute quality control measures in clinical trials and in current 
supplementation programs. 
 
Health equity assessment 
Assessments of inequalities in health have become increasingly popular in public 
health literature. As there is more emphasis now on devising new delivery strategies 
and increasing coverage of available interventions, it is imperative that these efforts 
go hand in hand with ensuring that gaps do not increase and that coverage between 
the rich and poor is equitable.  
 
In our study, introduction of IMCI was associated with an improvement in child 
health. But there was still the question of whether this widened the gap between the 
richer and the poorer children and we therefore sought to find out whether the 
introduction of IMCI was associated with any equity differentials that are important to 
address when scaling  up such interventions (Masanja et al. 2005). Although there 
might be fears that the absence of a strong community component for promoting 
IMCI at household and family level might lead to increased inequities, because 
access to health facilities was already inequitable when IMCI was introduced 
(Armstrong Schellenberg, Victora, Mushi, de Savigny, Schellenberg, Mshinda, & 
Bryce 2003). Such apprehension was not confirmed by our data. Therefore, IMCI 
introduction led to improvements that did not occur at the expense of equity. 
 
To our knowledge our results on equity differentials in child health were the first 
within the MCE framework. Other MCE sites either evaluated inequalities in health at 
one point in time or did not evaluate at all. 
 
In a previous assessment when IMCI implementation was still in the phasing  in 
stage, we showed that there were important inequities in nutrition and coverage of 
key interventions within all the four districts (Armstrong Schellenberg, Victora, Mushi, 
de Savigny, Schellenberg, Mshinda, & Bryce 2003).  
 
We used concentration indices based on household assets to assess inequalities in 
access and coverage of child health interventions. This proxy wealth index measures 
the extent to which a particular health variable is distributed unequally across all five 
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wealth quintiles. Other studies that have also used similar methods to ours are those 
commissioned by the World Bank in over forty countries including Tanzania, to 
measure inequality in health, nutrition and service used among individuals of 
different socio-economic classes (Gwatkin et al. 2000). Concentration indices have 
also been used to measure  Although the wealth index lacks a straightforward 
interpretation in intuitive units, concentration indices and concentration curves have 
become fairly standard measurement tools in health economics literature on equity, 
inequalities health and health care. Another measure of health inequality that is 
frequently used is the rich-poor ratio which compares extreme groups and ignores 
middle quintile groups. 
 
Review of the designs 
As in most studies, there are important limitations that need to be taken into account. 
Although limitations for each study design were presented in individual chapters of 
the thesis, further aspects of the designs are discussed here.  
 
Burden of disease 
The Verbal Autopsy (VA) is a crude method of determining causes of death in 
countries where like Tanzania where vital registration is incomplete. But it is the best 
available alternative.  The process of arriving at a probable cause of death begins 
from the interview with a relative or family member who took care of the diseased to 
a panel of physician or a computer algorithm using the WHO International 
Classification of Disease ICD-10 or similar. In our study we used lay field workers to 
collect information from the relatives on the causes leading to death and requested 
for any hospital documentation such discharge summaries or death certificates 
available. This was further reviewed by a panel of physicians without using pre-
defined diagnostic criteria to arrive at a final cause of death. 
Although this method of physicians review without pre-defined diagnostic criteria has 
several advantages, such as validity of VA diagnosis of selected causes being better 
than algorithms and also less VA interviews being classified as undetermined 
relative to other methods, it was also bound to some limitations. The major 
limitations which our results also suffer from this method have been reported. They 
include: 1) low repeatability of the diagnoses reached by physicians (Todd et al. 
1994); and 2) the difficulty of sustaining physician interest and diagnostic 
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consistency over long periods.  Other operational problems associated with 
physician coding is the cost and time delays incurred. 
 
Some causes of death (COD) could not be captured through the VA alone and 
hence supporting documents were required to arrive at a possible cause of death. In 
our study, VA interviewers requested from the respondents documents such as 
admission cards and laboratory tests that belonged to the deceased if he or she ever 
came into contact with formal health care providers. Although this improves the 
accuracy of the COD reached by VA, it makes comparisons between populations 
difficult. This implies that proportional mortality of causes that cannot be diagnosed 
using the symptom or sign checklist history will be underestimated in rural compared 
to urban settings. Results from our study showed that slightly more than half of the 
deaths occurred at home and most probably some without any contact with a health 
care provider and therefore are less likely to have any documentation which their 
urban counterparts are more like to have. 
 
Although the use of diagnostic criteria is beyond the scope of this thesis, it is worth 
mentioning that the procedure is much more transparent and repeatable. Bayesian 
probability methods have been used to assigning causes of deaths and have shown 
comparable results to physician reviews (Byass et al. 2006;Fantahun et al. 2006). 
However the methods are yet be validated against a “gold standard” other than the 
COD reached by physician review.  In a new development, King and Yang have 
demonstrated that the difficult assumptions underlying the present methods could be 
overcome by allowing more causes to be analysed simultaneously (King & Lu 2006). 
This approach sounds attractive and easier to use in practice than the physician 
reviews, expert algorithms and parametric statistical assumptions. 
 
Our results are also susceptible to the bias due to misclassification of causes of 
death within subgroups for instance deaths between malaria and other infectious 
diseases such pneumonia or meningitis. It is further argued that inadequate 
information could lead into overestimating or underestimating. 
We did not attempt to adjust for bias due to misclassification in our study and 
therefore caution should be exercised when interpreting the result.  Ways of dealing 
with misclassification errors have been suggested (Chandramohan, Setel, & Quigley 
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2001) and have shown provide reliable cause-specific mortality fractions for diseases 
of public health importance (Setel et al. 2006).  
 
As VA experts are in the process of agreeing on using standardized VA instruments 
and COD lists that will allow global comparison it is important to clear some 
definitions that will disfavour this analysis such as the definition of children and 
adults. In our study, three questionnaires, one each for deaths at 0-28 days, 29 days 
to less than 12 years and above 12 years were used to distinguish neonatal, child 
and adult deaths respectively.  Other sentinel sites in Tanzania have used AMMP 
questionnaires which categorized neonates, children and adults into 0-28 days, 29 
days to less than 5 years and more than five years age groups respectively. The 
proposed tools from the group of VA experts is likely to solve some of these 
problems in the short to medium term 
 
Health systems access 
A major limitation in our study on spatial access to health care by pregnant women 
and children younger than five was the failure to incorporate natural physical barriers 
such as land cover and land use in our travel time model.  Travel time over open 
country was assumed to be the same as travel time along the smallest path or track 
lending our model potentially to underestimate the actual travel times between 
households and health facilities if there are major obstacles in the open countryside.  
We also made educated guesses on the travel speeds on different road levels and 
on modes of transport which may not apply uniformly to every household or health 
seeker.  
 
Health systems interventions 
Epidemiology classifies the randomized controlled trial as the “gold standard” 
because they are not affected by the usual pitfalls of selection or information bias, 
confounding or chance. A randomized design was impossible in our case since the 
IMCI was already being implemented in two of the four districts that were included in 
this study. However, we made all possible efforts to document all potential activities 
in the districts that would have affected our impact results. The evaluation in 
Bangladesh is using a randomised design with half of 20 first level health facilities 
assigned to implementing IMCI and half are comparison. 
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Chapters 6, 7 and 8 present studies that were conducted during the evaluation 
Integrated Management of Childhood Illnesses (IMCI) in Tanzania. We used non-
randomized control trial or plausibility design (Habicht, Victora, & Vaughan 1999) in 
which there is monitoring of process measures to improve the internal validity of the 
study and of contextual (or external) factors to check whether any apparent effect of 
the intervention can be explained by other factors. 
 
The IMCI study evaluated the effectiveness of the integrated delivery of a number of 
individually well proven child health interventions delivered under real life conditions. 
IMCI in the study districts was managed and implemented by district health 
management teams since 1996. The first component of IMCI emphasizes proper 
case management of sick children using stipulated guidelines. Since implementation 
was already underway when the evaluation commenced in 1999, we were not able 
to do a before and after comparison that would have strengthen our hypothesis on 
impact of IMCI on mortality. Nonetheless, we were reassured from sub-national DHS 
mortality results that child mortality levels in intervention districts were similar to or 
worse of than comparisons districts at the commencement of the study. 
 
Vitamin A supplementation 
The MCE-IMCI study provided an opportunity to evaluate the coverage of other 
intervention such vitamin A supplementation and insecticide treated nets.  UNICEF 
supported the national delivery programme of vitamin A supplementation through 
twice annual campaigns since 2001.  To our knowledge, no records outside routine 
contacts are registered on the child’s MCH card. In our study, we depended on a 
large extent on mothers’ recall of vitamin A supplementation status of their children. 
Although we checked for this information on the children’s card, it was of limited use 
since the campaign staff were not trained to record vitamin A. Results from 
immunization studies using mother’s recall are mixed. In Kenya for instance they 
found sensitivity of mother’s recall was high but declined with the numbers of 
vaccines (Ndiritu et al. 2006). In another study in India, the found that maternal recall 
to have a low sensitivity (Ramakrishnan et al. 1999).  
 
 
Chapter 10: Discussion and Conclusions 
 - 201 - 
Kilombero vitamin A supplementation  
We were unable to use a placebo in this study because of ethical concerns of the 
marginal benefits of the lower dose regimen (25,000IU) of vitamin A in children 
younger than six months in a previous trial. It can still be argued though, that the use 
of a placebo would have increased the efficacy estimate of our study as there was 
no chance that the lower regimen would ever be widely implemented during the 
course of the study.   
 
A major strength of our study was the use of passive case detection (PCD) to detect 
safety signals and the potential effect of the intervention on morbidity for a longer 
period of time. This ensured that cases severe enough to require the attention of 
more qualified health personnel were attended during the follow up rather than the 
two days after supplementation.  
 
 
Policy Implications 
Tanzania started implementing IMCI in 1996 with a focus on strengthening the health 
system, improving health workers’ skills in case management, and improving 
household and community practices for child survival, growth and development albeit 
at later stages.  Facility-based IMCI has shown to improve quality of care, to reduce 
mortality in children younger than five and not costing more than conventional care. 
These results were a basis of adopting the strategy nationally and promoting it for all 
district health plans (IMCI/NMCP meeting Dodoma). While we appreciate the 
challenges of how best to accelerate implementation of IMCI in the country, it is 
discouraging to note that the scale-up is going at a slower pace than anticipated. The 
costs for introducing IMCI are affordable with the funds the districts have. Districts 
are encouraged to make this modest investment that has the potential to save the 
lives of more than 223,000 children younger than five each year.  One reason the 
uptake of IMCI in all districts has been slow could be that the TEHIP tools that drove 
the uptake in our studies (Burden Profiles and District Health Accounts, both using 
the DSS sentinel data) had until 2006 not been available to all districts.  The lessons 
of TEHIP in Rufiji and Morogoro Rural districts on using evidence to guide 
decentralized planning of the health sector are important to help districts plan better 
for additional resources once they become available.  In February 2006, the TEHIP 
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District Health Accounts and Burden Profiles have been incorporated into national 
planning software for districts and rolled out to more than 120 districts of mainland 
Tanzania using a planning and reporting tool (PlanRep) designed by the Ministry of 
Finance and the President’s Office, Regional Administration and Local Government 
(http://www.poralg.go.tz/mis/planrep.php).  This should now make it easier to 
accelerate the prioritization of the most effective health interventions including IMCI 
in all districts of the country. 
 
Tanzania is in the expansion phase of mainly the first two components of the 
strategy within implementing districts, to new districts and in pre-service training 
institutions. Expansion of IMCI to other districts has been possible because of a 
number of enabling factors including the government’s commitment to reducing the 
overwhelming burden of morbidity and mortality among children younger than five 
years. IMCI is now an integral part of the national package of essential intervention. 
Basket Funds from the Sector Wide Approach (SWAP) partners are now available to 
the districts and they are at liberty to tap them for IMCI implementation. Over time, 
more partners have joined to support the MoH in implementing the strategy. These 
include the first five key partners WHO, UNICEF, TEHIP and the Word Bank. Others 
now on board include NGOs, bilateral organization and foreign agencies. 
 
The third component i.e. community IMCI is being implemented in seven pilot 
districts. Lessons from the implementation are expected to be expanded to 
remaining districts. So far, two NGOs are involved in the implementation of 
community IMCI. It is widely acknowledged that government reforms on increased 
community participation in health service delivery through local governments and 
HSR will be particularly helpful for the community component. 
 
Sustaining the positive changes and scaling up of IMCI implementation are crucial in 
ensuring continued reduction in morbidity and mortality among children. A number of 
measures have been taken to ensure best practices are sustained and scaled up. 
These include IMCI is now an integral part of the district plans 
 
A concern about the stability of vitamin A capsules in our study merits careful 
consideration especially during the mass vitamin A supplementation campaigns 
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events that have been in effect since 2001. Undoubtedly, vitamin A has been 
rigorously evaluated in different settings and proved to reduce mortality in children 
between 6 months and five years of age. However, stringent and frequent quality 
control measures on the potency of the capsules need to be done by the relevant 
authorities if the benefits vitamin A supplementation confers are exploited to the 
maximum. The urgency to reduce child death needs to be balanced with sound 
evidence from studies conducted in difference settings. Our findings did not support 
the current recommendations by the International Vitamin A Consultative Group 
(IVACG) on the high dose regimen and this raises important questions on adopting 
such recommendations into national policies without sufficient clinical evidence to 
support them. 
 
Future work 
There is huge as yet untapped potential in Tanzania’s Demographic Surveillance 
System.  The sites still need to be joined into a national sentinel system.  Information 
on land use and land cover will form an important part in further understanding 
spatial access to equitable health care in rural settings in Tanzania.  The wealth of 
data that has already been collected from the DSS has the potential to allow further 
analyses such as coverage of health services, equity effectiveness and to assess 
household mobility between wealth quintiles over time, as well as the performance of 
the health system under new strategies of poverty reduction and scaled up health 
interventions.  
 
Conclusion 
Some key lessons from this work are:  
 Knowledge of causes of death can lead to more rational choices of 
interventions and delivery strategies that have the greatest impact on child 
survival 
 Strengthening of the health information system to include real time, population 
based burden of disease information from sentinel populations vital for 
tracking progress and trends in child survival. 
 Change in delivery strategy has a potential to quickly increase coverage of 
interventions, however, care needs to be exercised that the strategy does not 
undermine other essential health programmes. 
Chapter 10: Discussion and Conclusions 
 - 204 - 
 Evidence of improvements in child health and survival linked to IMCI at no 
extra cost supports a policy of more investments and expansion in the IMCI 
strategy. 
 The marginal cost of incorporating equity assessments of access and health 
outcomes in impact evaluation is low. 
 The use of empirical evidence as the basis for informing policy rather than just 
theoretical calculations and extrapolations from out-of-date data, retrospective 
surveys or models needs to be given more prominence 
 
We have used a set of studies employing different methodological approaches that 
show that mortality reduction in children younger than five is feasible in a low GDP 
setting with interventions that are available today. The national challenge is scaling 
up these interventions to reach more than 223,000 children who die annually from 
preventable conditions including, malaria, pneumonia, diarrhoea, measles and 
malnutrition in Tanzania and approximately 6 million worldwide. The global challenge 
is scaling up these interventions to reach more than 6 million children who die 
annually from preventable conditions including, malaria, pneumonia, diarrhoea, 
measles and malnutrition in just 42 countries accounting for 90% of child deaths 
worldwide. 
 
Key messages 
 
1. In the absence of complete vital registration, data collected from carefully 
selected sentinel sites can assist in understanding the magnitude of burden of 
disease and poverty conditions that is necessary to inform national health 
policies, allocation of resources, equity of the system, monitoring and 
evaluation, and trends in progress toward national and international goals. 
2. Evaluation of the impact of large-scale public health interventions 
programmes needs to go beyond classical randomized controlled designs and 
requires ample time to demonstrate measurable impact results in real health 
systems. 
3. Strong health systems are necessary for both implementing and evaluating 
national health policies and their effect on health status. More focused 
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investments in strengthening health systems is likely to improve health and 
meet the time-bound goals to which we have committed ourselves. 
 
References 
Acharya, L. B. & Cleland, J. 2000, "Maternal and child health services in rural Nepal: 
does access or quality matter more?", Health Policy and Planning, vol. 15, no. 2, pp. 
223-229. 
Adam, T., Manzi, F., Armstrong Schellenberg, J., Mgalula, L., de Savigny, D., & 
Evans, D. Does the Integrated Management of Childhood Illnesses cost more than 
routine care?  Results from Tanzania. Lancet Submitted. 2004.  
Ref Type: Journal (Full) 
Amaral, J., Gouws, E., Bryce, J., Leite, A. J., Cunha, A. L., & Victora, C. G. 2004, 
"Effect of Integrated Management of Childhood Illness (IMCI) on health worker 
performance in Northeast-Brazil", Cad.Saude Publica, vol. 20 Suppl 2, p. S209-
S219. 
Amaral, J., Leite, A. J., Cunha, A. J., & Victora, C. G. 2005, "Impact of IMCI health 
worker training on routinely collected child health indicators in Northeast Brazil", 
Health Policy and Planning, vol. 20 Suppl 1, p. i42-i48. 
Armstrong Schellenberg, J., Victora, C. G., Mushi, A., de Savigny, D., Schellenberg, 
D., Mshinda, H., & Bryce, J. 2003, "Inequities among the very poor: health care for 
children in rural southern Tanzania", Lancet, vol. 361, no. 9357, pp. 561-566. 
Bryce, J., Boschi-Pinto, C., Shibuya, K., & Black, R. E. 2005, "WHO estimates of the 
causes of death in children", Lancet, vol. 365, no. 9465, pp. 1147-1152. 
Bryce, J., Victora, C. G., Habicht, J. P., Vaughan, J. P., & Black, R. E. 2004, "The 
multi-country evaluation of the integrated management of childhood illness strategy: 
Lessons for the evaluation of public health interventions", American Journal of Public 
Health, vol. 94, no. 3, pp. 406-415. 
Byass, P., Fottrell, E., Dao, L. H., Berhane, Y., Corrah, T., Kahn, K., Muhe, L., & Do, 
D. V. 2006, "Refining a probabilistic model for interpreting verbal autopsy data", 
Scand.J.Public Health, vol. 34, no. 1, pp. 26-31. 
Chandramohan, D., Setel, P., & Quigley, M. 2001, "Effect of misclassification of 
causes of death in verbal autopsy: can it be adjusted?", Int.J.Epidemiol., vol. 30, no. 
3, pp. 509-514. 
Choi, Y., Bishai, D., & Hill, K. 2005, "Socioeconomic differentials in supplementation 
of vitamin A: evidence from the Philippines", J.Health Popul.Nutr., vol. 23, no. 2, pp. 
156-164. 
de Savigny, D., Kasale, H., Mbuya, C., & Graham, R. 2004, In Focus:Fixing health 
systems. Ottawa: International Development Research Centre. 
Chapter 10: Discussion and Conclusions 
 - 206 - 
Egunjobi, L. 1983, "Factors influencing choice of hospitals: a case study of the 
northern part of Oyo State, Nigeria", Social Science and Medicine, vol. 17, no. 9, pp. 
585-589. 
el Arifeen, S., Blum, L. S., Hoque, D. M., Chowdhury, E. K., Khan, R., Black, R. E., 
Victora, C. G., & Bryce, J. 2004, "Integrated Management of Childhood Illness (IMCI) 
in Bangladesh: early findings from a cluster-randomised study", Lancet, vol. 364, no. 
9445, pp. 1595-1602. 
Fantahun, M., Fottrell, E., Berhane, Y., Wall, S., Hogberg, U., & Byass, P. 2006, 
"Assessing a new approach to verbal autopsy interpretation in a rural Ethiopian 
community: the InterVA model", Bull.World Health Organ, vol. 84, no. 3, pp. 204-210. 
Fawzi, W. W. 2006, "The benefits and concerns related to vitamin a 
supplementation", J.Infect.Dis., vol. 193, no. 6, pp. 756-759. 
Gouws, E., Bryce, J., Habicht, J. P., Amaral, J., Pariyo, G., Schellenberg, J. A., & 
Fontaine, O. 2004, "Improving antimicrobial use among health workers in first-level 
facilities: results from the multi-country evaluation of the Integrated Management of 
Childhood Illness strategy", Bull.World Health Organ, vol. 82, no. 7, pp. 509-515. 
Gwatkin, D. R., Rustein, S., Johnson, K., Pande, R., & Wagstaff, A. 2000, Tanzania: 
Socio-economic differences in health, nutrition, and population., World Bank's Health 
and Population Advisory Service, Washington D.C.. 
Habicht, J. P., Victora, C. G., & Vaughan, J. P. 1999, "Evaluation designs for 
adequacy, plausibility and probability of public health programme performance and 
impact", International Journal of Epidemiology, vol. 28, no. 1, pp. 10-18. 
Huicho, L., Davila, M., Campos, M., Drasbek, C., Bryce, J., & Victora, C. G. 2005a, 
"Scaling up integrated management of childhood illness to the national level: 
achievements and challenges in Peru", Health Policy and Planning, vol. 20, no. 1, 
pp. 14-24. 
Huicho, L., Davila, M., Gonzales, F., Drasbek, C., Bryce, J., & Victora, C. G. 2005b, 
"Implementation of the Integrated Management of Childhood Illness strategy in Peru 
and its association with health indicators: an ecological analysis", Health Policy and 
Planning, vol. 20 Suppl 1, p. i32-i41. 
Humphrey, J. H., Agoestina, T., Wu, L., Usman, A., Nurachim, M., Subardja, D., 
Hidayat, S., Tielsch, J., West, K. P., Jr., & Sommer, A. 1996, "Impact of neonatal 
vitamin A supplementation on infant morbidity and mortality", J.Pediatr., vol. 128, no. 
4, pp. 489-496. 
Humphrey, J. H. & Rice, A. L. 2000, "Vitamin A supplementation of young infants", 
Lancet, vol. 356, no. 9227, pp. 422-424. 
King, G. & Lu, Y. 2006, Verbal Autopsy Methods with Multiple Causes, Harvard 
University,2006 (http://gking.harvard.edu/files/abs/vamc-abs.html). 
Chapter 10: Discussion and Conclusions 
 - 207 - 
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. 2006, 
"Global and regional burden of disease and risk factors, 2001: systematic analysis of 
population health data", Lancet, vol. 367, no. 9524, pp. 1747-1757. 
Masanja, H., Schellenberg, J. A., de Savigny, D., Mshinda, H., & Victora, C. G. 2005, 
"Impact of Integrated Management of Childhood Illness on inequalities in child health 
in rural Tanzania", Health Policy and Planning, vol. 20 Suppl 1, p. i77-i84. 
Murray, C. J. L. & Lopez, A. D. 1996, The Globa Burden of Disease: A 
comprehensive assessment of mortality and disability from diseases, injuries and 
risk factors in 1990 and projected to 2020. Volume I. 
Ndiritu, M., Cowgill, K. D., Ismail, A., Chiphatsi, S., Kamau, T., Fegan, G., Feikin, D. 
R., Newton, C. R., & Scott, J. A. 2006, "Immunization coverage and risk factors for 
failure to immunize within the Expanded Programme on Immunization in Kenya after 
introduction of new Haemophilus influenzae type b and hepatitis b virus antigens", 
BMC.Public Health, vol. 6, p. 132. 
Noor, A. M., Amin, A. A., Gething, P. W., Atkinson, P. M., Hay, S. I., & Snow, R. W. 
2006, "Modelling distances travelled to government health services in Kenya", 
Trop.Med.Int.Health, vol. 11, no. 2, pp. 188-196. 
Rahmathullah, L., Tielsch, J. M., Thulasiraj, R. D., Katz, J., Coles, C., Devi, S., John, 
R., Prakash, K., Sadanand, A. V., Edwin, N., & Kamaraj, C. 2003, "Impact of 
supplementing newborn infants with vitamin A on early infant mortality: community 
based randomised trial in southern India", BMJ, vol. 327, no. 7409, p. 254. 
Ramakrishnan, R., Rao, T. V., Sundaramoorthy, L., & Joshua, V. 1999, "Magnitude 
of recall bias in the estimation of immunization coverage and its determinants", 
Indian Pediatr., vol. 36, no. 9, pp. 881-885. 
Setel, P. W., Whiting, D. R., Hemed, Y., Chandramohan, D., Wolfson, L. J., Alberti, 
K. G., & Lopez, A. D. 2006, "Validity of verbal autopsy procedures for determining 
cause of death in Tanzania", Trop.Med.Int.Health, vol. 11, no. 5, pp. 681-696. 
Sommer, A. & West, K. P., Jr. 1996, Vitamin A Deficiency:Health, Survival and 
Vision Oxford University Press. 
Stock, R. 1983, "Distance and the utilization of health facilities in rural Nigeria", 
Social Science and Medicine, vol. 17, no. 9, pp. 563-570. 
Tanser, F. C., Gijsbertsen, B., & Herbst, K. 2006, "Modelling and understanding 
primary health care accessibility and utilization in rural South Africa: An exploration 
using a geographical information system", Social Science and Medicine. 
Todd, J. E., de Francisco, A., O'Dempsey, T. J., & Greenwood, B. M. 1994, "The 
limitations of verbal autopsy in a malaria-endemic region", Ann.Trop.Paediatr., vol. 
14, no. 1, pp. 31-36. 
WHO/CHD Immunisation-Linked Vitamin A Supplementation Study Group 1998, 
"Randomised trial to assess benefits and safety of vitamin A supplementation linked 
to immunization in early infancy.", Lancet, vol. 352, no. 9136, pp. 1257-1263. 
Chapter 10: Discussion and Conclusions 
 - 208 - 
 
